Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.7404222689561344,-2.1699556598834313,0.0,0.003507721018103066,0.003,11/19,16.29%,GRM7;GRM1;GRID2;GRIK4;GRM8;GRIA2;GRM3;GRIA1;GRIN2D;GRIK2;GRM5
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6379262309630567,-2.045887177936089,0.0,0.019292465599566863,0.027,15/29,22.19%,GRID2;GRIK4;GABRA2;GABRB1;GLRA3;GABRG3;GRIA2;GABRA5;GABRB2;GRIN2D;GRIK2;CHRNB1;GLRA2;GABRG1;GABRE
prerank,chemokine activity (GO:0008009),0.8030871698649931,2.0064140308992955,0.0,0.005659250497213862,0.006,8/31,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCL5;CXCL10
prerank,chemokine receptor binding (GO:0042379),0.7811496731707108,2.003432571834031,0.0,0.004244437872910397,0.008,8/35,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCL5;CXCL10
prerank,platelet-derived growth factor binding (GO:0048407),0.9571706277359042,1.9873112196319038,0.0,0.004401639275610782,0.013,7/11,2.67%,COL4A1;COL1A2;COL1A1;COL3A1;PDGFRA;COL5A1;PDGFRB
prerank,serine-type endopeptidase activity (GO:0004252),0.6823936602245717,1.9536344677613522,0.0,0.007781469433669061,0.03,8/80,6.23%,FAP;HP;HPR;MMP2;MASP1;PRTN3;KLK2;PLAT
prerank,metalloendopeptidase activity (GO:0004222),0.6586396196637423,1.8663994302548303,0.0,0.03886018674753519,0.163,24/76,12.76%,MMP3;MMP13;MMP27;MMP2;MMP14;ADAM19;ADAMTS2;MMP11;ADAMTS15;ADAMTS5;OMA1;ADAMTS4;ADAMTS14;ADAMTS12;ADAMTS1;ADAMTS9;ADAMTS18;PMPCB;MMP16;NLN;ADAMTS6;MMP15;ADAMTS7;SPG7
prerank,serine-type peptidase activity (GO:0008236),0.6395703379436417,1.8634273413602878,0.0,0.034112704385983565,0.173,9/96,6.23%,FAP;HP;HPR;MMP2;MASP1;PRTN3;KLK2;HTRA3;PLAT
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.568141970975513,-1.8236828153992386,0.0038461538461538464,0.20422731260955632,0.37,12/26,12.26%,ABCG2;SLC6A6;MPC1;SLC6A1;SLC6A12;SLC16A11;SLC5A6;SLC16A1;SLC27A1;SLC16A9;SLC16A4;MPC2
prerank,lipoprotein particle receptor binding (GO:0070325),0.7415511356666713,1.81248684262549,0.0,0.07572616141509979,0.365,5/27,3.78%,CLTC;LRP1;HSPG2;CRP;APOE
prerank,monocarboxylic acid binding (GO:0033293),0.8002167465986101,1.8089379794978844,0.0,0.06956162069492039,0.383,3/18,5.34%,NR1H4;NR2F2;PYGL
prerank,endopeptidase activity (GO:0004175),0.5900802667660209,1.8077912135350813,0.0,0.06424297323689071,0.394,47/257,10.17%,PSMA7;MMP3;MMP13;FAP;MMP27;CASP4;HP;HPR;MMP2;MMP14;ADAM19;ADAMTS2;MASP1;PRTN3;PDIA3;CASP1;MMP11;USP9X;KLK2;CTSS;ADAMTS15;ADAMTS5;OMA1;SFRP1;HTRA3;PLAT;ADAMTS4;CTSK;ADAMTS14;CTSL;ADAMTS12;ADAMTS1;TPP2;ADAMTS9;USP42;ADAMTS18;PMPCB;USP24;PSMB8;MMP16;HTRA4;PSMA6;NLN;USP12;CTSB;USP40;USP38
prerank,CXCR chemokine receptor binding (GO:0045236),0.8711823259770692,1.801874315223898,0.0015220700152207,0.06357224725203572,0.42,5/11,6.48%,CXCL5;CXCL1;CXCL12;CXCL10;YARS1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.8190442045565549,1.7842988515394471,0.003115264797507788,0.07828629854479177,0.523,3/13,3.47%,SLC7A2;SLC38A3;SLC7A7
prerank,semaphorin receptor binding (GO:0030215),-0.5685597582422558,-1.7791267859242712,0.0,0.24378661075816307,0.51,17/23,29.80%,SEMA6A;SEMA3C;SEMA3D;RIT2;SEMA6D;SEMA7A;SEMA4D;SEMA5A;SEMA5B;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F
prerank,cytokine activity (GO:0005125),0.5931846888823313,1.7653103338259781,0.0,0.09557845284183412,0.627,26/131,12.48%,CCL11;CXCL5;CCL7;IL34;ADIPOQ;WNT2;CXCL1;CXCL12;TNFSF11;IL16;TIMP1;XCL1;WNT9A;TSLP;CCL5;TGFB3;CXCL10;INHBB;AIMP1;WNT5A;IL7;BMP5;CCL2;TGFB2;TNF;FGF2
prerank,triglyceride lipase activity (GO:0004806),0.7398018102513445,1.7579865015025944,0.0040650406504065045,0.09802112079148628,0.666,2/20,1.54%,CEL;LIPC
prerank,CCR chemokine receptor binding (GO:0048020),0.6941602391680892,1.7432869974245149,0.004026845637583893,0.11433033444966577,0.73,4/28,5.67%,CCL11;CCL7;XCL1;CCL5
prerank,cholesterol transfer activity (GO:0120020),0.7818983873587821,1.7346594774638138,0.0014347202295552368,0.11928442436905219,0.765,6/16,11.03%,ABCA1;PLTP;ABCG1;GRAMD1A;NPC2;GRAMD1C
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5916535738117057,-1.7339156658752863,0.013377926421404682,0.3107840822039316,0.692,9/19,22.19%,GRID2;GRIK4;GABRA2;GABRG3;GABRA5;GRIK2;CHRNB1;GABRG1;GABRE
prerank,metallopeptidase activity (GO:0008237),0.5841244439655753,1.727081165513534,0.0,0.12438560988667968,0.806,30/113,12.76%,MMP3;MMP13;MMP27;MMP2;MMP14;ADAM19;ADAMTS2;ADAM12;MMP11;ANPEP;BMP1;ADAMTS15;ADAMTS5;OMA1;ADAMTS4;ADAMTS14;EIF3H;ADAMTS12;ADAMTS1;ADAMTS9;ADAMTS18;PMPCB;MMP16;NLN;PAPPA2;ADAM21;ADAMTS6;MMP15;ADAMTS7;SPG7
prerank,GABA receptor activity (GO:0016917),-0.5848652222358982,-1.722992726528878,0.011111111111111112,0.28626900975518915,0.722,6/21,8.10%,GABRA2;GABRB1;GABRG3;GABRA5;GPR156;GABRB2
prerank,PDZ domain binding (GO:0030165),-0.42905724805718404,-1.7059272757637336,0.0,0.28362429946376216,0.78,21/61,8.95%,CRIM1;GRID2;TGFBR3;ARHGAP29;CADM1;PRKN;CIT;CXADR;KIDINS220;RAPGEF2;ATP2B4;ATP2B2;DOCK4;USHBP1;PLEKHA1;GRIA1;FZD4;CLCN3;NSF;SLC22A4;CRIPT
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.7184086920325687,1.7028755284558181,0.006747638326585695,0.1627311932189045,0.902,4/22,3.78%,CLTC;HSPG2;CRP;APOE
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7896604001671387,1.6603036938035827,0.012403100775193798,0.2573386962205304,0.976,2/11,7.31%,ROR2;SASH1
prerank,GABA-A receptor activity (GO:0004890),-0.5846431203806084,-1.656859190449868,0.023809523809523808,0.3814646607187084,0.898,5/18,8.10%,GABRA2;GABRB1;GABRG3;GABRA5;GABRB2
prerank,poly(U) RNA binding (GO:0008266),0.700555765461794,1.6563873819892192,0.02086230876216968,0.25491448511572967,0.98,5/20,7.97%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,chloride transmembrane transporter activity (GO:0015108),-0.6006552879012144,-1.6550162623903009,0.0064516129032258064,0.34440623774041584,0.902,8/16,25.77%,SLC26A7;SLC26A2;SLC1A1;CLCN7;SLC4A8;SLC26A6;CFTR;SLC26A8
prerank,sterol transfer activity (GO:0120015),0.735719141082794,1.6530666908969591,0.014245014245014245,0.25160084502196634,0.983,6/17,11.03%,ABCA1;PLTP;ABCG1;GRAMD1A;NPC2;GRAMD1C
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.4934138291124939,-1.6522818616878332,0.024793388429752067,0.31873491651163194,0.907,9/28,22.19%,GRID2;GRIK4;GABRA2;GABRG3;GABRA5;GRIK2;CHRNB1;GABRG1;GABRE
prerank,metalloaminopeptidase activity (GO:0070006),0.7380857234460111,1.6501836777661416,0.021834061135371178,0.24860278969903754,0.985,9/16,14.50%,MMP14;ANPEP;XPNPEP1;NPEPPS;MMP16;ENPEP;MMP15;LVRN;XPNPEP3
prerank,steroid hydroxylase activity (GO:0008395),0.7420239176711149,1.649599379750807,0.01875901875901876,0.23893184106797616,0.985,5/16,12.52%,CYP1B1;CYP7B1;CYP2A6;CYP1A1;CYP2R1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.6026681605282636,-1.64868483681642,0.023323615160349854,0.29826258111506676,0.914,8/15,25.77%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC4A3;SLC26A6;CFTR;SLC26A8
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.7402637370972208,1.6440640569293534,0.015015015015015015,0.24273263545658594,0.989,7/15,16.09%,SH3PXD2B;SESTD1;PLEKHF1;PLA2G4A;PLEKHA5;PLA2G4E;RUBCNL
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.7792616273264823,1.6375872725410068,0.031007751937984496,0.24912492292943528,0.991,4/11,4.67%,CASP4;CFLAR;CASP1;CASP12
prerank,ligand-gated ion channel activity (GO:0015276),-0.49280403940253015,-1.632866531289406,0.004166666666666667,0.31023843671222673,0.935,10/30,16.55%,GRID2;GRIK4;GABRB1;GRIN3A;GRIA2;GRIA1;GRIN2D;GRIN2B;GRIK2;CHRNB1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.7918417129526496,1.6320040482404485,0.029921259842519685,0.2541758039981986,0.995,4/10,4.67%,CASP4;CFLAR;CASP1;CASP12
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5875325196909995,-1.6240791698005046,0.015105740181268883,0.3060711442206342,0.947,9/15,15.69%,HS3ST3A1;HS3ST1;HS6ST2;HS6ST3;NDST3;NDST1;HS6ST1;HS3ST2;HS3ST3B1
prerank,E-box binding (GO:0070888),0.6335176067799847,1.6215550229983613,0.0076726342710997444,0.27258723228246773,0.998,8/34,7.46%,ZEB1;TCF4;SNAI1;SNAI2;MITF;PPARG;AHR;BHLHE40
prerank,cytokine receptor binding (GO:0005126),0.5660482612086615,1.6204153936757106,0.0065717415115005475,0.2652162331780719,0.998,22/83,15.47%,IL34;IL23R;OSMR;CXCL12;TNFSF11;JAK1;JAK2;XCL1;SPRED1;SMAD2;TSLP;SPRED2;CCL5;PXDN;LIFR;TGFB2;TGFBRAP1;VEGFC;SMAD3;IL22;IL6R;TIMM50
prerank,ligand-gated channel activity (GO:0022834),-0.49644459354302894,-1.6165472480327707,0.01276595744680851,0.30191455905815673,0.954,10/29,16.55%,GRID2;GRIK4;GABRB1;GRIN3A;GRIA2;GRIA1;GRIN2D;GRIN2B;GRIK2;CHRNB1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.7971186549644117,1.612975198321424,0.012718600953895072,0.2759895197837689,0.999,4/10,5.37%,APOBEC1;LACC1;CDADC1;GDA
prerank,aminopeptidase activity (GO:0004177),0.6452405804608305,1.6026188341148981,0.02257636122177955,0.2948664655617292,1.0,10/26,14.50%,MMP14;XPNPEP2;ANPEP;XPNPEP1;NPEPPS;MMP16;ENPEP;MMP15;LVRN;XPNPEP3
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6490128737616958,-1.599553120667694,0.028735632183908046,0.3216190426820722,0.971,5/12,8.10%,GABRA2;GABRB1;GABRG3;GABRA5;GABRB2
prerank,protease binding (GO:0002020),0.5488427932439499,1.5907660520552271,0.0021645021645021645,0.3187415641153008,1.0,17/99,8.75%,FAP;COL1A2;COL1A1;COL3A1;CLTC;CCBE1;SLC2A13;TIMP1;TNFAIP3;CFLAR;PTEN;BCL2;ADAMTS4;BAG6;PZP;ITGA3;RAD23A
prerank,chloride channel activity (GO:0005254),-0.41364447710280605,-1.582370918813535,0.007518796992481203,0.34185664422262796,0.981,24/59,25.77%,SLC26A7;GABRA2;GABRB1;GLRA3;GABRG3;GABRA5;CLCN2;GLRA1;CLCN3;GABRB2;ANO3;CLCC1;CLCN7;CLIC4;ANO4;TTYH2;ANO1;GLRA2;FXYD1;GABRG1;GABRE;ANO2;CFTR;SLC26A8
prerank,MHC class II protein complex binding (GO:0023026),-0.6337368928956706,-1.580816881878713,0.016042780748663103,0.32656194890104623,0.982,4/11,3.44%,ATP1B1;CD81;ANXA11;HSP90AA1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5710164169467613,-1.5622326416769083,0.0438871473354232,0.35583880994756656,0.991,8/15,16.35%,COX5A;COX8A;COX4I1;COX6B1;COX6A1;COX10;CYB5A;COX5B
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.655419804198221,1.560500226460997,0.030707610146862484,0.40932202655386074,1.0,6/22,8.81%,RBMS3;ZFP36L1;ZFP36L2;ILF3;CPEB1;EXOSC4
prerank,calcium-release channel activity (GO:0015278),0.6880237241028406,1.5420489602644611,0.03473227206946455,0.4649427986617264,1.0,6/17,12.14%,MCOLN2;RASA3;ITPR1;PKD2;FKBP1B;TPCN2
prerank,anion channel activity (GO:0005253),-0.40771677512030446,-1.539844128103048,0.008928571428571428,0.39354168264507206,0.996,16/61,9.33%,SLC26A7;LRRC8D;GABRA2;GABRB1;GLRA3;GABRG3;GPR89B;GPR89A;GABRA5;GLRA1;CLCN3;VDAC1;GABRB2;ANO3;CLCC1;CLCN7
prerank,poly-pyrimidine tract binding (GO:0008187),0.6315339097376831,1.529282664542837,0.043010752688172046,0.5025300113233037,1.0,5/23,7.97%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,neurexin family protein binding (GO:0042043),0.7484735005629876,1.5160021228516893,0.0430622009569378,0.5430383749164773,1.0,1/10,0.08%,CEL
prerank,peptidoglycan binding (GO:0042834),0.7340490819573366,1.5151580515225889,0.05843071786310518,0.5311071847575752,1.0,3/10,5.65%,TLR2;NOD1;RNASE7
prerank,growth factor receptor binding (GO:0070851),0.5166497882037425,1.513247586692404,0.016268980477223426,0.5251312857206364,1.0,25/95,16.56%,GLMN;IL23R;PDGFRA;IL1R1;PDGFRB;FGF7;JAK2;ATXN2;TSLP;EGF;GRB2;FRS2;PTPRJ;ARF4;SNX2;VEGFC;FGF2;BTC;ITGA5;PSEN1;SRC;IL6R;TIMM50;FGF18;SNX4
prerank,active ion transmembrane transporter activity (GO:0022853),-0.43313850086784456,-1.507067995189862,0.04477611940298507,0.46290225035566795,0.999,14/37,16.35%,SLC22A8;SLCO1C1;COX5A;COX8A;SLC22A6;SLCO3A1;COX4I1;SLCO2A1;SLC22A4;COX6B1;COX6A1;COX10;CYB5A;COX5B
prerank,cytokine receptor activity (GO:0004896),0.5250783752951675,1.4939633110838118,0.018579234972677595,0.5915701217943464,1.0,9/83,7.36%,IL23R;IL1RL2;OSMR;GHR;CMKLR1;IL1R1;CCR1;IL3RA;IFNAR2
prerank,sterol binding (GO:0032934),0.5451797292221728,1.4922515245647971,0.03210463733650416,0.5835977968881243,1.0,13/56,11.03%,RORA;ABCA1;APOD;INSIG2;ABCG1;OSBPL11;VDAC2;SOAT1;GRAMD1A;OSBPL3;NPC2;OSBPL5;GRAMD1C
prerank,retinoic acid receptor binding (GO:0042974),0.6547386619826133,1.4898228738727703,0.056439942112879886,0.5792750765353266,1.0,5/17,5.97%,NRIP1;ASXL1;TACC1;ARID5A;PPARG
prerank,CARD domain binding (GO:0050700),0.6706820769248973,1.4891107798111063,0.07886904761904762,0.5675049238185252,1.0,3/14,5.14%,CASP4;CASP1;NOD1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6016544503415153,-1.4870729997364422,0.07449856733524356,0.5025506334825123,0.999,6/11,30.28%,KCND3;KCNJ3;KCNQ1;KCNE4;KCNJ8;KCNH2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5650742004320922,1.4819641907447354,0.055288461538461536,0.5829718164629939,1.0,6/38,8.82%,SERPING1;TFPI2;SERPINE2;SERPINH1;SERPINF1;SERPINA2
prerank,anion transmembrane transporter activity (GO:0008509),-0.5884602532948311,-1.4803663547006405,0.07692307692307693,0.49878729931662535,1.0,3/12,5.49%,ABCG2;SLC22A6;SLC39A8
prerank,ligand-gated anion channel activity (GO:0099095),-0.5274681836470194,-1.4776792906465928,0.07098765432098765,0.48482804854563677,1.0,7/17,8.10%,GABRA2;GABRB1;GLRA3;GABRG3;GABRA5;GLRA1;GABRB2
prerank,phosphatase inhibitor activity (GO:0019212),0.639271915499199,1.4759396366286945,0.06995884773662552,0.5955687428020303,1.0,3/20,1.92%,MGAT5;PPP1R9B;PTN
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5247525472950285,-1.4754847562842304,0.06761565836298933,0.4709602650278103,1.0,7/17,15.65%,GRIK4;GRIN3A;GRIA2;GRIA1;GRIN2D;GRIN2B;GRIK2
prerank,AMP binding (GO:0016208),-0.5982819210703106,-1.4739021068112301,0.058355437665782495,0.4562843500348468,1.0,2/11,0.10%,PRKAG2;MPPED2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5609321155801947,-1.4709206108113981,0.0658682634730539,0.4467397512030238,1.0,3/13,3.01%,BMP6;BMP4;CDH5
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6621771105299322,1.4700623640846553,0.06676557863501484,0.6072507393987154,1.0,2/15,4.31%,CMKLR1;CCR1
prerank,chloride channel inhibitor activity (GO:0019869),-0.5902938175148503,-1.4700606134975573,0.07865168539325842,0.43296536714807965,1.0,5/10,24.46%,WNK4;WNK3;VAMP8;WNK2;CFTR
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6567439131598434,1.4639133324352824,0.08022922636103152,0.6200523508784507,1.0,5/15,12.81%,KMT2A;CXXC1;RBBP5;SETMAR;KMT2B
prerank,cysteine-type endopeptidase activity (GO:0004197),0.5116164936894153,1.457749784771408,0.03455964325529543,0.633060528767964,1.0,22/78,13.18%,CASP4;PDIA3;CFLAR;CASP1;USP9X;CASP12;CTSS;SFRP1;CAPN5;CTSK;CTSL;CAPN2;CAPN15;USP42;USP24;USP12;CTSB;USP40;USP38;CASP8;CTSC;CTSW
prerank,frizzled binding (GO:0005109),0.5677117821192987,1.4515128660298608,0.06717363751584284,0.646979459922424,1.0,6/34,9.14%,WNT2;WNT9A;FZD1;SFRP1;LRP6;WNT5A
prerank,mRNA 5'-UTR binding (GO:0048027),0.5927246397996098,1.4504775141020794,0.07670454545454546,0.6379901863720777,1.0,3/24,2.23%,IGF2BP1;IGF2BP2;SYNCRIP
prerank,phospholipid transfer activity (GO:0120014),-0.4841728004310182,-1.4464655791687286,0.05985915492957746,0.4808083309814131,1.0,6/21,9.97%,PITPNC1;CERT1;PITPNM2;PITPNA;ABCA3;TNFAIP8L3
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.4504198469967975,-1.4437539143165017,0.048582995951417005,0.4712038567651785,1.0,10/25,12.16%,NOS3;MICAL3;FMO2;CYP26B1;FMO5;MSMO1;FMO1;CYP27A1;MICAL1;SQLE
prerank,alpha-actinin binding (GO:0051393),0.5875755925490985,1.440996073765745,0.09264305177111716,0.6643724281625025,1.0,6/24,8.37%,PALLD;CACNA1C;KCNA5;PKD2;PPARG;PDLIM4
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3976880878621774,-1.439259361821873,0.032432432432432434,0.46734536364526513,1.0,14/42,12.02%,LRRC4C;STXBP6;BSG;NTNG1;CNTN4;CD47;ESAM;TMOD3;BAIAP2L1;DSCAML1;CD200;PDLIM5;NEXN;ROBO4
prerank,lipase activity (GO:0016298),0.5322809336573898,1.4305937250444503,0.06028368794326241,0.6970695178762096,1.0,3/43,1.54%,CEL;PLA1A;LIPC
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5815143738919821,1.4277552282620822,0.08224543080939947,0.6952011952460749,1.0,11/28,16.63%,TNFSF11;STAT1;CASP8AP2;SIVA1;BABAM2;EDA;TRAP1;TNF;TRAF2;RIPK1;TRAF5
prerank,actinin binding (GO:0042805),0.5966097737128763,1.4240499106137576,0.0890125173852573,0.6979927222723803,1.0,6/21,8.37%,CSRP1;CACNA1C;KCNA5;PKD2;PPARG;PDLIM4
prerank,cell adhesion mediator activity (GO:0098631),-0.4533479370017375,-1.423573401562532,0.06934306569343066,0.49375888008588426,1.0,9/24,12.02%,LRRC4C;BSG;NTNG1;CNTN4;CD47;ESAM;DSCAML1;NEXN;ROBO4
prerank,ubiquitin-specific protease binding (GO:1990381),0.6218913501019481,1.4211678278233548,0.07670454545454546,0.6969221878331764,1.0,6/19,14.19%,CLTC;PTEN;BAG6;RAD23A;LCOR;RHBDD2
prerank,adenylate cyclase binding (GO:0008179),-0.5868131127868774,-1.4194615696747812,0.08645533141210375,0.4895828533496144,1.0,5/10,4.54%,ADCY5;AKAP6;CALM1;AKAP12;CAP1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.5924578319124165,1.4189500675389053,0.09054593874833555,0.693881059391096,1.0,6/26,13.24%,MGAT5;PPP1R9B;PTN;PABIR1;PPP1R2;PPME1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4659745875260284,1.4164507256075751,0.012345679012345678,0.6919481742195284,1.0,29/173,10.21%,CREB3L1;TRPS1;ZEB2;POU5F1;ZEB1;ETV6;DEAF1;SNAI1;TBX18;BCL6;BACH1;SNAI2;MITF;TBX2;PRDM5;PRDM2;FOXK2;PPARG;ENO1;E2F8;ZBTB12;BHLHE40;HEYL;ZBTB5;FOXO3;FOXP4;PRDM1;NR2F1;TBX3
prerank,neuropeptide receptor binding (GO:0071855),0.6585907411176785,1.4162590493381773,0.1069364161849711,0.6801561635454516,1.0,1/14,0.47%,QRFP
prerank,BMP receptor binding (GO:0070700),-0.5609339912143787,-1.4161400708134146,0.09171597633136094,0.4827545340571139,1.0,3/12,3.01%,BMP6;BMP4;CDH5
prerank,receptor antagonist activity (GO:0048019),0.613218120788765,1.4108264242151884,0.10656934306569343,0.6902096015634729,1.0,4/17,8.72%,CCL5;DKK2;WFIKKN1;PXDN
prerank,anion:anion antiporter activity (GO:0015301),-0.5039046902589339,-1.4102301434515936,0.08940397350993377,0.48385916396774653,1.0,4/17,10.82%,SLC26A7;SLC26A2;SLC25A4;SLC4A3
prerank,Toll-like receptor binding (GO:0035325),0.6753638953131649,1.4091728772505396,0.12463343108504399,0.6849513328396883,1.0,3/11,7.77%,TLR2;CD36;TIRAP
prerank,alkali metal ion binding (GO:0031420),-0.547827303561323,-1.4071849119073665,0.09302325581395349,0.4780188576003502,1.0,3/13,11.89%,ATP1A2;HDAC4;PDXK
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.6350901288368858,1.4046295746161015,0.10708898944193061,0.6926076973458001,1.0,5/14,18.95%,AKR1A1;RDH12;RDH10;ADH1A;DHRS3
prerank,protein tyrosine kinase activity (GO:0004713),0.4775216690965381,1.4019096044937065,0.02975557917109458,0.6917554470761047,1.0,18/108,8.07%,ROR2;ROR1;EPHA7;PDGFRA;TEC;JAK1;PEAK1;PDGFRB;JAK2;EGFR;EPHB3;BLK;DDR2;EPHA1;STYK1;HIPK4;MERTK;FRK
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6621204643002508,1.4012307125579573,0.10725075528700906,0.6832758968372238,1.0,5/12,13.29%,GAB2;IRS1;SH2B2;FRS2;PIK3R1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4588421252966434,1.3986093718175088,0.017258883248730966,0.6830220552279452,1.0,55/188,18.79%,RUNX1;CREB3L1;POU5F1;YAP1;TCF7L2;TBX18;SOX5;CREB3L3;GATA6;ARID5B;STAT3;RBBP5;ARID5A;PRDM5;TAF7;TCF12;FOXK2;PPARG;ZBTB48;ETV5;AHR;IRF1;CARM1;CREB3L2;AHRR;NONO;FOXO3;TBL1X;HMGB2;TCF7;LIN54;NFE2L2;ARID4B;TNF;ZBTB20;ELK1;SPI1;CTCF;SMAD3;EGR2;SMAD4;MAFK;GABPB1;BNC2;CALCOCO1;MZF1;ATF4;TAF2;GLI1;ETS1;PAX8;HDAC5;SOX2;HINFP;ARID4A
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5934743676573976,1.3979039825587152,0.09809264305177112,0.6750177521824632,1.0,9/23,15.97%,SH3PXD2B;WIPI1;SESTD1;MAPKAP1;GBF1;KIF16B;PLEKHA5;WDR45;PLA2G4E
prerank,nuclear receptor binding (GO:0016922),0.4734316580689531,1.3967029123322474,0.029411764705882353,0.6690940845793246,1.0,44/111,22.80%,NR1H4;NCOR2;TCF7L2;NRIP1;ASXL1;DNAAF4;STAT1;WIPI1;TACC1;PADI2;ARID5A;PPID;TAF7;STRN;GTF2H1;TGFB1I1;OASL;RERG;CALR;LCOR;MED13;SMAD3;HMGN3;MMS19;BAZ2A;HIF1A;STAT5B;NSD1;SMARCA4;THRAP3;ZBTB7A;BCAS3;KDM1A;MED12;MED1;TMF1;FOXP1;TADA3;RNF14;PKN1;LATS1;MED14;NCOR1;SMARCD3
prerank,I-SMAD binding (GO:0070411),0.6516375373486436,1.3950166939538624,0.10588235294117647,0.6650798344746541,1.0,8/13,15.51%,SMAD2;TGFBR1;SMAD5;TGFB1I1;SMAD3;SMAD4;SMAD1;SMURF1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6594941778717288,1.394652085914291,0.12048192771084337,0.6563134377909892,1.0,7/12,16.63%,TNFSF11;STAT1;BABAM2;TRAP1;TNF;TRAF2;TRAF5
prerank,transcription cis-regulatory region binding (GO:0000976),0.44650118270921063,1.392091349734021,0.003,0.6563444383473259,1.0,99/406,18.89%,RORA;RUNX1;NR1H4;CREB3L1;TRPS1;RUNX3;POU5F1;ETV6;YAP1;DEAF1;TCF7L2;SNAI1;TBX18;SOX5;GLI3;CREB3L3;SATB2;GATA6;SNAI2;NPAS4;ARID5B;SMAD2;STAT3;RBBP5;ZBTB10;ARID5A;E2F1;PRDM5;PRDM2;TAF7;TCF12;FOXK2;PPARG;ZBTB48;ETV5;ENO1;AHR;MLXIP;E2F8;ARNT;IRF1;CARM1;CREB3L2;SNAPC3;AHRR;HDAC1;ZBTB5;NONO;FOXO3;TBL1X;HMGB2;TCF7;TEAD1;FOXN2;KLF10;BBX;NFE2L2;SP3;ARID4B;E2F3;TNF;ZBTB20;ELK1;SPI1;CTCF;SMAD3;EGR2;DRAP1;TFAP2C;TAF4;SMAD4;MAFK;GABPB1;SETX;BNC2;CREB3;HIF1A;MAX;NFXL1;TCF3;SREBF1;POLRMT;CALCOCO1;MZF1;ZNF25;ATF4;TAF2;GLI1;ETS1;ZNF3;LHX6;PAX8;ZBTB9;HDAC5;NR2C2;SOX2;HINFP;ARID4A;NR3C1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.536208931625061,1.391876073683754,0.08700980392156862,0.6474069946912216,1.0,13/34,17.84%,MYO1B;MYO10;GAB2;CYTH3;DAPP1;MAPKAP1;GBF1;OGT;KIF16B;PLA2G4E;ARHGAP9;AKT1;ZFYVE16
prerank,SH2 domain binding (GO:0042169),0.5508292468277646,1.3910357238372353,0.0992063492063492,0.6412152744735354,1.0,8/31,11.01%,DLC1;SH3PXD2B;IRS1;JAK2;KHDRBS1;SH2B2;LAT2;PTK2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.5623637460750535,-1.3865266400606098,0.11420612813370473,0.5176162024584126,1.0,3/10,5.86%,CD47;CXADR;CD200
prerank,low-density lipoprotein particle binding (GO:0030169),0.6312297846384478,1.3856936578105594,0.11499272197962154,0.6521944455859193,1.0,6/16,5.55%,LIPC;COLEC12;CRP;TREM2;PLTP;CD36
prerank,lipase activator activity (GO:0060229),0.6693747581039291,1.3856651905764905,0.12908496732026145,0.6431064469786267,1.0,4/10,14.06%,APOH;CCL5;ARHGAP6;SRC
prerank,hexosaminidase activity (GO:0015929),0.6586495569877091,1.3846164169642243,0.12206572769953052,0.638459105389902,1.0,2/12,5.03%,CEMIP;CEMIP2
prerank,hormone activity (GO:0005179),0.5131963094058175,1.3842516869691965,0.06141367323290846,0.6310195305562374,1.0,7/54,14.33%,QRFP;ADIPOQ;EDN3;INHBB;HCRT;INSL6;NPY
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4958843246377594,1.3792799886860228,0.08068181818181819,0.6409553411307947,1.0,15/60,12.55%,ROR2;ROR1;EPHA7;PDGFRA;PDGFRB;EGFR;EPHB3;DDR2;ACVR1;EPHA1;MERTK;ACVR1B;FGFR1;ACVR2A;NTRK3
prerank,transcription coactivator binding (GO:0001223),0.5875958582736033,1.379154471614376,0.12661870503597122,0.6328673551523935,1.0,5/20,14.44%,RORA;AHR;TERT;SMAD3;SMAD4
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4427006758761567,1.3740192762233865,0.0,0.6437460321141849,1.0,179/731,18.67%,RORA;RUNX1;NR1H4;RUNX2;CREB3L1;SOHLH2;RUNX3;ZEB2;POU5F1;PAX1;GLI2;ZEB1;TCF7L2;TCF4;NRIP1;SNAI1;TBX18;SOX5;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;STAT1;EGR3;CCAR1;RARB;IRF7;BACH1;GATA6;MAFB;SNAI2;NPAS4;BATF;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;ZIC4;REL;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;SOX21;HOXB3;ELF4;NR2F2;E2F1;PRDM5;MYBL1;CEBPD;HIVEP2;PBX3;TCF12;HIVEP1;FOXK2;PPARG;STAT5A;ZBTB48;ZNF250;AHR;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;ZBTB12;ARNT;IRF1;NFE2L3;BHLHE40;HEYL;CREB3L2;SNAPC3;HOXA1;POU2F1;ZFHX4;ZNF182;HDAC1;ZBTB5;SALL1;FOXO3;ZSCAN22;ZBTB38;SMAD5;FOXP4;PRDM1;NR2F1;JUNB;TGIF2;ZIC1;TBX3;TCF7;NEUROD6;TEAD1;KLF10;CHD2;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;ZSCAN21;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;KCNIP3;IRF9;EGR2;ZFP62;HOXB5;TFAP2C;SMAD4;MAFK;SMAD1;CREB3L4;CREB3;PATZ1;NR6A1;HIF1A;STAT5B;RBMX;RELB;NPAS2;NSD1;POU3F3;MAX;ZKSCAN8;CLOCK;TCF7L1;TCF3;SREBF1;ZNF18;ZFHX3;BACH2;CALCOCO1;THRAP3;ZNF445;MZF1;NFE2L1;ATF4;GLI1;ETS1;PRDM4;SALL3;ZSCAN29;PAX8;ZBTB40;RBPJ;HDAC5;NR2C2;MXD4;SOX2;HINFP;ZBTB25;ZBTB7A
prerank,hyaluronic acid binding (GO:0005540),0.6835608730189263,1.3726452412392398,0.12295081967213115,0.6404136933272582,1.0,1/10,0.40%,CEMIP
prerank,retinoid X receptor binding (GO:0046965),0.6539346765919251,1.3722846356247216,0.12599681020733652,0.6335053202692843,1.0,4/11,5.97%,NRIP1;TACC1;ARID5A;PPARG
prerank,acylglycerol lipase activity (GO:0047372),-0.5507202243292604,-1.3716581668260361,0.12394366197183099,0.5472676810045847,1.0,4/11,10.71%,MGLL;ABHD6;ABHD3;LIPE
prerank,transcription corepressor binding (GO:0001222),0.5559648654431382,1.3707085218228756,0.09465020576131687,0.6311152621796767,1.0,4/27,6.40%,RORA;NEK6;PHF1;EHMT1
prerank,transforming growth factor beta binding (GO:0050431),0.5706444792154222,1.3666262519305996,0.11279229711141678,0.6378596156406131,1.0,7/23,9.75%,LTBP3;ACVR1;CD36;TGFB3;WFIKKN1;TGFBR1;LTBP1
prerank,lipoprotein particle binding (GO:0071813),0.5871497560532447,1.3635630957879348,0.13480055020632736,0.6409454891250775,1.0,7/20,8.76%,LIPC;COLEC12;CRP;TREM2;PLTP;CD36;LPL
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5800297725498671,1.3632020445939876,0.10556348074179743,0.6341970366867462,1.0,1/20,0.13%,SLC39A14
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4388511765275495,1.3616191542590528,0.0,0.631903628688904,1.0,178/732,18.67%,RORA;RUNX1;NR1H4;RUNX2;SOHLH2;RUNX3;ZEB2;POU5F1;PAX1;GLI2;ZEB1;TCF7L2;TCF4;NRIP1;SNAI1;TBX18;SOX5;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;STAT1;EGR3;CCAR1;RARB;IRF7;BACH1;GATA6;MAFB;SNAI2;NPAS4;BATF;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;ZIC4;REL;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;SOX21;HOXB3;ELF4;NR2F2;E2F1;PRDM5;MYBL1;CEBPD;HIVEP2;PBX3;TCF12;HIVEP1;FOXK2;PPARG;STAT5A;ZBTB48;ZNF250;AHR;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;ZBTB12;ARNT;IRF1;NFE2L3;BHLHE40;HEYL;SNAPC3;HOXA1;POU2F1;ZFHX4;ZNF182;HDAC1;ZBTB5;SALL1;FOXO3;ZSCAN22;ZBTB38;SMAD5;FOXP4;PRDM1;NR2F1;JUNB;HMGB2;TGIF2;ZIC1;TBX3;TCF7;NEUROD6;TEAD1;FOXN2;KLF10;CHD2;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;ZSCAN21;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;KCNIP3;IRF9;EGR2;ZFP62;HOXB5;TFAP2C;SMAD4;MAFK;SMAD1;CREB3L4;CREB3;PATZ1;NR6A1;HIF1A;STAT5B;RBMX;RELB;NPAS2;NSD1;POU3F3;ZKSCAN8;CLOCK;TCF7L1;TCF3;SREBF1;ZNF18;ZFHX3;BACH2;CALCOCO1;THRAP3;ZNF445;MZF1;NFE2L1;ATF4;GLI1;ETS1;PRDM4;SALL3;ZSCAN29;PAX8;ZBTB40;RBPJ;HDAC5;NR2C2;MXD4;SOX2;HINFP;ZBTB25;ZBTB7A
prerank,MAP-kinase scaffold activity (GO:0005078),0.6365531389357041,1.358637367729544,0.15,0.6350519990678761,1.0,9/11,28.09%,SH3RF1;MAP2K1;AKAP13;MAPK8IP1;SPAG9;MAPK8IP3;MAPK8IP2;MAP2K2;KSR1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5098458403791144,1.3561908178204913,0.10110974106041924,0.6357000151771143,1.0,18/42,19.95%,SH3BP2;VAV2;IRS1;PTPN3;NCK2;PTPN6;FBXW7;GRB2;SHB;VAV1;PIK3R1;NEDD4;YES1;RASA1;PTPN5;YWHAE;SHD;PIN1
prerank,carboxylic acid binding (GO:0031406),-0.3839054670205331,-1.3553193638589918,0.0821256038647343,0.5768354905822647,1.0,13/38,17.88%,GRM7;GLRA3;NOS3;GCLC;GRIN3A;GLUD1;GLRA1;SESN2;SESN3;GRIN2B;PHYH;MAG;GLRA2
prerank,phosphotyrosine residue binding (GO:0001784),0.5168284010160831,1.355195750337549,0.11645569620253164,0.6312505549705981,1.0,14/37,18.62%,SH3BP2;VAV2;IRS1;PTPN3;NCK2;PTPN6;GRB2;SHB;VAV1;PIK3R1;YES1;RASA1;PTPN5;SHD
prerank,retinoid binding (GO:0005501),-0.44399792344515304,-1.353615460752056,0.11538461538461539,0.5663320515552728,1.0,5/22,7.83%,PTGDS;RBP4;ABCA4;CYP26B1;CRABP2
prerank,chloride channel regulator activity (GO:0017081),-0.4940665815258815,-1.3535451073137275,0.11572700296735905,0.5523783673257803,1.0,5/14,24.46%,WNK4;WNK3;VAMP8;WNK2;CFTR
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.49209115851788693,1.3531175465271932,0.09006928406466513,0.6308967550421128,1.0,11/60,7.98%,ROR2;ROR1;EPHA7;PDGFRA;PDGFRB;NRP1;EGFR;EPHB3;DDR2;EPHA1;MERTK
prerank,sequence-specific DNA binding (GO:0043565),0.4367673061119799,1.3525102484717832,0.001,0.6259326196487401,1.0,108/590,14.46%,RORA;NR1H4;RUNX2;KMT2A;CREB3L1;SOHLH2;RUNX3;ZEB2;POU5F1;CXXC1;PAX1;GLI2;TCF7L2;TCF4;SNAI1;TBX18;GLI3;BCL6;MEIS2;EGR3;RARB;IRF7;GATA6;MAFB;SNAI2;BATF;RXRG;NFIX;ZIC4;PRRX2;BHLHE22;UBP1;GLIS1;USF1;TBX2;PKNOX2;ELF4;NR2F2;ARID5A;MBD2;E2F1;PRDM5;PRDM2;BCL2;CEBPD;SMG7;TCF12;HIVEP1;FOXK2;PPARG;ETV5;ZNF250;MBD1;AHR;FOXE1;E2F8;BCL11B;ZBTB12;ARNT;BHLHE40;TERT;SMG6;HOXA1;POU2F1;FOXO3;ZBTB38;SMAD5;PRDM1;NR2F1;JUNB;CXXC5;TGIF2;ZIC1;TBX3;TCF7;CBFB;TEAD1;FOXN2;KLF10;BBX;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;KDM2A;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;KMT2B;ELK1;FOXJ3;NFKB2;TFCP2L1;SAFB2;CTCF;SMAD3;LRWD1;IRF9;CTC1;EGR2;HOXB5;TFAP2C;SMAD4;MAFK
prerank,DNA secondary structure binding (GO:0000217),0.5386490234290991,1.3496973512461148,0.11124845488257108,0.6284876352369873,1.0,5/31,11.00%,RAD51B;KMT2A;XRCC3;HMGB2;LIN54
prerank,mRNA 3'-UTR binding (GO:0003730),0.4737762804097789,1.3488340088118635,0.07079646017699115,0.6248914725050903,1.0,13/79,8.81%,RBMS3;IGF2BP1;RBMS1;ZFP36L1;IGF2BP2;ZFP36L2;ILF3;PUM1;CPEB1;CARHSP1;PABPC4;CELF1;EXOSC4
prerank,ferrous iron binding (GO:0008198),0.5709093222132821,1.3470633721122545,0.13535911602209943,0.6247183743313303,1.0,5/21,12.02%,HEPH;FXN;FTO;ALKBH1;TET2
prerank,glutamate receptor binding (GO:0035254),-0.46922402428314386,-1.3439741584310627,0.10437710437710437,0.5647430839145936,1.0,8/17,12.51%,SHANK3;SHISA6;HOMER2;NSF;SYNDIG1;SHANK1;IGSF11;HIP1
prerank,cysteine-type peptidase activity (GO:0008234),0.4741559225463987,1.3436144055762407,0.07709497206703911,0.6294827860747111,1.0,19/73,13.18%,CASP4;PDIA3;CASP1;USP9X;OTULINL;CTSS;SFRP1;CTSK;CTSL;CAPN2;USP42;USP24;USP12;CTSB;USP40;USP38;CASP8;CTSC;CTSW
prerank,myosin II binding (GO:0045159),-0.5678299037331139,-1.3429520756000126,0.13054830287206268,0.5537466569133975,1.0,4/10,4.90%,SHROOM4;GSN;STXBP5L;TRIOBP
prerank,solute:anion antiporter activity (GO:0140323),-0.49884564487542477,-1.340269801746328,0.13675213675213677,0.5487544020646355,1.0,3/14,10.82%,SLC26A7;SLC26A2;SLC4A3
prerank,estrogen receptor binding (GO:0030331),0.5294940524839146,1.3352880776418576,0.10911424903722722,0.6512444023261215,1.0,12/32,16.10%,NRIP1;DNAAF4;WIPI1;TACC1;PADI2;ARID5A;PPID;STRN;RERG;LCOR;MMS19;NSD1
prerank,Wnt-activated receptor activity (GO:0042813),0.5936346390323637,1.3343177858527704,0.15578635014836795,0.6477103472295093,1.0,2/15,5.85%,ROR1;FZD1
prerank,NAD binding (GO:0051287),-0.4193237750472131,-1.334093372828093,0.10843373493975904,0.5537415952669067,1.0,14/26,25.72%,ALDH1A1;ME1;GLUD1;ALDH2;SIRT5;NUDT6;HPGD;CTBP1;CRYZ;NNT;ZC3HAV1;CRYL1;UXS1;HADH
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.535934846733647,-1.331008319810007,0.1478494623655914,0.5499327062826028,1.0,8/10,30.09%,DNAJC2;ANKRD13A;IDE;FAAP20;USP15;FAN1;DNAJB2;ANKRD13D
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5700101044111683,-1.3296810677497597,0.1503957783641161,0.5412311857860043,1.0,5/10,22.19%,GABRA2;GABRG3;GABRA5;GABRG1;GABRE
prerank,endopeptidase inhibitor activity (GO:0004866),0.46207042785524327,1.3296030927156708,0.08444444444444445,0.6575266415459703,1.0,15/82,14.45%,KNG1;SERPING1;TFPI2;FETUB;SERPINE2;TIMP1;PROS1;SERPINH1;SERPINF1;PZP;SERPINA2;GAPDH;PSMF1;SERPINB8;ITIH3
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5096967846387758,1.3243565258735328,0.13630573248407643,0.669191478531073,1.0,9/35,16.15%,TEC;PEAK1;BLK;STYK1;FRK;PTK2;SRC;FES;YES1
prerank,poly-purine tract binding (GO:0070717),0.5414276620607674,1.3211969902688272,0.15128205128205127,0.673745561798513,1.0,5/27,7.97%,RBMS3;RBMS1;ATXN1;KHDRBS1;PABPC4
prerank,carbohydrate kinase activity (GO:0019200),0.6375840413758223,1.3199207796114436,0.17363344051446947,0.6713601925758362,1.0,6/11,22.76%,HK2;GALK2;GALK1;KHK;POMK;GNE
prerank,sialyltransferase activity (GO:0008373),-0.45909369821551493,-1.3190718000944752,0.11278195488721804,0.5560359750044088,1.0,8/20,12.49%,ST3GAL6;ST6GALNAC3;ST8SIA4;ST3GAL4;ST3GAL5;ST8SIA6;ST8SIA2;ST6GALNAC5
prerank,bHLH transcription factor binding (GO:0043425),0.558745762455527,1.3119711933596787,0.16231884057971013,0.6924882198546556,1.0,8/19,19.43%,FHL2;USF1;TCF12;CREBBP;BHLHE40;SMAD3;TCF3;KDM1A
prerank,ephrin receptor binding (GO:0046875),0.5566604715401056,1.3104765114544064,0.17354196301564723,0.6908763464738439,1.0,6/21,8.60%,EFNA4;ANKS1B;PTPN1;CBL;GRB2;EFNA5
prerank,receptor ligand activity (GO:0048018),0.4286965696280471,1.3100712005747222,0.02721774193548387,0.6854012598017329,1.0,41/245,15.01%,CCL11;EPHA7;IL34;ADIPOQ;WNT2;CXCL1;EDN3;TNFSF11;PTN;IL16;TIMP1;FGF7;WNT9A;TSLP;JAG1;MDK;SHH;CCL5;EGF;TGFB3;CXCL10;INHBB;AIMP1;GPNMB;WNT5A;IL7;BMP5;GREM2;HMGB2;SEMA3E;TGFB2;EDA;TNF;VEGFC;FGF2;BTC;INSL6;BMP7;NPY;CX3CL1;FAM3C
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.344513589729797,-1.3061668721224782,0.0784313725490196,0.5786765312920585,1.0,29/57,28.94%,COX5A;COX8A;NDUFS1;COX4I1;NDUFV2;COX6B1;NDUFA13;NDUFA6;COX6A1;NDUFA12;COX10;NDUFB6;NDUFA8;CYB5A;NDUFB7;NDUFS3;COX5B;NDUFA1;NDUFC2;NDUFA10;UQCRH;NDUFS2;UQCRFS1;CYBRD1;CYB561A3;UQCR10;UQCR11;NDUFS5;NDUFV1
prerank,four-way junction DNA binding (GO:0000400),0.5848603106958195,1.304902701563524,0.14957264957264957,0.6972458096088802,1.0,3/17,10.06%,RAD51B;XRCC3;HMGB2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.4188693471377254,1.3041802305233268,0.002,0.6929807716686387,1.0,189/831,18.67%,RORA;RUNX1;NR1H4;RUNX2;SOHLH2;TRPS1;RUNX3;ZEB2;POU5F1;PAX1;GLI2;ZEB1;ETV6;DEAF1;TCF7L2;TCF4;NRIP1;SNAI1;TBX18;SOX5;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;STAT1;EGR3;CCAR1;RARB;IRF7;BACH1;GATA6;MAFB;SNAI2;NPAS4;BATF;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;ZIC4;REL;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;ZBTB10;SOX21;HOXB3;ELF4;NR2F2;E2F1;PRDM5;MYBL1;PRDM2;CEBPD;HIVEP2;PBX3;TCF12;HIVEP1;FOXK2;PPARG;STAT5A;ZBTB48;ETV5;ENO1;ZNF250;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;ZBTB12;ARNT;IRF1;NFE2L3;BHLHE40;HEYL;SNAPC3;HOXA1;POU2F1;ZFHX4;ZNF182;HDAC1;ZBTB5;SALL1;FOXO3;ZSCAN22;ZBTB38;SMAD5;FOXP4;PRDM1;NR2F1;JUNB;TGIF2;ZIC1;TBX3;TCF7;NEUROD6;TEAD1;KLF10;BBX;CHD2;ELK4;NFE2L2;ZGPAT;SAFB;SP3;E2F3;ZSCAN21;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;KCNIP3;IRF9;EGR2;ZFP62;HOXB5;TFAP2C;SMAD4;MAFK;SMAD1;CREB3L4;CREB3;PATZ1;NR6A1;HIF1A;STAT5B;RBMX;RELB;NPAS2;NSD1;POU3F3;MAX;NFXL1;ZKSCAN8;CLOCK;TCF7L1;TCF3;SREBF1;ZNF18;ZFHX3;BACH2;CALCOCO1;THRAP3;ZNF445;MZF1;ZNF25;NFE2L1;ATF4;GLI1;ETS1;ZNF3;PRDM4;SALL3;LHX6;ZSCAN29;PAX8;ZBTB40;RBPJ;ZBTB9;HDAC5;NR2C2;MXD4;SOX2;HINFP;ZBTB25;ZBTB7A
prerank,insulin-like growth factor binding (GO:0005520),-0.46216763025587093,-1.3039708349156145,0.1691842900302115,0.5719732843804795,1.0,6/15,10.36%,IGF1R;IGFBP2;ITGA6;INSR;IGFBP3;ITGB4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.49850407508679706,1.3021837264342344,0.1354916067146283,0.6933497595413392,1.0,14/44,16.10%,KMT2A;CXXC1;RBBP5;KMT5A;EHMT1;SETMAR;SETD2;SETDB1;KMT2E;SETDB2;KMT2B;NSD3;ASH1L;NSD1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.6047514484237675,1.3014976223376415,0.182648401826484,0.6892404808281442,1.0,3/12,5.14%,CASP8AP2;CASP1;NOD1
prerank,diacylglycerol kinase activity (GO:0004143),-0.5099049079336269,-1.3013064641369978,0.16243654822335024,0.567806493603737,1.0,5/11,16.74%,DGKB;DGKI;DGKA;DGKG;DGKQ
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5398054168847127,-1.2993090186260838,0.16153846153846155,0.5615334045516235,1.0,4/10,7.90%,PRKAG2;PRKAR1A;PRKAR2A;PKIA
prerank,cation:chloride symporter activity (GO:0015377),-0.5281759388594445,-1.2954297120721703,0.1771117166212534,0.5604708595976732,1.0,4/10,4.88%,SLC12A2;SLC12A7;SLC12A6;SLC6A1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6112354770357226,1.2908230867303334,0.18125,0.7208986839720745,1.0,5/12,15.15%,SULF1;GALNS;ARSG;GNS;IDS
prerank,insulin-like growth factor I binding (GO:0031994),-0.48630161136434397,-1.2895799897194318,0.17417417417417416,0.5639268217908842,1.0,6/13,10.36%,IGF1R;IGFBP2;ITGA6;INSR;IGFBP3;ITGB4
prerank,poly(A) binding (GO:0008143),0.5516643368281334,1.2876958015140643,0.17208672086720866,0.7248289732736586,1.0,4/21,7.97%,RBMS3;RBMS1;KHDRBS1;PABPC4
prerank,double-stranded DNA binding (GO:0003690),0.4156732494950457,1.2860964310351295,0.009,0.7238110865681113,1.0,83/531,13.00%,RUNX2;RAD51B;ZBP1;CREB3L1;SOHLH2;RUNX3;POU5F1;PAX1;RBMS1;GLI2;TCF4;SNAI1;TBX18;GLI3;BCL6;MEIS2;STAT1;EGR3;RARB;IRF7;GATA6;SNAI2;BATF;RXRG;SMAD2;NFIX;EGFR;ZIC4;PRRX2;BHLHE22;UBP1;GLIS1;USF1;CGGBP1;TBX2;PKNOX2;ELF4;E2F1;CEBPD;TCF12;HIVEP1;PPARG;ZBTB48;DDX11;ETV5;ZNF250;MBD1;AHR;FOXE1;E2F8;BCL11B;ZBTB12;ARNT;BHLHE40;HOXA1;FOXO3;SMAD5;SETMAR;PRDM1;NR2F1;JUNB;FBH1;HMGB2;TGIF2;ZIC1;TBX3;TCF7;TEAD1;FOXN2;KLF10;BBX;ELK4;SAFB;SP3;E2F3;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;FOXJ3;NFKB2
prerank,neuropeptide binding (GO:0042923),-0.4470930842683767,-1.2828484296574119,0.16666666666666666,0.5716502629564139,1.0,11/18,46.62%,SORL1;GPR37;OPRK1;OPRM1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,pseudouridine synthase activity (GO:0009982),0.5953482458370724,1.2828001151007222,0.19099378881987578,0.7288119031527687,1.0,4/13,9.72%,RPUSD3;PUS7L;TRUB2;PUS3
prerank,vinculin binding (GO:0017166),-0.5112741209160954,-1.2825370172447048,0.1954674220963173,0.5622557908290295,1.0,3/11,4.72%,DMD;RTCB;SORBS3
prerank,nuclease activity (GO:0004518),0.47472695506634077,1.2824266109338849,0.14906103286384975,0.7233889354978399,1.0,10/52,9.99%,ENPP1;ERN2;DNA2;REXO1;MAP1S;RNASE7;RNASEH1;SND1;SETMAR;RNASEH2A
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.377272758859716,-1.2817929445677565,0.12254901960784313,0.5539067314836681,1.0,10/32,24.07%,KCNC2;KCNB2;KCNQ5;KCNQ3;KCNQ4;KCNQ1;KCNC1;KCNQ2;KCNC3;KCNE4
prerank,inward rectifier potassium channel activity (GO:0005242),-0.4129365898980048,-1.2813419444486422,0.16030534351145037,0.5452762579135422,1.0,8/24,15.79%,KCNJ2;KCNJ3;KCNJ13;ABCC9;KCNJ10;KCNJ12;KCNN2;KCNN3
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4132311768946424,1.279984869881972,0.006,0.7254301675231625,1.0,137/597,18.89%,RUNX1;RUNX2;CREB3L1;SOHLH2;RUNX3;POU5F1;PAX1;GLI2;YAP1;TCF7L2;TCF4;SNAI1;TBX18;SOX5;GLI3;BCL6;CREB3L3;MEIS2;EGR3;RARB;IRF7;GATA6;SNAI2;BATF;RXRG;ARID5B;NFIX;ZIC4;PRRX2;BHLHE22;UBP1;GLIS1;USF1;STAT3;TBX2;PKNOX2;RBBP5;ELF4;ARID5A;MBD2;E2F1;PRDM5;CEBPD;MCM2;TAF7;TCF12;HIVEP1;FOXK2;PPARG;ZBTB48;DDX11;ETV5;ZNF250;AHR;FOXE1;E2F8;BCL11B;ZBTB12;ARNT;IRF1;BHLHE40;CARM1;CREB3L2;HOXA1;MCM7;AHRR;NONO;FOXO3;TBL1X;SMAD5;PRDM1;NR2F1;GRWD1;JUNB;HMGB2;TGIF2;ZIC1;TBX3;TCF7;MCM9;TEAD1;FOXN2;KLF10;BBX;ELK4;NFE2L2;SP3;ARID4B;E2F3;TNF;HOXB2;KLF6;ZBTB20;NKX2-8;SKOR2;ELK1;FOXJ3;NFKB2;SPI1;TFCP2L1;CTCF;SMAD3;IRF9;EGR2;HOXB5;TFAP2C;SMAD4;MAFK;GABPB1;BNC2;CREB3L4;CREB3;NR6A1;NPAS2;MAX;CLOCK;TCF7L1;SREBF1;HSPD1;BACH2;CALCOCO1;MZF1;ATF4;TAF2;GLI1;ETS1;PRDM4;LHX6;ZSCAN29;PAX8;HDAC5;NR2C2;SOX2;HINFP;ZBTB7A;ARID4A;NR3C1
prerank,metalloexopeptidase activity (GO:0008235),0.4649986295381421,1.279142297454511,0.14982164090368608,0.7216903963646706,1.0,13/51,14.50%,MMP14;ANPEP;CPQ;XPNPEP1;CPXM1;NPEPPS;CPA6;MMP16;ENPEP;AGTPBP1;MMP15;LVRN;XPNPEP3
prerank,chemokine receptor activity (GO:0004950),0.52676884936106,1.27814357363925,0.1774193548387097,0.7186153335978513,1.0,3/24,8.99%,CMKLR1;CCR1;CXCR4
prerank,exopeptidase activity (GO:0008238),0.47222034320295825,1.2750963298675129,0.15474794841735054,0.7227647500792749,1.0,15/50,18.97%,FAP;XPNPEP2;ANPEP;DPEP2;XPNPEP1;NPEPPS;ENPEP;DPP7;XPNPEP3;DPP8;CNDP2;GGH;CTSA;LAP3;DPEP3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.37729720988487364,-1.2738208699954496,0.15350877192982457,0.5538570531687566,1.0,9/33,13.36%,ERCC5;HNRNPU;CTR9;RPRD2;WDR43;RPRD1A;URI1;UVSSA;LLPH
prerank,protein kinase inhibitor activity (GO:0004860),0.49002706049272887,1.270377413561633,0.16992665036674817,0.7333776386294438,1.0,18/42,20.44%,SPRED1;PARVA;SPRED2;NCK1;TAOK3;GSKIP;RPTOR;IBTK;GMFB;SPRY2;SMCR8;SH3BP5L;CDKN1B;TRIB1;DNAJC3;MAPK8IP1;DUS2;SPRY4
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6237184232230839,1.26833063814146,0.22535211267605634,0.7345379072891001,1.0,6/10,18.48%,SETMAR;SETD2;NSD3;ASH1L;NSD1;SETD3
prerank,thyroid hormone receptor binding (GO:0046966),0.5137275865863948,1.2653496592086988,0.18064516129032257,0.7386460253849163,1.0,11/28,19.61%,TACC1;ARID5A;TAF7;GTF2H1;OASL;MED13;HMGN3;NSD1;THRAP3;MED12;MED1
prerank,pentosyltransferase activity (GO:0016763),0.48163998792861173,1.2604432478081922,0.196405648267009,0.749399240698723,1.0,4/36,6.77%,PARP8;PARP3;LACC1;PARP11
prerank,glucuronosyltransferase activity (GO:0015020),0.5546313146763865,1.2595924345877416,0.21225071225071226,0.7458220718828202,1.0,3/19,9.33%,EXT1;EXT2;CHSY1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.6206855621766305,1.25933312653063,0.23937007874015748,0.7406326119897167,1.0,1/10,0.09%,FAP
prerank,kinase inhibitor activity (GO:0019210),0.4952502891698218,1.2587681532745925,0.1809169764560099,0.736441411230494,1.0,14/33,20.44%,PARVA;NCK1;LRP6;TAOK3;GSKIP;GMFB;SMCR8;SH3BP5L;CDKN1B;TRIB1;DNAJC3;MAPK8IP1;DUS2;SPRY4
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.4172462855006765,-1.257702289975914,0.16262975778546712,0.5858092276560827,1.0,4/21,16.55%,GRM1;GRIA1;GRM5;CHRNB1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5877281348934431,1.2557112530645198,0.2115987460815047,0.741018830256397,1.0,3/12,9.16%,STAT1;POU2F1;HDAC1
prerank,neuropeptide hormone activity (GO:0005184),0.5325673771517263,1.2511439088416427,0.21592442645074225,0.7507011246987242,1.0,3/22,14.33%,QRFP;HCRT;NPY
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.37618379931749646,-1.2509970438454214,0.13875598086124402,0.5934284469070809,1.0,8/31,7.17%,SLC12A2;SLC12A7;KCNK5;TMEM175;SLC12A6;KCNK10;ABCC9;KCNQ4
prerank,calcium ion binding (GO:0005509),0.4099327263873438,1.2492124664674837,0.037037037037037035,0.7514917201578067,1.0,63/323,15.97%,MMP13;SCUBE1;ENPP1;LRP1;FBLN1;SPARC;CDH11;THBS4;PCDHB6;MASP1;CRP;SLIT3;SLIT1;PAM;CALR3;ADGRL3;CALML4;ITSN1;GALNT3;CALU;PADI2;SHH;FBN1;ITPR1;AIF1;PKD2;CEMIP2;DCHS1;ASTN2;NUCB2;RCN2;CDH6;CANX;SYT2;LPL;LCP1;S100A6;ANXA1;MAN1C1;PGS1;TNNC1;ATP2A2;PPP3CA;CDH18;CDH24;RCN3;CALR;MICU2;AIF1L;CALM2;COLEC11;PLSCR4;TPM4;FKBP9;TRPM4;PLA2G4A;HSPA5;ANXA6;IDS;KCNIP2;HPCA;BGLAP;PLA2G4E
prerank,nuclear receptor coactivator activity (GO:0030374),0.4609108970943213,1.2490499784839817,0.17319098457888493,0.7459409398652885,1.0,22/52,22.53%,CCAR1;ZMIZ1;TACC1;PPRC1;CARM1;CCAR2;PSMC3IP;MED13;FGF2;ELK1;USP22;SLC30A9;CALCOCO1;THRAP3;ETS1;KDM1A;MED12;MED1;TMF1;ACTN1;PKN1;MED14
prerank,high voltage-gated calcium channel activity (GO:0008331),0.6139852112600513,1.248302759415204,0.24444444444444444,0.7424559368978109,1.0,3/10,3.91%,CACNA1A;CACNA1C;CACNB1
prerank,phosphatase binding (GO:0019902),0.427689837210055,1.247283353765124,0.14224598930481283,0.7402239764107085,1.0,36/105,20.50%,JAK1;SPRED1;AP3B1;SMAD2;EGFR;STAT3;IKBKE;STX17;CDC27;CARHSP1;DLG4;MAST2;PDLIM4;MVP;PTK2;RCAN3;CTSC;TRAF2;PPME1;PIK3R1;GTF2F1;SMAD3;CDKN1B;VRK3;MTMR9;CEP192;ITGA1;SH3YL1;MAPK1;MTMR3;EIF2AK3;TRPC4AP;HSP90B1;SPTBN4;KIFAP3;DLG1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4826537598495286,-1.246858766263643,0.18662952646239556,0.5942616105150237,1.0,5/13,7.24%,GABRA2;GLRA3;GABRG3;GABRA5;GLRA1
prerank,neuropeptide receptor activity (GO:0008188),-0.3662381303368887,-1.2442447289812437,0.18141592920353983,0.5912772961321797,1.0,19/29,48.25%,SORCS1;SORCS3;SORCS2;GPR37;NPSR1;HCRTR2;OPRM1;NPY5R;NMUR2;GRPR;KISS1R;SSTR2;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL
prerank,hormone receptor binding (GO:0051427),0.5775355068786477,1.2436909352613676,0.23884892086330936,0.746159552433179,1.0,2/14,2.75%,JAK1;JAK2
prerank,potassium ion leak channel activity (GO:0022841),-0.4541826046440277,-1.2425904359973723,0.1891025641025641,0.5860863599506705,1.0,7/15,25.92%,KCNK5;TMEM175;KCNK10;KCNK2;KCNK13;KCNK6;KCNK12
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.40415315455189743,1.2411596073411144,0.07847082494969819,0.7496812081185504,1.0,59/254,18.89%,RUNX1;NR1H4;CREB3L1;TCF4;PRRX1;CREB3L3;SATB2;MEIS2;NPAS4;MITF;SMAD2;REL;UBP1;STAT3;LITAF;MEIS1;HOXB3;ELF4;MYBL1;PRDM2;TCF12;FOXK2;ETV5;MLXIP;IRF1;HOXA1;FOXO3;KLF10;ELK4;E2F3;ZSCAN21;HOXB2;KLF6;NKX2-8;ELK1;FOXJ3;NFKB2;TFCP2L1;SMAD3;EGR2;ZFP62;TFAP2C;SMAD4;SMAD1;CREB3;HIF1A;CLOCK;TCF3;ZNF445;MZF1;MDM2;ATF4;ETS1;RLF;PRDM4;RBPJ;NR2C2;HINFP;NR3C1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.47984714925148325,1.2376052067025243,0.1910828025477707,0.7561753054545965,1.0,17/35,26.44%,STAT1;SNAPC3;POU2F1;HDAC1;KLF10;DRAP1;TAF4;BAZ2A;SMARCA4;NR3C1;AGO2;FOXP1;AGO1;RRN3;RELA;FOS;PIH1D1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.40946285860532594,1.2370673200294031,0.11235955056179775,0.7520926247316562,1.0,47/181,18.77%,NR1H4;MDFIC;NCOR2;TCF7L2;NRIP1;PRRX1;STAT1;RERE;ZFPM2;MIER2;TACC1;STAT3;TEAD3;CREBBP;PPARG;PIAS2;ARNT;BHLHE40;PSMA6;HDAC1;MTA2;TBX3;NFE2L2;GSK3B;DUSP26;ELK1;COMMD7;SPI1;DDRGK1;SMAD3;DACT1;EGR2;TAF4;DTX3L;BAZ2A;HIF1A;TCF3;SMARCA4;MTA3;TCERG1;ATF4;RBPJ;HDAC5;NFKBIA;SPEN;RBBP8;BCAS3
prerank,nucleotidyltransferase activity (GO:0016779),0.5297844167537192,1.2328983394346793,0.22753623188405797,0.7604923858361576,1.0,7/19,20.33%,PAPSS2;TERT;REV1;CGAS;CRPPA;TUT7;TENT4A
prerank,peptidase inhibitor activity (GO:0030414),0.4764857866312461,1.2325884452815123,0.21777221526908636,0.7558243441834515,1.0,5/33,7.34%,KNG1;FETUB;TIMP1;PROS1;PZP
prerank,leak channel activity (GO:0022840),-0.4176683852612355,-1.2286866236904748,0.20689655172413793,0.6128829010119977,1.0,7/18,21.31%,KCNK5;TMEM175;KCNK10;KCNK2;NALCN;KCNK13;KCNK6
prerank,signal sequence binding (GO:0005048),0.4759542835364204,1.2286806900395673,0.20632911392405062,0.7633605557895993,1.0,14/35,19.93%,CEMIP;KDELR3;BABAM2;KPNA3;BRAP;NUP153;TNPO1;KDELR2;SEC61A1;SEC61A2;KCNIP2;NFKBIA;NUP214;KPNA2
prerank,copper ion binding (GO:0005507),0.470116706255212,1.2276349529429151,0.2,0.7611339975313763,1.0,3/42,2.51%,HEPH;LACC1;PAM
prerank,zinc ion binding (GO:0008270),0.39909513903499555,1.2272344168630147,0.07615230460921844,0.7567815260576716,1.0,48/293,14.00%,MMP13;ENPP1;KMT2A;KNG1;CBLB;GLI2;ZEB1;SEC24D;SEC23A;CSRP1;MYCBP2;PAM;TIMP1;RASSF1;ZFPM2;ANPEP;LITAF;SHH;PHF2;RABIF;SEC24A;CDADC1;PRDM2;GDA;LIMS1;RNF2;PPARG;MBD1;PTPN1;NPEPPS;TRIM8;MMP16;ARIH1;ENPEP;MSRB3;TARS1;PAPPA2;CXXC5;UBA5;EEA1;CALR;TET2;KDM2A;KMT2B;LVRN;CTCF;SMAD3;RNF11
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.3695540249960957,-1.227126414824684,0.1759656652360515,0.607429350457971,1.0,8/27,9.76%,SLC12A2;ITPR2;TMEM165;MRS2;ATP2B4;SLC9B2;ZDHHC13;SLC4A8
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.5653933503613522,1.2264527795531368,0.24287856071964017,0.7539148094977086,1.0,5/13,13.51%,PDGFRA;IL1R1;PDGFRB;PTPRJ;ITGA5
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.36036243057371486,-1.225142311097868,0.17647058823529413,0.6032040047747036,1.0,8/33,11.32%,ERCC5;HNRNPU;CTR9;RPRD2;WDR43;RPRD1A;URI1;UVSSA
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.49861660494611965,1.2246874678746655,0.22727272727272727,0.7547181970870779,1.0,3/25,6.77%,PARP8;PARP3;PARP11
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.598100834451085,1.2235965204302002,0.2717219589257504,0.7528990311245052,1.0,2/11,4.84%,RASA3;ITPR1
prerank,cholesterol binding (GO:0015485),0.46113224953936877,1.2231712994715878,0.2103960396039604,0.7488599827602215,1.0,10/47,11.03%,ABCA1;APOD;ABCG1;VDAC2;SOAT1;GRAMD1A;OSBPL3;NPC2;OSBPL5;GRAMD1C
prerank,R-SMAD binding (GO:0070412),0.5243537017775117,1.2204147562086038,0.2336065573770492,0.7521615515005325,1.0,7/18,17.22%,PMEPA1;SMAD2;LDLRAD4;SMAD3;SMAD4;SMURF1;TRIM33
prerank,DNA-binding transcription factor binding (GO:0140297),0.40237357952167796,1.220314482387997,0.1017293997965412,0.7472016800098005,1.0,53/189,19.43%,NEK6;YAP1;TCF7L2;PRRX1;STAT1;RERE;ZFPM2;FHL2;SMAD2;MIER2;TLE1;USF1;STAT3;CGGBP1;TEAD3;PRDM5;BCL2;TCF12;CREBBP;PPARG;RUNX1T1;PIAS2;NOC2L;BHLHE40;CRTC1;HDAC1;MTA2;CXXC5;TBX3;YWHAZ;CRTC3;NFE2L2;GSK3B;DUSP26;ELK1;SPI1;DDRGK1;SMAD3;DACT1;EGR2;TCF3;MTA3;TCERG1;ATF4;RBPJ;DDX20;HDAC5;SPEN;RBBP8;ZBTB7A;TLE5;GABPA;KDM1A
prerank,muscle alpha-actinin binding (GO:0051371),0.547958863985775,1.2199457056644736,0.24962178517397882,0.7431419549627781,1.0,3/15,8.37%,PALLD;PKD2;PDLIM4
prerank,iron ion binding (GO:0005506),0.45190197108269675,1.2195113548624743,0.19830713422007254,0.7391192216978916,1.0,10/48,12.52%,HEPH;FXN;PHF2;ABCE1;ACO2;SCD5;FTO;ALKBH1;TET2;CYP2R1
prerank,metal ion binding (GO:0046872),0.3970368852006264,1.2192080443495497,0.028,0.7350803090854465,1.0,92/477,16.28%,MMP13;SCUBE1;ENPP1;POSTN;NEK6;LRP1;FBLN1;SPARC;CDH11;PDXP;THBS4;PCDHB6;MASP1;CRP;ERN2;LRRK2;SLIT3;SLIT1;PAM;CALR3;PPA1;ADGRL3;MARK1;IRAK3;APOE;CALML4;ITSN1;GALNT3;CALU;PADI2;ADCY2;SHH;FBN1;ITPR1;EPHX2;AIF1;PKD2;CEMIP2;DCHS1;ASTN2;NUCB2;RCN2;MVK;FOXK2;RAP2A;PLK1;CDH6;HSPE1;CANX;MAST2;SYT2;RRAGC;IDH2;LPL;LCP1;S100A6;ANXA1;MAN1C1;PGS1;TNNC1;ATP2A2;PPP3CA;CDC42BPA;GNAI1;CDH18;CDH24;RCN3;CALR;TDP2;MICU2;ACVR1C;PAPOLG;ADPRH;AIF1L;MAP3K6;CALM2;COLEC11;PLSCR4;TPM4;FKBP9;TRPM4;PLA2G4A;HSPA5;DXO;ANXA6;IDS;KCNIP2;HPCA;BGLAP;PLA2G4E;STK4;MCTP2
prerank,heme binding (GO:0020037),0.43766643034787656,1.216768406388748,0.19204545454545455,0.7380963625492672,1.0,12/65,15.30%,CYP1B1;STEAP4;BACH1;JAK2;CYP2A6;PTGES2;PXDN;HEBP1;CYP2R1;TBXAS1;SRC;CYCS
prerank,leucine zipper domain binding (GO:0043522),0.59700396237142,1.2160660313452882,0.28019323671497587,0.735302024077497,1.0,4/10,19.75%,MRTFA;PAWR;ATF4;PMF1
prerank,phospholipase activator activity (GO:0016004),0.5870083285653347,1.2152691480749314,0.2818471337579618,0.7327895264000073,1.0,3/10,14.06%,CCL5;ARHGAP6;SRC
prerank,mannose binding (GO:0005537),0.5710603374263377,1.2140434707991807,0.25609756097560976,0.731560095242319,1.0,3/12,13.95%,LMAN2L;LMAN1;COLEC11
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.4750138192718071,1.2138589962078739,0.23462986198243413,0.7272263494076352,1.0,11/34,16.20%,TAOK1;RICTOR;FAM20A;CKS1B;MAP2K1;DBF4;SPRY2;CALM2;CCNT1;ALS2;STK4
prerank,chemorepellent activity (GO:0045499),-0.39183245210187,-1.2132014938700235,0.22764227642276422,0.6239904115586729,1.0,7/25,3.17%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;NRG3;SEMA7A;DPP4
prerank,histone acetyltransferase binding (GO:0035035),0.5114431739892198,1.21315182638887,0.25961538461538464,0.7246858903365592,1.0,8/21,18.77%,GLI3;STAT1;TAF7;KANSL1;EID1;HIF1A;ZBTB7A;BCAS3
prerank,transcription coregulator binding (GO:0001221),0.44581735194281075,1.2104954391505387,0.22019464720194648,0.7281881293749454,1.0,10/50,14.44%,RORA;NEK6;PHF1;EHMT1;AHR;TERT;LCOR;CTCF;SMAD3;SMAD4
prerank,transition metal ion binding (GO:0046914),0.39084662839356205,1.206880702582924,0.06606606606606606,0.7347159189919062,1.0,69/397,15.81%,MMP13;HEPH;ENPP1;KMT2A;MGAT5;KNG1;CBLB;GLI2;ZEB1;SEC24D;SEC23A;CSRP1;LACC1;MYCBP2;PAM;TIMP1;RASSF1;ZFPM2;SLC11A2;ANPEP;LITAF;GALNT3;ADCY2;SHH;PHF2;XPNPEP1;RABIF;SEC24A;CDADC1;PRDM2;GDA;LIMS1;RNF2;PPARG;MBD1;PTPN1;NPEPPS;ABCE1;ACO2;NEK4;TRIM8;SCD5;MMP16;ARIH1;ENPEP;MSRB3;TARS1;PAPPA2;CXXC5;LOXL3;UBA5;EEA1;CALR;TDP2;TET2;KDM2A;CYP2R1;KMT2B;LVRN;CTCF;SMAD3;RNF11;XPNPEP3;SIRT3;RABGGTB;SMPDL3B;B4GALT7;FNTB;FBXL19
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4309067387058552,1.206459595756207,0.21140939597315436,0.731171465383497,1.0,13/70,16.66%,CHSY3;B4GALNT2;EXT1;EXT2;GXYLT2;B4GALNT1;OGT;MGAT4A;CHSY1;GCNT2;POGLUT3;CHPF2;B3GNT9
prerank,endopeptidase regulator activity (GO:0061135),0.4537813988008344,1.205866863411996,0.21411483253588517,0.7282916413676411,1.0,10/40,17.78%,KNG1;FETUB;PROS1;ABCA2;PZP;PSMF1;ITIH3;PSENEN;PSMD14;PCSK1N
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4367344656328529,1.2026202510991124,0.22446555819477435,0.733670102631276,1.0,4/53,3.47%,SLC7A2;SLC1A3;SLC38A3;SLC7A7
prerank,NAD+ binding (GO:0070403),-0.4686798270212037,-1.2017562211729924,0.2395543175487465,0.6444577635220731,1.0,7/12,25.72%,GLUD1;SIRT5;HPGD;ZC3HAV1;CRYL1;UXS1;HADH
prerank,MAP kinase phosphatase activity (GO:0033549),0.5697688526165513,1.197962912781611,0.2987987987987988,0.7433752023311402,1.0,2/12,3.00%,DUSP2;DUSP5
prerank,glycerophospholipid flippase activity (GO:0140333),-0.4823731203839494,-1.1946057976692475,0.26344086021505375,0.6538425868768445,1.0,5/11,9.89%,ATP10A;ATP8A1;ABCA4;ABCA3;ATP8A2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.5688693000110749,1.193880980958247,0.28188976377952757,0.7514186997765616,1.0,1/11,4.11%,PADI2
prerank,ADP binding (GO:0043531),-0.39926269194898023,-1.1935514164685317,0.20152091254752852,0.646907272905303,1.0,10/25,17.00%,PRKAG2;GCLC;ME1;GLUD1;MYO18A;MSH2;PPP5C;ERN1;PGK1;ATP5F1D
prerank,solute:proton symporter activity (GO:0015295),0.5239304945663719,1.1917263354796057,0.27627627627627627,0.7534145859724366,1.0,4/16,10.09%,SLC2A13;SLC11A2;SLC36A2;SLC15A1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.591378570343178,1.1906236212294095,0.29513343799058084,0.7476105708923564,1.0,2/10,3.00%,DUSP2;DUSP5
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.591378570343178,1.1906236212294095,0.29513343799058084,0.7476105708923564,1.0,2/10,3.00%,DUSP2;DUSP5
prerank,MAP kinase activity (GO:0004707),-0.44581420167229896,-1.1903161972028071,0.2606060606060606,0.6460464579351327,1.0,8/14,24.49%,MAPK4;MAPK12;MAPK9;MAPK10;MAPK3;MAPK6;MAPK14;MAPK7
prerank,sodium channel regulator activity (GO:0017080),-0.34533975536541994,-1.188904976086981,0.18691588785046728,0.6409223399142301,1.0,8/37,10.52%,FGF12;FGF14;FXYD5;SNTA1;ATP2B4;GPD1L;FXYD6;GPLD1
prerank,ATPase binding (GO:0051117),0.4256599937149713,1.1881144414424507,0.21475770925110133,0.7504423930549762,1.0,19/71,16.67%,ABCA1;NKD2;SLC2A13;DNAJB1;EGFR;CHMP4A;BBC3;PTPN3;PKD2;RALA;PPP3CA;VCPKMT;PEX19;SNX10;PSEN1;SRC;TMTC4;TOR1AIP2;ATP6V1G1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.36413545081540283,-1.1837815328553547,0.25,0.6455648202495163,1.0,4/29,3.71%,SLC13A3;SLC26A7;SLC26A2;SLC1A1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4843754438582638,1.183605589245099,0.261558784676354,0.7595505996548679,1.0,4/26,9.33%,CHSY3;B4GALNT2;B4GALNT1;CHSY1
prerank,cAMP binding (GO:0030552),-0.46055110009249045,-1.1814879489345333,0.25936599423631124,0.6428293779302033,1.0,5/11,11.42%,PDE4B;RAPGEF2;PDE4D;PDE10A;PDE2A
prerank,regulatory RNA binding (GO:0061980),0.45049494951368696,1.1806957084100629,0.2674271229404309,0.7640508961161772,1.0,14/38,24.18%,POU5F1;PUM1;TLR7;DICER1;FMR1;RBM10;ZNF346;TUT7;SOX2;AGO2;ZC3H12A;YBX1;DDX21;AGO1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4483981755494951,-1.1797330672057709,0.2688821752265861,0.6385455341354821,1.0,2/14,1.78%,SLC26A7;SLC26A2
prerank,gamma-tubulin binding (GO:0043015),-0.3877046935460492,-1.1790888499979992,0.22614840989399293,0.6318667102390835,1.0,10/21,29.72%,DIXDC1;TUBGCP3;BRCA2;OFD1;GIT1;CDK5RAP2;BLOC1S2;RACGAP1;RAD51D;B9D2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.5343279758487814,1.1789145155320482,0.27521613832853026,0.7648730102901079,1.0,3/14,12.47%,TSEN2;POP1;POP4
prerank,lysine N-methyltransferase activity (GO:0016278),0.507975340857509,1.1788234225660026,0.2627939142461964,0.7605461026791066,1.0,12/20,27.81%,ANTKMT;KMT5A;EHMT1;SETD2;VCPKMT;ETFBKMT;SETD3;EEF2KMT;SETD7;SETD4;METTL21A;EEF1AKMT3
prerank,DNA binding (GO:0003677),0.3800107119039133,1.1785396274123316,0.046,0.7568849801534782,1.0,159/694,18.79%,RORA;NR1H4;RAD51B;ZBP1;ZEB2;POU5F1;RBMS1;C1D;GLI2;MPG;TCF7L2;TCF4;BCL6;MEIS2;STAT1;RARB;IRF7;BRIP1;MAFB;SNAI2;SMC1A;DNA2;BATF;RAD52;ZNF496;ARID5B;SMAD2;EGFR;ZIC4;USF1;STAT3;CGGBP1;MEIS1;TBX2;SOX21;ILF3;NR2F2;ARID5A;MAP1S;E2F1;PRDM5;PHF1;KHDRBS1;PRDM2;BCL2;MCM2;HIVEP2;INO80;FOXK2;CREBBP;PPARG;YAF2;ZNF292;DDX11;ETV5;MBD1;AHR;PDS5B;TSHZ3;FOXE1;SUB1;ARNT;IRF1;FUBP1;DCLRE1C;AIFM2;SNAPC3;TERT;HOXA1;POU2F1;MCM7;RAD23A;FOXO3;RAD23B;SETMAR;NR2F1;OASL;JUNB;FBH1;HMGB2;CXXC5;TBX3;MCM9;CBFB;ZMYM4;TEAD1;CHD2;XRN1;ELK4;NFE2L2;ZGPAT;SAFB;CALR;TIMELESS;TDP2;SPTY2D1;E2F3;HOXB2;GLYR1;NKX2-8;FOXJ3;SAFB2;CTCF;SMAD3;RBM6;COLEC11;RNF11;CTC1;EGR2;DRAP1;TFAP2C;TAF4;SMAD4;MAFK;SIRT3;SETX;PATZ1;POLG;NR6A1;CCNT1;HIF1A;GTF3C4;PRKDC;NPAS2;NUP35;CGAS;POU3F3;MAX;LIN9;CLOCK;TCF7L1;TCF3;SMARCA4;SREBF1;HMGN1;PNKP;AIFM1;POLRMT;HSPD1;NUCKS1;RC3H2;CALCOCO1;THRAP3;DDB1;ATF4;GLI1;ETS1;ZNF3;RLF;PAX8;RBPJ;NR2C2;SOX2;RBBP8;CDK9;HINFP;ZBTB7A;HMCES;ARID4A
prerank,potassium channel activity (GO:0005267),-0.27780162517769,-1.1767692060931205,0.13157894736842105,0.629324631490318,1.0,22/89,16.07%,KCNC2;KCND3;GRIK4;KCNB2;KCNK5;KCND2;KCNQ5;KCNH5;TMEM175;KCNH7;KCNK10;ABCC9;KCNQ3;KCNQ4;KCNK2;KCNQ1;LRRC38;CCDC51;KCNN2;GRIK2;KCNC1;KCNT1
prerank,protein phosphatase regulator activity (GO:0019888),0.4320561942647616,1.1748685207106102,0.2532544378698225,0.7634622614380079,1.0,14/53,13.64%,MGAT5;PPP1R9B;PTN;RCAN2;EIF2AK2;PPP4R1;PPP2R2A;PPP2R5A;RCAN3;PPP4R2;PPP1R2;PPP1R16A;PPME1;CALM2
prerank,sulfotransferase activity (GO:0008146),-0.3384243604728246,-1.1733290001753387,0.17560975609756097,0.6305203481344067,1.0,11/33,13.49%,HS3ST3A1;HS3ST1;UST;SULT1A1;CHST8;CHST9;GAL3ST1;TPST2;CHST3;HS6ST1;HS3ST2
prerank,WW domain binding (GO:0050699),0.48020154728053815,1.1726887554577574,0.29740791268758526,0.7659357629785726,1.0,3/26,8.17%,PMEPA1;LITAF;PRRG4
prerank,O-methyltransferase activity (GO:0008171),0.5785517865327766,1.1690787414480552,0.3065326633165829,0.7724486250654707,1.0,5/10,24.63%,ASMT;COMT;BCDIN3D;FTSJ3;COQ3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.46707664319252196,1.1690002636053902,0.28222523744911804,0.768132289300758,1.0,7/30,18.03%,SLC39A14;SLC11A2;SLC25A37;SLC31A1;SLC39A6;TTYH1;ATP7A
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5404889787096404,1.168564314264799,0.28,0.7649585730561477,1.0,3/14,8.05%,CAPN5;CAPN2;CAPN15
prerank,gated channel activity (GO:0022836),0.5291060848843825,1.155030303220791,0.3023255813953488,0.8038329213988341,1.0,3/14,6.89%,TMC3;PIEZO2;TMEM266
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.45463831380009767,1.1532500340981062,0.2934648581997534,0.8047585056760593,1.0,19/34,27.81%,ANTKMT;KMT5A;EHMT1;SETD2;SETDB1;CAMKMT;KMT2E;VCPKMT;NSD3;ETFBKMT;SETD3;N6AMT1;EEF2KMT;DOT1L;SETD7;KMT5B;SETD4;METTL21A;EEF1AKMT3
prerank,Notch binding (GO:0005112),0.47801145006392887,1.1496696650362224,0.30896551724137933,0.8118639338771266,1.0,5/22,11.75%,NCOR2;JAG1;GALNT11;SNED1;KCTD10
prerank,alpha-tubulin binding (GO:0043014),0.45820979358018177,1.1494694005677648,0.30076142131979694,0.8079523293188992,1.0,5/31,9.84%,DLEC1;TAOK1;EML4;INO80;SETD2
prerank,RNA polymerase II complex binding (GO:0000993),-0.3444902927302677,-1.1488270317974634,0.24778761061946902,0.6865364858469569,1.0,8/32,11.32%,ERCC5;HNRNPU;CTR9;RPRD2;WDR43;RPRD1A;URI1;UVSSA
prerank,cAMP response element binding (GO:0035497),0.5498000239382248,1.1467470760766663,0.3376835236541599,0.8119095173559661,1.0,2/10,7.92%,CREB3L1;CREB3L2
prerank,amino acid binding (GO:0016597),-0.34703636014218897,-1.1467264015069512,0.24152542372881355,0.6835671334028349,1.0,7/31,11.06%,GRM7;GLRA3;NOS3;GCLC;GRIN3A;GLRA1;GRIN2B
prerank,double-stranded RNA binding (GO:0003725),0.40772242203503717,1.1462184118085408,0.26567844925883694,0.8090223646294835,1.0,11/70,9.83%,ZBP1;CLTC;RFTN1;ILF3;ZFR;EIF4A1;EIF2AK2;TLR7;MSN;DICER1;OASL
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.502077047044481,1.1452210543830574,0.3217893217893218,0.8032710647549096,1.0,4/17,6.60%,EPHA7;EFNA4;EPHB3;EPHA1
prerank,ephrin receptor activity (GO:0005003),0.502077047044481,1.1452210543830574,0.3217893217893218,0.8032710647549096,1.0,4/17,6.60%,EPHA7;EFNA4;EPHB3;EPHA1
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5162135582456017,1.1451064057569955,0.31221719457013575,0.7992014512352444,1.0,4/17,4.34%,ABCA1;ATP8B1;PLTP;ABCG1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5092141782951732,1.1429915820923684,0.3403298350824588,0.8012477329195297,1.0,3/14,5.14%,CASP8AP2;CASP1;NOD1
prerank,outward rectifier potassium channel activity (GO:0015271),0.546167305367723,1.1425578663958509,0.3397626112759644,0.7982756328643225,1.0,3/11,5.01%,KCNT2;KCNA5;PKD2
prerank,Tat protein binding (GO:0030957),0.5561287058444089,1.1423773716417738,0.33176100628930816,0.7945474306912544,1.0,1/10,0.69%,MDFIC
prerank,methylation-dependent protein binding (GO:0140034),0.4159464985234095,1.1416022370638772,0.2971360381861575,0.7924796103870239,1.0,21/57,24.39%,CXXC1;RBBP5;PHF1;PHF2;MORC3;CBX8;KMT2E;GLYR1;LRWD1;ATRX;FMR1;NCAPG2;ING5;THAP7;SUZ12;CHD8;CBX5;MSH6;MPHOSPH8;ZMYND8;KDM7A
prerank,voltage-gated potassium channel activity (GO:0005249),-0.27958863474500933,-1.1405647829974863,0.18478260869565216,0.6913674821483389,1.0,21/80,16.07%,KCNC2;KCND3;KCNB2;KCND2;KCNQ5;KCNH5;KCNH7;KCNJ2;KCNJ3;KCNJ13;KCNQ3;KCNQ4;KCNJ10;KCNK2;KCNQ1;LRRC38;KCNJ12;KCNN2;KCNN3;KCNC1;KCNT1
prerank,syntaxin-1 binding (GO:0017075),-0.3758550745261672,-1.1397800933580897,0.2789115646258503,0.685003730527119,1.0,5/22,9.63%,UNC13C;SNAP25;UNC13B;NSF;CPLX1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3004193249545195,-1.1391716849930666,0.1949685534591195,0.6782016585322728,1.0,7/48,5.75%,TRPM3;SLC12A2;SLC12A7;TRPM6;TMEM165;SLC12A6;ABCC9
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.259077317344661,-1.1369851486490192,0.20833333333333334,0.6755842841810806,1.0,30/134,12.26%,ABCC4;ABCG2;SLC6A6;SLC13A3;SLC26A7;SLC26A2;SLCO1C1;SLC6A9;SLC38A9;SLC7A5;SLC1A2;SLC1A1;MPC1;SLC22A6;SLCO3A1;SLC6A1;SLC16A11;SLC39A8;SLC52A1;SLC5A6;SLC16A1;SLC25A42;SLCO2A1;SLC4A8;SLC27A1;SLC4A3;SLC38A5;SLC25A12;SLC25A38;MPC2
prerank,protein phosphatase binding (GO:0019903),0.38569195151723085,1.1324951763271354,0.27136752136752135,0.8157886068091854,1.0,32/117,18.76%,PPP1R9B;JAK1;SLC9A1;AP3B1;EGFR;STAT3;IKBKE;SMG7;STRN;STX17;CDC27;DLG4;PDLIM4;MVP;PTK2;TRAF2;PPP1R16A;PPME1;PIK3R1;AKAP11;GTF2F1;CTTNBP2NL;CDKN1B;VRK3;MTMR9;ITGA1;PTPA;MTMR3;EIF2AK3;ANKLE2;MFHAS1;HSP90B1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.4772671488531459,-1.1324842376594197,0.30809399477806787,0.6787096275811972,1.0,4/10,8.27%,SLCO1C1;SLC22A6;SLCO3A1;SLCO2A1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5195830973764021,1.1323156541727115,0.32220609579100146,0.811869179752634,1.0,3/15,12.90%,P2RX5;P2RY14;P2RX7
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3996963171814527,1.1320746381228342,0.3032329988851728,0.8082741298373682,1.0,8/73,12.75%,MC5R;EDNRA;RXFP2;ADCYAP1R1;GLP2R;S1PR2;CALCRL;MC1R
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.39058230076436423,-1.1320215182881541,0.26621160409556316,0.6720004913247296,1.0,5/20,14.31%,LPGAT1;LPCAT2;AGPAT3;DGAT1;GPAT4
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5398148335458233,1.130303708116635,0.3553459119496855,0.8091925480448844,1.0,2/11,5.18%,AKR1A1;RDH12
prerank,semaphorin receptor activity (GO:0017154),0.5341552560683114,1.1297252600406003,0.3333333333333333,0.8065380157466677,1.0,4/11,8.57%,NRP1;PLXNC1;PLXND1;PLXNA3
prerank,glutathione transferase activity (GO:0004364),0.47325380391418553,1.1286926238577801,0.3285340314136126,0.8056886291200137,1.0,3/23,10.94%,PTGES;MGST1;GSTK1
prerank,hydro-lyase activity (GO:0016836),0.43212400014739744,1.1284750424832588,0.3146341463414634,0.8020777705130653,1.0,14/41,20.42%,EHHADH;PCBD1;GMDS;ENO1;HACD2;ACO1;ACO2;IREB2;TBXAS1;ECHS1;FAHD2A;PCBD2;AUH;ECHDC2
prerank,ribosome binding (GO:0043022),0.42002607472126735,1.1253838478237161,0.3011015911872705,0.8071751648842992,1.0,17/46,21.08%,RPSA;CPEB1;SHFL;ERI1;BAG6;SRP68;SEC61A1;YTHDF3;FMR1;CPEB4;SEC61A2;NAA15;MAIP1;SRP72;MRPS27;ETF1;ZC3H12A
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.5224779250035276,1.125286329872491,0.34169278996865204,0.8033056839192869,1.0,1/14,0.63%,SLC1A3
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4973947871960579,1.1233234244973673,0.3511560693641618,0.8049262833485676,1.0,6/18,13.74%,SMAD2;TGFB3;TGFBR1;TGFB2;TGFBRAP1;SMAD3
prerank,amyloid-beta binding (GO:0001540),0.39013437151900476,1.1231801400104773,0.30033003300330036,0.8011805765871901,1.0,9/79,5.55%,CACNA1A;LRP1;HSPG2;IAPP;TLR2;TREM2;APOE;GSAP;CD36
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3864908173313497,-1.1230504665843082,0.3,0.6869488586947131,1.0,6/17,14.16%,LBR;TECR;BLVRB;BLVRA;MECR;DHCR24
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4282107689030673,1.123017957153063,0.32112332112332115,0.7976318968220243,1.0,9/42,15.57%,CDKN2B;CCNE2;CCNL1;CCND3;CKS1B;CCNB2;CCNI;CDKN1B;CCNT1
prerank,fatty acid synthase activity (GO:0004312),-0.4586816256637546,-1.1227271830517194,0.34554973821989526,0.6799796914525023,1.0,5/10,22.99%,ELOVL7;ELOVL5;ELOVL4;CBR4;OXSM
prerank,protein kinase binding (GO:0019901),0.36368257671816795,1.120167933360587,0.161,0.8019952739308844,1.0,123/479,18.90%,ROR2;TRIML2;CLTC;NEK6;FAM83A;TCF7L2;RND3;GHR;TNIP1;PTN;JTB;DUSP2;IRS1;PDGFRB;GATA6;JAK2;DUSP5;SLC12A4;SPRED1;NELL1;PRKCSH;SUFU;CDKN2B;IRAK3;TREM2;USF1;STAT3;RICTOR;ERRFI1;SPRED2;KHDRBS1;KIF13B;KCNA5;PRKD2;ACVR1;RHOD;LIMS1;TRIM21;CACUL1;CCND3;PLK1;CKS1B;PTPN6;CDC42;EPHA1;TOM1L1;LLGL1;ADD2;SASH1;IFNAR2;PTPN1;GSKIP;RPTOR;TIRAP;NEK9;MAPKAP1;BORA;NISCH;MSN;PRKAR1B;GRB2;FOXO3;TPX2;IRAK4;MVP;IBTK;PTPRJ;PTPN23;PTPN2;PTK2;TOP2B;YWHAZ;FBXO7;NBR1;TRAP1;SPRY2;UTRN;RHOA;PPP1CB;TPCN2;PJA2;MAP3K2;MAML1;GSK3B;TRAF2;SMCR8;CALM2;SMAD3;DACT1;TRIB3;CDKN1B;PDCD10;RAC1;AP2A2;TRIB1;SMAD1;HIF1A;NBEA;RHOF;PRKAB1;WDR45;SQSTM1;RELB;CEP192;TCF3;PLEK;ACVRL1;PTPRC;DUSP6;DNAJC3;KIF20A;STX1B;TEX14;RAD9A;ATF4;MAP3K12;GYS1;HDAC5;FBXO5;SHC2;TBL2;NR3C1;PARN
prerank,ligand-gated cation channel activity (GO:0099094),-0.28277565587813297,-1.1172880986404934,0.24528301886792453,0.6857397527412948,1.0,16/75,16.55%,GRIK4;KCNJ2;KCNJ3;GRIN3A;GRIA2;KCNJ13;GRIA1;KCNJ10;GRIN2D;GRIN2B;KCNJ12;CCDC51;KCNN2;GRIK2;KCNN3;CHRNB1
prerank,beta-tubulin binding (GO:0048487),0.4434584383467771,1.1167536054822662,0.3244949494949495,0.807938991018064,1.0,4/31,4.52%,DLEC1;TAOK1;EML4;MAP1S
prerank,kinase binding (GO:0019900),0.36222329319354585,1.1137526604083396,0.1971971971971972,0.8127517908377256,1.0,114/434,18.90%,TRIML2;CLTC;NEK6;FAM83A;TCF7L2;SNAI1;RND3;GHR;PTN;JTB;PDGFRB;GATA6;JAK2;SLC12A4;SPRED1;CASP1;SUFU;CDKN2B;EGFR;IRAK3;USF1;STAT3;RICTOR;ERRFI1;SPRED2;KIF13B;KCNA5;RHOD;LIMS1;TRIM21;CACUL1;CCND3;PLK1;CKS1B;PTPN6;CDC42;EPHA1;TOM1L1;LLGL1;DLG4;ADD2;SASH1;IFNAR2;PTPN1;GSKIP;ABI2;RPTOR;NEK9;MAPKAP1;BORA;NISCH;MSN;BTG1;GRB2;RAD23A;TTC28;SP100;FOXO3;CDC37;TPX2;IRAK4;PPP2R5A;MVP;IBTK;PTPRJ;PTPN23;PTPN2;PTK2;YWHAZ;FBXO7;TRAP1;SPRY2;UTRN;RHOA;PPP1CB;TPCN2;MAP3K2;MAML1;GSK3B;TRAF2;SMCR8;CALM2;SMAD3;SRC;TRIB3;CDKN1B;PDCD10;RAC1;AP2A2;SMAD1;HIF1A;NBEA;RHOF;PRKAB1;WDR45;SQSTM1;RELB;CEP192;ACVRL1;PTPRC;DNAJC3;KIF20A;STX1B;TEX14;RAD9A;ATF4;MAP3K12;GYS1;FBXO5;PIP5K1A;SHC2;TBL2;NR3C1;PARN
prerank,carboxylic ester hydrolase activity (GO:0052689),0.38792080270497414,1.1128586129586715,0.3115468409586057,0.8113290154489035,1.0,14/85,16.48%,CEL;LIPC;ASPG;PLA2G7;LPL;PLA2G12A;H6PD;ABHD16A;LYPLAL1;ABHD8;PLA2G4A;PLA2G4E;DDHD2;LYPLA2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5229275330097894,1.112626268712598,0.3678832116788321,0.8079495137713881,1.0,1/13,0.80%,EHHADH
prerank,tau-protein kinase activity (GO:0050321),0.4763828748404598,1.108280640505488,0.36,0.81714067348426,1.0,9/20,22.93%,TAOK1;MARK1;GSK3B;SIK3;PHKG2;DYRK1A;MARK2;ROCK2;ROCK1
prerank,ATP binding (GO:0005524),0.36211289921359585,1.1067955586111557,0.2530241935483871,0.817501501422244,1.0,37/266,10.56%,ABCA1;ENPP1;RUNX3;NEK6;MYO1B;KIFC1;MAP4K4;TAOK1;PEAK1;ERN2;MARK1;P2RX5;IRAK3;MTHFD1L;STK36;ABCA2;MYH9;ABCG1;AKT3;ACVR1;PYGL;MVK;CDK6;PLK1;VPS4A;CARS2;ABCE1;PXK;MAST2;TGFBR1;GUK1;MAP4K5;TARS1;MLKL;ACVR1B;CDC42BPA;GALK1
prerank,methylated histone binding (GO:0035064),0.40070806569400835,1.10610768775482,0.32857142857142857,0.8155007707909182,1.0,22/62,24.39%,CXXC1;RBBP5;PHF1;PHF2;MORC3;TAF7;CBX8;KMT2E;GLYR1;LRWD1;ATRX;FMR1;NCAPG2;ING5;THAP7;SUZ12;CHD8;CBX5;MSH6;MPHOSPH8;ZMYND8;KDM7A
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4229869718046079,1.1032456104929582,0.3374233128834356,0.8198965685796855,1.0,11/38,16.09%,SH3PXD2B;WIPI1;SESTD1;ZFYVE26;PLEKHF1;KIF16B;PLA2G4A;PLEKHA5;WDR45;PLA2G4E;RUBCNL
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.37905801260635424,1.1008387220867815,0.32903225806451614,0.8230775462222133,1.0,24/100,17.84%,SH3PXD2B;MYO1B;MYO10;GAB2;WIPI1;CYTH3;SESTD1;DAPP1;ZFYVE26;MAPKAP1;GBF1;OGT;ANKFY1;OSBPL5;PLEKHF1;KIF16B;PLA2G4A;PLEKHA5;WDR45;PLA2G4E;RUBCNL;ARHGAP9;AKT1;ZFYVE16
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3604315772225462,1.0998699894116974,0.2871587462082912,0.8221496664358227,1.0,47/232,16.40%,TRIML2;SH3RF3;CBLB;DTX4;RNF150;PDZRN3;MYLIP;MYCBP2;BIRC3;SMURF2;UBR5;TRIM21;UBR4;RNF2;RNF144A;ANAPC11;CDC42;PIAS2;SIAH2;RNF111;TRIM13;CBL;AREL1;ARIH1;BRAP;SH3RF1;RNF145;DTX2;PELI3;TRIM44;NEURL2;RNF19B;RNF181;RNF149;KCMF1;NSMCE2;FBXO2;RNF11;EGR2;DTX3L;RNFT2;SMURF1;ITCH;NEDD4;TRIM56;PELI2;TRAF3IP2
prerank,miRNA binding (GO:0035198),0.4429257583159171,1.0968383927924632,0.35405405405405405,0.8271166918600251,1.0,12/30,24.18%,POU5F1;PUM1;FMR1;RBM10;ZNF346;TUT7;SOX2;AGO2;ZC3H12A;YBX1;DDX21;AGO1
prerank,nucleotide diphosphatase activity (GO:0004551),0.5096631911943585,1.0936148584138181,0.38291605301914583,0.8325371243815963,1.0,1/14,0.33%,ENPP1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3239150554801065,-1.0935755348365315,0.3080568720379147,0.7409605946166306,1.0,8/32,11.55%,SLC6A6;SLC6A9;SLC38A9;SLC7A5;SLC1A1;SLC43A2;SLC38A5;SLC25A38
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5160231312736925,1.0904714362629717,0.37333333333333335,0.8377577152708923,1.0,2/12,3.43%,PDE3A;PDE7B
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5347161854523055,1.0882537795292715,0.3716535433070866,0.840260123192172,1.0,1/10,0.80%,EHHADH
prerank,androgen receptor binding (GO:0050681),0.4430254127980342,1.0860708282393292,0.37270341207349084,0.8428368036102156,1.0,12/25,21.80%,WIPI1;ARID5A;TGFB1I1;CALR;NSD1;SMARCA4;ZBTB7A;KDM1A;TMF1;FOXP1;RNF14;PKN1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4927242697251048,1.0838664101055138,0.3903177004538578,0.8450616024149489,1.0,1/15,0.63%,SLC1A3
prerank,palmitoyltransferase activity (GO:0016409),-0.3300087958304134,-1.0838282353317246,0.3215686274509804,0.7589397706091348,1.0,8/28,16.77%,GLUL;ZDHHC13;ZDHHC21;ZDHHC17;ZDHHC14;ZDHHC5;ZDHHC15;ZDHHC2
prerank,ubiquitin protein ligase activity (GO:0061630),0.3554742581735196,1.0830980976067004,0.31243680485338726,0.8432415466327563,1.0,45/228,16.40%,TRIML2;SH3RF3;CBLB;DTX4;RNF150;PDZRN3;MYLIP;MYCBP2;BIRC3;SMURF2;UBR5;TRIM21;UBR4;RNF2;RNF144A;ANAPC11;CDC42;SIAH2;RNF111;TRIM13;CBL;AREL1;ARIH1;BRAP;SH3RF1;RNF145;DTX2;PELI3;TRIM44;NEURL2;RNF19B;RNF181;RNF149;UBE2K;KCMF1;FBXO2;RNF11;DTX3L;RNFT2;SMURF1;ITCH;NEDD4;TRIM56;PELI2;TRAF3IP2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.45795338407079084,1.0822172238494632,0.3670886075949367,0.8418727361750677,1.0,3/21,12.90%,P2RX5;GLRB;P2RX7
prerank,amino acid transmembrane transporter activity (GO:0015171),0.39907676752394755,1.0815552031377278,0.37589498806682575,0.8399183612168964,1.0,7/47,11.38%,SLC7A2;SLC38A3;SLC7A7;SLC38A4;SLC36A2;SLC7A8;PDPN
prerank,protein homodimerization activity (GO:0042803),0.3490607744520153,1.081524203810798,0.254,0.8361303547592508,1.0,114/589,17.14%,FAP;ENPP1;KMT2A;ADIPOQ;SOHLH2;TRIML2;PDGFRA;MID1;ASMT;TBX18;GHR;MASP1;JAML;CREB3L3;STAT1;LRRK2;XCL1;ST6GAL1;EXT1;CRYM;TENM3;IRAK3;CPQ;APOE;USF1;STAT3;MTHFD1L;CHMP4A;CHMP4B;PADI2;MAD2L1;NR2F2;MYH9;ABCG1;CAMK2D;XPNPEP1;CDADC1;EPHX2;BCL2;PKD2;TRPC6;NOD1;ACVR1;PIP4K2A;EXT2;TRIM21;CCL5;LRP6;ENO1;ZHX2;GLDC;AHR;INHBB;TMEM266;IRAK2;BCL2L2;ARNT;TENM4;ACOX1;KYAT1;ADD2;BHLHE40;AIMP1;MIGA2;TRIM8;GOLGA5;TERT;PDLIM4;LPL;HSD11B1;S100A6;ZBTB38;TNNC1;SETMAR;FGFR1;UBA5;EEA1;SNX9;TGFB2;CLN6;ATG7;SNX2;CYP2R1;PSMF1;TPST1;SPPL3;GGCT;ABCG4;DPYD;SMAD3;MKLN1;TPM4;FMR1;SMAD4;XPNPEP3;PDCD10;PEX11A;RIPK1;ALDH3A2;IL6R;PANK1;NR6A1;ALS2;POU3F3;STK4;TCF3;PLEK;CRPPA;ZDHHC3;SH3GLB1;GNPTG;PTPA;AKT1;KLHL7
prerank,protein serine/threonine kinase activity (GO:0004674),0.3500062348573633,1.0779100152868346,0.2832832832832833,0.8422029094305539,1.0,99/334,22.19%,MAP3K14;NEK6;MAP4K4;TAOK1;MAST4;ERN2;LRRK2;ALPK1;PRKCA;MARK1;EGFR;KALRN;NUAK1;IRAK3;STK36;IKBKE;CASK;AKT3;CAMK2D;PRKD2;ACVR1;FAM20A;CDK6;ATM;CDK14;EIF2AK2;PLK1;IRAK2;TAOK3;CDK10;HIPK4;NEK4;MAPK11;MAST2;ATR;TRIO;TGFBR1;MAP2K1;MYLK;CSNK2A1;CSNK2A2;RPS6KC1;MAP4K5;HIPK3;IRAK4;RPS6KB1;ACVR1B;CDC42BPA;GAK;NRK;CSNK1G2;CDK7;ACVR2A;MAP3K2;GSK3B;CSNK1A1;ACVR1C;MAP3K6;MKNK1;STK24;DAPK2;VRK3;RIPK1;PIK3R4;PRKDC;SQSTM1;MOK;STK4;ACVRL1;CSNK1D;MAPK1;AKT1;LATS2;BRD4;CDKL1;EIF2AK3;TESK2;MAP3K12;SIK3;CDK16;CDK9;CPNE3;FAM20C;CDK13;PLK2;PRKCD;PHKG2;BMPR1A;MAP3K20;CDK12;DYRK1A;VRK2;PKN1;PAK1;RPS6KA4;MARK2;CDC7;RAF1;LATS1
prerank,phospholipase inhibitor activity (GO:0004859),0.5226343372540659,1.0733227736422328,0.3877551020408163,0.8511056217708656,1.0,6/10,31.20%,ANXA1;ANXA9;ANXA5;ANXA2;APOC1;ANXA4
prerank,potassium channel regulator activity (GO:0015459),-0.29087755101220336,-1.0729058462975771,0.26666666666666666,0.780734818344527,1.0,7/49,5.75%,KCNIP4;DPP10;DPP6;WNK4;WNK3;ARPP19;ABCC9
prerank,nucleosomal DNA binding (GO:0031492),0.458784941102263,1.0725419189253864,0.41192411924119243,0.8492519960156122,1.0,10/21,21.53%,MBD2;SMARCC1;HDAC1;MTA2;GATAD2B;RCC1;SMARCA4;MBD3;HMGA2;HNRNPC
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4387325696463291,-1.0689490253636496,0.3806970509383378,0.7833281649925145,1.0,6/10,17.62%,SHANK3;SHISA6;NSF;SHANK1;IGSF11;SHISA7
prerank,protein tyrosine kinase binding (GO:1990782),-0.2666528822084207,-1.0687607891713395,0.2980769230769231,0.7755670680841995,1.0,22/71,16.29%,EPHA4;TJP2;NEDD9;GRB14;NRG3;CDH5;GAS6;PITPNM2;HSP90AA1;DOCK4;CRK;FLT3LG;TOB1;RNF41;BLNK;FIZ1;RACK1;PIK3R2;PCNA;SHC4;MAP3K7;GRM5
prerank,chemoattractant activity (GO:0042056),0.436255678288424,1.0687150429781542,0.3986394557823129,0.8567021203289864,1.0,11/26,21.75%,FGF7;CCL5;CXCL10;GPNMB;HMGB2;VEGFC;FGF2;CX3CL1;CCL15;GDNF;VEGFB
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.3113024768507871,-1.0676429753357877,0.33004926108374383,0.7705293836433068,1.0,19/35,28.35%,TRMT9B;DTWD2;DUS4L;MTFMT;TRDMT1;PUS10;GATB;NT5C3A;QTRT1;LCMT2;TRMT5;ELAC1;QRSL1;MRPL58;GATC;TYW3;TRMT12;AARS1;DUS3L
prerank,protein heterodimerization activity (GO:0046982),0.3548994651013302,1.067208585178328,0.3631687242798354,0.8573084713429486,1.0,35/178,14.87%,SOHLH2;KRT25;TCF4;CREB3L3;SMC1A;NPAS4;EXT1;TENM3;IRAK3;USF1;ABCG1;BCL2;TAF7;EXT2;ZHX2;AHR;IRAK2;BCL2L2;ARNT;TENM4;ADD2;VAPA;BHLHE40;MIGA2;RRAGC;ITGA3;TOP2B;FBXO7;SNX2;MICU2;PSMF1;ABCG4;TPM4;FMR1;NOLC1
prerank,"DNA binding, bending (GO:0008301)",-0.38947099402612867,-1.0667036427817356,0.3704819277108434,0.765085108313126,1.0,5/14,19.57%,LEF1;FOXD1;FOXL1;TFAM;HHEX
prerank,translation initiation factor activity (GO:0003743),0.40693022416033137,1.0664348806772217,0.41125,0.8555069520321091,1.0,14/36,24.24%,EIF4G2;EIF4G3;EIF4A1;EIF3H;EIF5B;EIF5;EIF1;EIF2B3;EIF3K;AGO2;EIF4G1;EIF3E;EIF2S1;EIF2A
prerank,mechanosensitive ion channel activity (GO:0008381),0.5035959545003208,1.0663809779917899,0.4050632911392405,0.851877208401292,1.0,2/12,4.18%,TMC3;PIEZO2
prerank,SH3 domain binding (GO:0017124),0.3789047313262503,1.065799579064406,0.3822525597269625,0.8497511342875803,1.0,9/62,8.42%,CBLB;SH3BP2;ADAM12;DPYSL3;WIPF1;KHDRBS1;ABI2;CBL;GRB2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3728195318362755,1.0636884020657447,0.391156462585034,0.8521762835730856,1.0,27/71,20.59%,PTPN7;PTPN3;PTPN13;PTEN;PTPRZ1;PTPN6;HACD2;PTPN18;PTPN1;PTPRJ;PTPN23;PTPN9;PTPN2;PTPRM;DUSP26;UBASH3B;CDC14A;TIMM50;PALD1;PTPRC;PTPN5;PTPRA;MTMR3;MTMR6;CDC14B;DUSP11;DUSP15
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.4976863394792107,1.0582483014751811,0.41139240506329117,0.8633930396964508,1.0,4/12,19.71%,DHRS4;AIFM2;NDUFS7;DCXR
prerank,single-stranded DNA binding (GO:0003697),0.36716619447953347,1.0564900599964615,0.39265850945494996,0.8646573574003391,1.0,15/93,11.85%,RAD51B;RBMS1;RAD52;MCM2;DDX11;SUB1;FUBP1;MCM7;RAD23A;RAD23B;SETMAR;FBH1;HMGB2;MCM9;TDP2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.37632183877026604,-1.0560916962103746,0.3591331269349845,0.7772226880349933,1.0,7/16,14.61%,PTPRB;PTPRT;PTPRO;PTPRK;PTPRG;PTPRD;PTPRN2
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.37632183877026604,-1.0560916962103746,0.3591331269349845,0.7772226880349933,1.0,7/16,14.61%,PTPRB;PTPRT;PTPRO;PTPRK;PTPRG;PTPRD;PTPRN2
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3414257694890817,1.0557006315162727,0.331,0.863035700825114,1.0,84/431,17.22%,ABCA1;ENPP1;RUNX3;NEK6;MYO1B;KIFC1;MAP4K4;RND3;TAOK1;PEAK1;ERN2;RHOJ;LRRK2;MARK1;P2RX5;IRAK3;RAB2A;MTHFD1L;STK36;ABCA2;MYH9;ABCG1;AKT3;TUBG1;ACVR1;RHOD;GNL1;PYGL;MVK;RAB42;RALA;CDK6;RAP2A;ATL2;PLK1;RAB21;CDC42;VPS4A;CARS2;RAB7A;ABCE1;PXK;MAST2;RRAGC;PSMA6;TGFBR1;GUK1;RAB9A;MAP4K5;TARS1;MLKL;RAB32;RAB27B;GBP7;ACVR1B;RERG;CDC42BPA;GALK1;ARF4;GNAI1;RIT1;GCK;RHOA;GNL3;P2RX7;RAB10;MAP3K6;ARF1;MKNK1;DAPK2;RAC1;HSPA5;TRIB1;ANXA6;RHOF;STK4;TUBG2;ACVRL1;PNKP;PEX6;MTREX;PTPA;AKT1;LATS2
prerank,alanine transmembrane transporter activity (GO:0022858),0.48794972124709773,1.0553017188093146,0.4155844155844156,0.8604316254151642,1.0,3/12,9.68%,SLC38A3;SLC36A2;SLC7A8
prerank,cGMP binding (GO:0030553),-0.42078943331815855,-1.052135620817401,0.40947075208913647,0.7797770117819423,1.0,4/11,16.90%,RAPGEF2;PDE10A;PDE2A;PDE11A
prerank,magnesium ion binding (GO:0000287),0.3521567637615003,1.0508139818211724,0.407061266874351,0.8692706759400098,1.0,21/135,13.57%,NEK6;PDXP;ERN2;LRRK2;PPA1;MARK1;IRAK3;ADCY2;EPHX2;MVK;FOXK2;RAP2A;PLK1;MAST2;RRAGC;IDH2;CDC42BPA;GNAI1;TDP2;ADPRH;MAP3K6
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.39271529459599763,-1.050442130356678,0.3625,0.7767263574419556,1.0,3/14,4.59%,KCND3;KCNJ2;KCNJ3
prerank,receptor tyrosine kinase binding (GO:0030971),0.37531327458307867,1.0485996449353816,0.3865450399087799,0.871528642124453,1.0,11/56,11.03%,CBLB;GAB2;IRS1;NCK1;PTPN1;SH2B2;ANGPT1;CBL;FRS2;PTPN2;SOCS5
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3858413812890933,1.0482317221021655,0.4244946492271106,0.8688042501516733,1.0,11/49,16.50%,TNIP1;TNFAIP3;IKBKE;BABAM2;BAG6;RAD23A;RNF169;RAD23B;EPS15;SQSTM1;ATRIP
prerank,phospholipase C activity (GO:0004629),0.43479342910256585,1.046546366436305,0.41644562334217505,0.8699565933491286,1.0,6/25,10.87%,PDIA3;EDNRA;CCR1;CCL5;PLCL1;PLCB3
prerank,MAP kinase kinase activity (GO:0004708),0.46984915660768284,1.0456756794757516,0.43833580980683506,0.8686989649751627,1.0,3/15,9.11%,LRRK2;MAP2K4;MAP2K1
prerank,voltage-gated calcium channel activity (GO:0005245),0.4035981633339789,1.0443022314761006,0.41935483870967744,0.8689267567805471,1.0,5/37,5.01%,CACNA1A;CACNA2D1;CACNA1C;CACNB1;PKD2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.39280541092951116,1.0425038892415768,0.431924882629108,0.8701674707906606,1.0,8/46,16.66%,MGAT5;EXT1;EXT2;OGT;MGAT4A;GCNT2;PIGP;B3GNT9
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.3063348758480337,-1.037258934462012,0.3807531380753138,0.7960577977195012,1.0,13/34,21.80%,NDUFS1;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFB6;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;NDUFA10;NDUFS2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.3063348758480337,-1.037258934462012,0.3807531380753138,0.7960577977195012,1.0,13/34,21.80%,NDUFS1;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFB6;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;NDUFA10;NDUFS2
prerank,1-phosphatidylinositol binding (GO:0005545),0.47503485744991525,1.0371160280875742,0.42795389048991356,0.8815154522736492,1.0,8/15,20.47%,SESTD1;WDFY3;EEA1;SNX9;SNX10;PICALM;ZFYVE16;ZFYVE1
prerank,ion channel activity (GO:0005216),-0.2495112753408332,-1.0360398368804928,0.35051546391752575,0.7916551726876103,1.0,19/80,16.55%,TRPM3;TRPM6;GRID2;GRIK4;GABRB1;GRIN3A;GRIA2;ABCC9;GRIA1;TMC7;MCUB;GRIN2D;GRIN2B;TRPV2;TMC6;TRPV4;NALCN;GRIK2;CHRNB1
prerank,growth factor activity (GO:0008083),0.36206306688306866,1.0359786187446824,0.4157303370786517,0.8810434832649934,1.0,10/74,13.23%,CXCL1;PTN;FGF7;JAG1;MDK;EGF;IL7;VEGFC;FGF2;BTC
prerank,cardiolipin binding (GO:1901612),0.5026686326899925,1.0358636626504623,0.42901234567901236,0.8777104517671951,1.0,1/10,2.82%,STOML2
prerank,motor activity (GO:0003774),0.36947242237846967,1.0346626891306234,0.42660550458715596,0.8776260783172394,1.0,16/60,17.50%,KIF26B;KIFC1;KIF1C;MYH9;KIF13B;KIF2A;APPBP2;KIF5B;DYNC2H1;KIF16B;KIF27;MYO1E;GPR88;KIF5A;KIF9;KIF20A
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.4236769193364808,-1.0341282737851665,0.41192411924119243,0.7889224335972062,1.0,6/10,30.09%,ANKRD13A;IDE;FAAP20;FAN1;DNAJB2;ANKRD13D
prerank,CoA hydrolase activity (GO:0016289),0.4645583570427553,1.032850829975441,0.46153846153846156,0.8788519807959777,1.0,5/16,22.83%,HIBCH;ACOT13;ACOT9;NUDT7;ACAA2
prerank,ubiquitin binding (GO:0043130),0.36816496652751557,1.0321249201061804,0.4356984478935698,0.8771644194875684,1.0,19/73,17.55%,TNFAIP3;OTULINL;ILRUN;RAE1;CKS1B;TOM1L1;FBXW7;RAD23A;CXCR4;RAD23B;USPL1;FBXO7;NBR1;RNF19B;SMAD3;NEDD4;SQSTM1;RBCK1;MDM2
prerank,GTPase regulator activity (GO:0030695),0.3381922606302185,1.0318690298072175,0.43438453713123093,0.8742923520873318,1.0,48/212,16.40%,DLC1;RGS16;SYDE1;SEC23A;ARHGAP15;LRRK2;ARHGAP24;VAV3;NRP1;ARHGAP32;ARHGAP42;SIPA1L3;ASAP1;ASAP3;DOCK1;ERRFI1;ARFGAP3;TBC1D16;NF1;OPHN1;ARFGAP1;NPRL2;TBC1D2B;RABGAP1L;GPSM2;LLGL1;TBC1D8B;EIF5;RABGAP1;RAB3GAP2;PREX1;RALGDS;PDE6D;RIN2;RGS10;TBC1D1;ADPRH;RAB3GAP1;ARHGAP22;ACAP2;ARHGAP35;TBC1D10B;RTKN;SIPA1L2;ALS2;ARHGAP9;ITGB1BP1;RASA1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.42282516383779223,-1.0317924833342251,0.4481012658227848,0.787600292598075,1.0,7/10,33.95%,DSEL;GALM;RENBP;DSE;GALE;FUOM;RPE
prerank,cyclic nucleotide binding (GO:0030551),-0.3343299844879203,-1.0317749291633278,0.4166666666666667,0.7802473151431458,1.0,7/21,17.76%,PDE4B;RAPGEF2;PDE4D;PDE10A;PDE2A;PDE11A;HCN1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.39351169700856714,-1.0300418392424877,0.4161676646706587,0.7772170012852977,1.0,5/13,12.33%,EZR;PRKAR1A;PRKAR2A;PKIA;KCNQ1
prerank,phospholipase activity (GO:0004620),0.3638305408264055,1.0281352827848729,0.4404494382022472,0.8807410702378261,1.0,16/67,16.48%,LIPC;ASPG;PDIA3;LPL;PLCL1;PLD4;PLA2G12A;PLCB3;ABHD16A;SEC23IP;LYPLAL1;SMPD3;PLA2G4A;PLA2G4E;DDHD2;LYPLA2
prerank,galactosyltransferase activity (GO:0008378),0.4937829749534846,1.0266940997795382,0.45592705167173253,0.8810946912328901,1.0,4/11,17.68%,B4GALT5;B4GALT2;B4GALT7;B4GALT4
prerank,death domain binding (GO:0070513),0.4826009238445148,1.0265570109929867,0.45980707395498394,0.8779437399216882,1.0,2/11,4.98%,DAP;BCL2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.41431911712167646,1.0264328128454203,0.46153846153846156,0.8746926919366467,1.0,2/30,2.96%,KNG1;BIRC3
prerank,G protein-coupled receptor activity (GO:0004930),0.3344971455175602,1.0248562298764883,0.4472361809045226,0.8753655939766745,1.0,25/239,12.75%,MC5R;P2RY10;GPR176;CMKLR1;GPR63;PDGFRB;ADGRL3;RXFP2;ADCYAP1R1;GLP2R;S1PR3;P2RY14;GPR161;S1PR2;CXCR4;DRD3;HRH1;TM2D1;LPAR3;OPN1MW;OPN1MW3;LPAR2;CALCRL;TAPT1;MC1R
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.4002835524569279,-1.0246080823106718,0.4273972602739726,0.784484483619649,1.0,3/12,4.70%,CDH5;VEGFD;CCDC88A
prerank,telomerase RNA binding (GO:0070034),0.42808971695495285,1.0244171504975461,0.44536652835408025,0.8729544805298977,1.0,10/22,21.53%,SMG7;PINX1;TERT;SMG6;DCP2;XRN1;TEP1;PARN;SNRPB;HNRNPC
prerank,syntaxin binding (GO:0019905),0.36781267171067467,1.0243040067553864,0.4539089848308051,0.8697997452440948,1.0,8/61,11.00%,ABCA1;CACNA1A;LRRK2;STX6;STXBP1;SYT2;STXBP3;PTPN2
prerank,Hsp70 protein binding (GO:0030544),0.39782531038919733,1.0234142739361827,0.4411764705882353,0.8687136657750304,1.0,5/31,9.08%,SPN;DNAJB1;IQCG;PPID;CYP1A1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.37700281835839067,1.022696166777159,0.4532710280373832,0.8671328788860087,1.0,16/53,20.08%,STEAP4;ETFA;MTHFR;POR;ACOX1;AIFM2;PPOX;ACOX3;DPYD;AIFM1;MTRR;XDH;CYBB;KDM1A;CYB5R3;SQOR
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3961454934843015,-1.0217940412682702,0.39766081871345027,0.784356455179499,1.0,3/12,19.98%,SLC2A1;SLC5A3;SLC2A8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.4991294414581662,1.0215257198958503,0.4691358024691358,0.8667268392727719,1.0,1/10,3.07%,DPYSL3
prerank,GDP binding (GO:0019003),0.3648762972520997,1.0208198442303829,0.44815668202764974,0.8651551456191686,1.0,14/63,13.50%,RAB2A;RAB42;RALA;RAP2A;RAB21;RAB8B;RAB7A;RRAGC;RAB9A;RAB27B;RERG;GNAI1;RIT1;RAB10
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4701703199424566,1.020616507173415,0.4506172839506173,0.8623098724735834,1.0,7/12,26.60%,PHF2;KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,disordered domain specific binding (GO:0097718),0.42826177268751126,1.0182301342615148,0.4578313253012048,0.8649367979441522,1.0,5/23,13.64%,CLTC;SMAD2;BCL2L2;GAPDH;CALM2
prerank,single-stranded DNA helicase activity (GO:0017116),0.43690457185312614,1.0171252006514577,0.4388888888888889,0.8643920199042268,1.0,3/19,8.70%,DNA2;MCM2;MCM7
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3530435125121176,1.012846411039124,0.4522776572668113,0.872260206300946,1.0,18/91,16.09%,SVIL;SH3PXD2B;MYO1B;SLC9A1;WIPI1;MARK1;SESTD1;TIRAP;MAPKAP1;GBF1;SNX18;EXOC1;VILL;KIF16B;PLEKHA5;WDR45;PLA2G4E;CGAS
prerank,adenyl ribonucleotide binding (GO:0032559),0.33021912013723337,1.012540579364488,0.4763819095477387,0.8697506192035389,1.0,38/291,10.56%,ABCA1;ENPP1;RUNX3;NEK6;MYO1B;KIFC1;MAP4K4;TAOK1;PEAK1;ERN2;RAPGEF4;MARK1;P2RX5;IRAK3;MTHFD1L;STK36;ABCA2;MYH9;ABCG1;AKT3;ACVR1;PYGL;MVK;CDK6;PLK1;VPS4A;CARS2;ABCE1;PXK;MAST2;TGFBR1;GUK1;MAP4K5;TARS1;MLKL;ACVR1B;CDC42BPA;GALK1
prerank,hexosyltransferase activity (GO:0016758),0.3491852574432611,1.0104237220013748,0.46344086021505376,0.8716763572356111,1.0,20/101,18.25%,CHSY3;B4GALNT2;B4GALT5;EXT1;EXT2;B4GALNT1;ALG5;OGT;MGAT4A;CHSY1;GCNT2;DPY19L3;POGLUT3;TMTC4;CHPF2;B4GALT2;B4GALT7;B3GNT9;B4GALT4;FUT4
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.4141824696976152,-1.0095037167019691,0.4441340782122905,0.8081789225709464,1.0,3/11,28.05%,SLC5A3;SLC2A9;SLC17A5
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.4080785035172398,1.0090884853554873,0.4738219895287958,0.8718017790443989,1.0,1/27,0.13%,SLC39A14
prerank,phosphatase activator activity (GO:0019211),0.4626667276574094,1.0082607496229736,0.47234678624813153,0.8707140628748827,1.0,10/14,27.73%,FRS2;PPP2R5A;GTF2F1;CALM2;PPP2R5C;PHACTR4;CALM3;PPP2R5E;PPP2R5D;B3GAT3
prerank,3'-5' exonuclease activity (GO:0008408),-0.2659328396453155,-1.005893108214422,0.43820224719101125,0.8103994258460699,1.0,17/45,25.65%,MRE11;CNOT8;EXOSC7;APLF;CNOT6L;RAD1;EXOSC3;EXD1;ANGEL2;REXO4;TOE1;ANGEL1;PDE12;EXOSC10;NOCT;TATDN1;RAD50
prerank,amino acid:sodium symporter activity (GO:0005283),0.4793769924312922,1.0058709441313167,0.4799357945425361,0.873582485842649,1.0,1/11,0.63%,SLC1A3
prerank,mRNA methyltransferase activity (GO:0008174),0.48085600228087455,1.0053131998459968,0.5,0.8717381331934713,1.0,8/12,31.41%,METTL16;TRMT61B;TRMT61A;PCIF1;RNMT;METTL14;METTL8;NSUN2
prerank,voltage-gated anion channel activity (GO:0008308),-0.36581448778519177,-1.0034531596598535,0.44047619047619047,0.8095423403238162,1.0,5/15,7.65%,GPR89B;GPR89A;CLCN2;CLCN3;VDAC1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.4105369155323918,1.0011415930726453,0.47549668874172185,0.8788645819150657,1.0,5/29,11.67%,TNIP1;DUSP2;DUSP5;PTPRJ;NBR1
prerank,GTPase activator activity (GO:0005096),0.32637078796011354,1.0003926098146387,0.5075528700906344,0.877416979710356,1.0,73/313,16.62%,DLC1;RGS16;SYDE1;FARP2;SEC23A;VAV2;ARHGAP15;FARP1;LRRK2;MYCBP2;ARHGAP24;VAV3;RAPGEF4;NRP1;ARHGAP32;CYTH3;ARHGAP42;SIPA1L3;KALRN;ASAP1;ITSN1;ASAP3;DOCK1;ERRFI1;ARFGEF2;RABIF;ARFGAP3;TBC1D16;NF1;NUCB2;OPHN1;FGD4;EGF;ARFGAP1;NPRL2;TBC1D2B;RABGAP1L;LLGL1;DENND4C;TBC1D8B;RABGAP1;RAB3GAP2;PREX1;FNIP1;DENND5A;FGD6;RASGEF1B;VAV1;RIN2;IQSEC2;AKAP13;RGS10;TBC1D1;SMCR8;ADPRH;SH3BP5L;RAB3GAP1;ANKRD27;ARHGAP22;ACAP2;ARHGEF18;ARHGAP35;TBC1D10B;DNMBP;SIPA1L2;ALS2;RCC1;ARHGAP9;RGL1;EIF2B3;RASA1;DOCK2;LAMTOR5
prerank,protein kinase C activity (GO:0004697),-0.3784503517228411,-0.9995162581210942,0.4376899696048632,0.8122598817731288,1.0,3/14,4.77%,PRKCH;PRKCZ;PRKCB
prerank,phosphatidylinositol binding (GO:0035091),-0.2396870012291939,-0.995693155776663,0.4691358024691358,0.8154425717669131,1.0,25/91,17.80%,PITPNC1;MCF2L;EPB41;DENND1A;ITPR2;PITPNM2;PITPNA;HIP1R;ESYT2;CCDC88A;ESYT1;SCARB1;PLEKHF2;ITPR3;PARD3;SNX16;TNFAIP8L3;HIP1;GPAA1;ESYT3;MREG;SNX11;SNX13;FCHO2;SNAP91
prerank,DNA replication origin binding (GO:0003688),0.41983213554094,0.9953003393672014,0.48923959827833574,0.8867954023840013,1.0,5/23,10.37%,MCM2;DDX11;MCM7;GRWD1;MCM9
prerank,N-acetyltransferase activity (GO:0008080),0.42559734010256334,0.9916352128187391,0.5007278020378457,0.8930746097530143,1.0,3/19,10.81%,NAT1;NAA50;NAT10
prerank,channel activity (GO:0015267),0.3763566382314694,0.9896838283923817,0.48825710754017304,0.8944620079071733,1.0,7/41,18.56%,P2RX5;TMEM120B;BCL2;TMEM266;PDPN;TMEM120A;PANX1
prerank,carboxy-lyase activity (GO:0016831),-0.31436682200006055,-0.989101480737929,0.42448979591836733,0.825565018051979,1.0,7/23,25.24%,PPCDC;ECHDC1;DDC;GAD1;CSAD;UXS1;MLYCD
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3242252514556736,0.9868295141921345,0.541497975708502,0.8981014749699048,1.0,59/268,18.40%,GLMN;POU5F1;NEK6;NKD2;MID1;JAK1;STAT1;CD40;SMAD2;EGFR;IKBKE;CUL1;BCL2;AMBRA1;RALA;BAG6;SPOP;ABI2;FBXW7;ARIH1;CXCR4;SMAD5;UBE2L3;ACVR1B;UQCRC1;SNX9;YWHAZ;UBE2J1;FBXO7;CASP8;CALR;GSK3B;MC1R;UBE2K;TANK;TRAF2;DDRGK1;SMAD3;UBE2W;EGR2;TRIB3;RPL11;DTX3L;WASHC1;HSPA5;TRIB1;RIPK1;PATZ1;ITCH;HIF1A;SQSTM1;TRAF5;BAG4;HSPD1;YWHAE;MDM2;SLF2;NFKBIA;MFHAS1
prerank,nuclear localization sequence binding (GO:0008139),0.43183829767653387,0.9839153922921036,0.49487554904831627,0.902192720809513,1.0,8/18,23.08%,KPNA3;BRAP;NUP153;TNPO1;NFKBIA;NUP214;KPNA2;KPNB1
prerank,phosphate ion binding (GO:0042301),-0.4079137305136157,-0.9829631910581694,0.4723756906077348,0.833970751712102,1.0,4/10,31.93%,PDE2A;MTHFD2;ADSS1;RPH3A
prerank,manganese ion binding (GO:0030145),0.3663450026922196,0.9819444600791448,0.5066666666666667,0.9037836863954073,1.0,8/48,15.52%,MGAT5;GALNT3;ADCY2;XPNPEP1;NEK4;TDP2;XPNPEP3;B4GALT7
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4633216197323626,0.9811511108643517,0.5265486725663717,0.9024198157512844,1.0,5/13,16.70%,GPSM2;ARHGDIG;EIF5;ITGB1BP1;ARHGDIA
prerank,3'-5' DNA helicase activity (GO:0043138),0.4270570706429532,0.9811485218790079,0.4658119658119658,0.8991588682412696,1.0,4/16,10.03%,ASCC3;MCM2;MCM7;FBH1
prerank,SUMO binding (GO:0032183),0.4451209684853197,0.9811076960021577,0.5207715133531158,0.8960172385960145,1.0,3/13,9.90%,CASP8AP2;RNF111;USPL1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.4448062959754366,0.9802913256110095,0.5050215208034433,0.894767683607025,1.0,3/15,15.97%,PLA2G12A;PLA2G4A;PLA2G4E
prerank,histone methyltransferase activity (GO:0042054),0.3921418236078891,0.9770333980668945,0.5006501950585176,0.8994238672415521,1.0,14/32,25.64%,KMT5A;EHMT1;CARM1;SETD2;SETDB1;KMT2E;NSD3;N6AMT1;SUZ12;DOT1L;PRMT5;KMT2C;SETD7;KMT5B
prerank,pre-mRNA binding (GO:0036002),-0.3017844213495848,-0.9764085397933144,0.4845814977973568,0.8442414925593417,1.0,6/28,11.96%,DDX5;CELF2;HNRNPU;U2AF2;SNRPC;HNRNPA1
prerank,peptidase activator activity (GO:0016504),-0.317935781197478,-0.9758538211657521,0.4833948339483395,0.8383651409595034,1.0,7/22,12.72%,CAV1;MAL;APH1A;VSIR;APH1B;PCOLCE2;PINK1
prerank,DNA polymerase activity (GO:0034061),0.4058205687903727,0.972923043869395,0.5060240963855421,0.9061663566455767,1.0,5/22,15.52%,POLE3;TERT;POLI;REV1;POLG
prerank,RNA binding (GO:0003723),0.3122582658945684,0.9719586185305488,0.646,0.9050859531803049,1.0,335/1321,22.00%,RBMS3;IGF2BP1;ZBP1;DCN;FNDC3B;RBM46;POU5F1;CLTC;BICC1;RPSA;RRBP1;RBMS1;RFTN1;C1D;LRP1;RPUSD3;ALDH18A1;ZFP36L1;IGF2BP2;APOBEC1;RBFOX1;EIF4G2;MAK16;CCAR1;CSRP1;SYNCRIP;ZFP36L2;ATXN2;ZCCHC24;AFF2;PDIA3;EIF4G3;SMC1A;DNA2;SREK1;DNTTIP2;ASCC3;MRPS26;RPL3L;ARCN1;NOL11;STAT3;FSCN1;ILF3;DYNC1H1;PPRC1;KIF1C;MYH9;ZC3H13;KHDRBS1;PUM1;SNRNP40;DNAJC21;SERPINH1;SMG7;ZFR;SPATS2;PES1;SELENOH;XPOT;TENT5A;SHFL;RAE1;ARL6IP4;SNTB2;CNOT4;CSTF1;METTL16;EIF4A1;ERI1;MYO5A;EIF2AK2;DDX11;ENO1;DHX35;YARS1;PTBP3;STXBP1;CCDC86;TLR7;DAP3;PINX1;SUB1;TRUB2;ACO1;PDAP1;DDX17;NOC2L;EIF3H;HSPE1;CAPRIN1;PTPN1;GIGYF2;FUBP1;ZC3H15;POP1;RRP1B;RRP1;DIDO1;CANX;SAMD4A;AIMP1;NMD3;CCAR2;PABPC4;CKAP4;MSN;CELF1;BUD13;TERT;TNRC6B;GRB2;SMG6;EIF5B;UBFD1;SAP18;EIF5;CCDC9B;PSMA6;DCP2;MTERF4;NONO;RNASEH1;SEC63;DICER1;SND1;NOP14;UBE2L3;OASL;DHX8;DHX34;GRWD1;NOP2;HMGB2;PELP1;NIP7;ALKBH5;NCBP2;ALKBH1;HNRNPH2;DDX28;RAMAC;UTP3;CCDC59;NAT10;CHD2;MOV10;SEC23IP;XRN1;DMGDH;YWHAZ;TNPO1;RPL12;CS;STAU1;MRM1;RCAN3;MTIF2;SNRNP35;SAFB;TRAP1;CALR;ANKRD17;ZCCHC8;RARS2;UBAP2L;SRP68;DDX31;POP4;AGFG1;ANP32A;HEATR6;GNL3;IREB2;SRSF12;RPL22;RPL14;SAFB2;MRPL15;NUDT4;GTF2F1;LSM14B;COL14A1;YBX3;NSRP1;ARF1;RBM6;ELP1;ZCCHC17;MRPS14;YTHDF3;FMR1;RBM10;CCT3;PPHLN1;CPEB4;RPL11;HELZ;AKAP1;DCP1A;BAZ2A;NOLC1;SNRNP200;DXO;PATL1;NAA15;KYAT3;SETX;GSPT1;RTRAF;FLNB;CTNNA1;RBM28;PRPF31;WDR36;NOP16;BYSL;TRIM56;RPN1;LSM7;EIF1;EIF1AX;PRKDC;RBMX;MAP4;SLC4A1AP;SRP14;DDX50;RSRC2;HNRNPUL1;BAG4;RBM47;FNDC3A;RPF1;DHX29;SIDT2;POLRMT;TEP1;PRRC2C;HSPD1;MTREX;NUCKS1;DHX15;RC3H2;TCERG1;THRAP3;YWHAE;RBFOX2;ZNFX1;DDX1;ZCCHC7;RPL36A;ZNF346;TUT7;NUDT7;RPS9;SRFBP1;PRPF3;USP36;MSI1;DDX20;R3HDM1;RBM15;SPEN;CDC42EP4;RBM39;SRSF2;SPTBN1;HSP90B1;TBL2;CPNE3;PARN;GANAB;FASN;MBNL2;SON;RPL6;SRP72;TASOR;MRPS27;EFTUD2;PUF60;KDM1A;CELF5;AGO2;FARS2;SNRPB;LGALS1;MYEF2;DUS2;ETF1;KPNA2;NAP1L1;CDK13;ATP5F1A;DUSP11;HNRNPDL;POLR1G;CAST;UTP11;RBM4B;EIF4G1;ZC3H12B;ACTN1;RBMS2;SCAF11;DDX24;BZW1;NEMF;TOP3B;DHX57;LYAR;YY1;CSDE1;MAP3K20;ZC3H12A;ZRANB2;ERI3;DHX37;BMS1;FAM133B;HNRNPC;RPS27A;KRI1;YBX1;CLUH;FTSJ3;RBBP6;SCAF4;MARK2;RSL1D1;ANKHD1;DDX10;FYTTD1;USO1
prerank,microtubule motor activity (GO:0003777),0.35481160432853737,0.9718491892436029,0.5178997613365155,0.9020999696783615,1.0,6/51,6.00%,KIF26B;KIFC1;KIF1C;KIF13B;KIF2A;APPBP2
prerank,ubiquitin protein ligase binding (GO:0031625),0.319300328357168,0.9710317545995222,0.569838056680162,0.9008610340833832,1.0,55/253,18.40%,GLMN;POU5F1;NEK6;NKD2;MID1;JAK1;CD40;SMAD2;EGFR;IKBKE;CUL1;BCL2;AMBRA1;RALA;BAG6;SPOP;ABI2;FBXW7;ARIH1;CXCR4;SMAD5;UBE2L3;ACVR1B;UQCRC1;SNX9;YWHAZ;UBE2J1;FBXO7;CASP8;CALR;GSK3B;MC1R;UBE2K;TANK;TRAF2;SMAD3;UBE2W;EGR2;TRIB3;RPL11;WASHC1;HSPA5;TRIB1;RIPK1;PATZ1;HIF1A;SQSTM1;TRAF5;BAG4;HSPD1;YWHAE;MDM2;SLF2;NFKBIA;MFHAS1
prerank,retinoic acid binding (GO:0001972),0.4656849957046714,0.9707226774967468,0.5126984126984127,0.8983343592562049,1.0,1/12,4.15%,NR2F2
prerank,death receptor activity (GO:0005035),0.4677284462407655,0.969878038740516,0.5184049079754601,0.8971672250973365,1.0,3/11,11.94%,EDA2R;TNFRSF1A;TNFRSF4
prerank,mRNA binding (GO:0003729),0.31622226717853436,0.969395962849842,0.5865191146881288,0.8951610485306433,1.0,36/249,14.89%,RBMS3;IGF2BP1;RBM46;RBMS1;ZFP36L1;IGF2BP2;RBFOX1;EIF4G2;SYNCRIP;EIF4G3;KHDRBS1;PUM1;CPEB1;SHFL;EIF4A1;PTBP3;CARHSP1;ACO1;FUBP1;SAMD4A;PABPC4;CELF1;NCBP2;SNRNP35;CALR;MARF1;GNL3;IREB2;LSM14B;YBX3;NSRP1;YTHDF3;FMR1;CPEB4;DCP1A;DXO
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3150203603997516,0.9690294958753897,0.5737211634904714,0.8928984707856452,1.0,65/346,16.63%,TRIML2;SH3RF3;CBLB;DTX4;RNF150;PDZRN3;MYLIP;MYCBP2;TNFAIP3;BIRC3;CUL1;SMURF2;UBR5;TRIM21;UBR4;RNF2;CNOT4;RNF144A;ANAPC11;CDC42;SIAH2;MIB1;RNF111;KLHL13;TRIM13;CBL;AREL1;ARIH1;BRAP;SH3RF1;RNF145;DTX2;UBE2L3;PELI3;TRIM44;UBE2R2;NEURL2;UBE2J1;FBXO7;RNF213;KCTD10;RNF19B;PJA2;FBXW11;RNF181;RNF149;UBE2K;TRAF2;KCMF1;MAEA;UBE2W;FBXO2;RNF11;DTX3L;RNFT2;RNF141;SMURF1;ITCH;NEDD4;TRIM56;PELI2;RBCK1;TRAIP;TRAF3IP2;TRAF5
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3441149670218995,0.9683801401328784,0.5472972972972973,0.8911906363707767,1.0,24/74,20.26%,PAPSS2;DCAKD;HK2;FAM20A;MVK;TRPT1;DGKH;GALK2;ADPGK;PANK2;GALK1;GK;KHK;PI4KA;SPHK2;COASY;PANK1;NADK;FAM20B;PIK3C3;POMK;FAM20C;HYKK;ETNK1
prerank,cation transmembrane transporter activity (GO:0008324),0.3580180128159356,0.9678916353100906,0.5125448028673835,0.8893440105728682,1.0,2/48,1.80%,SLC7A2;SLC38A3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.4259746613295179,0.9667910863917075,0.5445402298850575,0.8887177320607403,1.0,3/18,9.05%,ALDH18A1;ALDH1A2;HSD17B12
prerank,kinase activator activity (GO:0019209),-0.288321022032978,-0.9653088892712837,0.5255813953488372,0.8597650202999232,1.0,3/30,4.99%,PRKAG2;MALT1;MADD
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.4646087635102525,0.965300947687203,0.5213270142180095,0.8891040299832571,1.0,3/11,12.85%,UBR5;ANAPC11;UBE2K
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.370530536963725,-0.9645893524018545,0.4868035190615836,0.8544905836794016,1.0,4/12,13.05%,PIK3R3;PIK3CB;PIK3R6;PIK3CD
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.44387177606582406,0.9621258855285915,0.5066469719350074,0.8934809126924278,1.0,2/13,9.55%,DNA2;DICER1
prerank,translation elongation factor activity (GO:0003746),-0.35803710952160983,-0.9613349707609932,0.5075075075075075,0.8560385387099569,1.0,8/14,36.78%,EEF1B2;GTPBP2;TSFM;EEF2;GFM1;TUFM;EIF5A;EIF5AL1
prerank,methyltransferase activity (GO:0008168),0.35787069135832256,0.961146101969135,0.5481852315394243,0.8926950832825443,1.0,15/46,24.63%,ASMT;AMT;EHMT1;DNMT3B;MRM2;MGMT;COQ5;COMT;PRMT3;BCDIN3D;N6AMT1;FTSJ3;NDUFAF7;PRMT5;COQ3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.30521343683399993,-0.9606636312072133,0.5390334572490706,0.8507469380736966,1.0,6/24,16.77%,GLUL;ZDHHC21;ZDHHC17;ZDHHC14;ZDHHC15;ZDHHC2
prerank,tropomyosin binding (GO:0005523),-0.34605664320204194,-0.9598350965895441,0.5,0.845788536218705,1.0,2/16,3.95%,NEBL;TMOD3
prerank,C-C chemokine receptor activity (GO:0016493),0.4055512707081622,0.959771174606377,0.5373961218836565,0.8928127583332075,1.0,2/21,8.99%,CCR1;CXCR4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3992796668394041,0.959350625181646,0.5317460317460317,0.8877061962129684,1.0,10/21,23.92%,CDK6;CDK14;CDK10;CDK7;CDKL1;CDK9;CDK13;CDK12;CDK11B;CDK8
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3992796668394041,0.959350625181646,0.5317460317460317,0.8877061962129684,1.0,10/21,23.92%,CDK6;CDK14;CDK10;CDK7;CDKL1;CDK9;CDK13;CDK12;CDK11B;CDK8
prerank,myosin binding (GO:0017022),0.348146497818627,0.9582269996876542,0.5239766081871345,0.8873456231467608,1.0,11/55,13.50%,NKD2;MLPH;CALD1;TRAK1;RALA;LLGL1;CXCR4;RAB27B;RHOA;GIPC1;RAB10
prerank,LRR domain binding (GO:0030275),0.4371108992120909,0.9569608612620154,0.5210843373493976,0.8872066074100158,1.0,4/14,19.75%,MRTFA;PAWR;ATF4;PMF1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.4512656294344423,0.954837355622129,0.52,0.8889802625285045,1.0,1/11,3.41%,SLC25A47
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.3484390070024952,0.9535469790235709,0.5448113207547169,0.8890922276406027,1.0,10/55,16.24%,SLC7A2;SLC38A3;SLC38A4;SLC16A12;SLC36A2;SLC7A8;PDPN;ABCC1;SLC25A10;SLC16A6
prerank,phosphoric diester hydrolase activity (GO:0008081),0.36424842934076956,0.9531599938595047,0.5314070351758794,0.8869837625124907,1.0,9/35,15.26%,ENPP1;PLCXD3;PDIA3;PLCL1;PLD4;PLCB3;TDP2;SMPD3;SMPDL3B
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.40226689145547084,0.951821207673749,0.5337837837837838,0.8870452120707689,1.0,6/22,20.59%,DUSP2;DUSP5;DUSP6;MTMR3;MTMR2;DUSP15
prerank,exonuclease activity (GO:0004527),0.35337525185687274,0.9517336222605877,0.5457788347205708,0.8843016150831324,1.0,5/46,8.81%,ENPP1;REXO1;ERI1;DCLRE1C;EXOSC4
prerank,voltage-gated ion channel activity (GO:0005244),0.43373516169541737,0.9514725674869788,0.5464071856287425,0.8819714658276178,1.0,3/14,5.25%,HVCN1;PKD2;VDAC2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.45165969211339196,0.9512753844797549,0.5375191424196019,0.8795139241752801,1.0,8/12,23.92%,CDK6;CDK7;MAPK1;BRD4;CDK9;CDK13;CDK12;CDK8
prerank,lysine-acetylated histone binding (GO:0070577),0.4020011392494632,0.9511263983844862,0.5350756533700137,0.8741291880470491,1.0,6/20,19.16%,KMT2A;CARM1;BAZ2A;SMARCA4;BRD4;THAP7
prerank,acetylation-dependent protein binding (GO:0140033),0.4020011392494632,0.9511263983844862,0.5350756533700137,0.8741291880470491,1.0,6/20,19.16%,KMT2A;CARM1;BAZ2A;SMARCA4;BRD4;THAP7
prerank,pyridoxal phosphate binding (GO:0030170),-0.3169934591987686,-0.9508836049838517,0.5321428571428571,0.8617018420412599,1.0,8/20,19.46%,ABAT;PYGM;PLPBP;PYGB;ACCS;PDXK;PSAT1;CBS
prerank,thioesterase binding (GO:0031996),0.4543734135031138,0.9507107316164716,0.5321821036106751,0.8721513339549912,1.0,4/11,16.63%,CDC42;TRAF2;RAC1;TRAF5
prerank,histone methyltransferase binding (GO:1990226),0.4593778910665633,0.9467965338656016,0.5373608903020668,0.8778361108105224,1.0,4/11,17.86%,PHF1;LCOR;LCORL;PRDM4
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.44433568434533416,0.9447620272453569,0.5358208955223881,0.879317492708684,1.0,4/12,23.10%,OPN1MW;OPN1MW3;GPR88;RRH
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3655723398916589,0.9438676934077588,0.5689655172413793,0.8784039127936234,1.0,10/38,14.71%,GAB2;LRRK2;IRS1;NCK1;NCK2;SH2B2;FRS2;PIK3R1;DLG5;MMS19
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.45877268721083286,0.9427261791036934,0.5402843601895735,0.8781785935006708,1.0,2/11,5.13%,ITPR1;TRPC6
prerank,cadherin binding (GO:0045296),0.30505076046617513,0.942352534013488,0.6576576576576577,0.8762224800285578,1.0,84/315,17.95%,CDH11;MYO1B;EIF4G2;FMNL2;STAT1;GOLGA3;DNAJB1;CALD1;TNKS1BP1;EGFR;ASAP1;FSCN1;CHMP4B;MYH9;PARVA;LIMA1;BAG3;NCK1;BAIAP2;CEMIP2;DCHS1;ACVR1;ENO1;CDH6;VAPA;PTPN1;GIGYF2;ZC3H15;EPS15L1;CBL;UBFD1;EIF5;ANXA1;CCT8;LASP1;PPFIBP1;SND1;DBN1;MB21D2;CNN3;CLINT1;PLCB3;PTPRJ;SNX9;YWHAZ;CCNB2;CDH18;CDH24;RUVBL1;DBNL;PTPRM;SNX2;EPS15;NUMB;PI4KA;SNX5;KIF5B;RARS1;ABI1;PPME1;GIPC1;RPL14;RAB1A;RAB10;PCMT1;PSEN1;SRC;STK24;PHLDB2;HSPA5;CHMP2B;FLNB;CTNNA1;CDC42EP1;EXOC3;LYPLA2;SH3GLB1;DHX29;CSNK1D;YWHAE;CTTN;CKAP5;PICALM;CAPZA1
prerank,histone acetyltransferase activity (GO:0004402),0.3742369984984364,0.9368583961716309,0.5472186287192755,0.885476828861723,1.0,10/30,21.43%,BAZ1A;NAA50;CREBBP;EPC2;USP22;SRCAP;CLOCK;KAT6B;KAT7;TADA3
prerank,GTPase binding (GO:0051020),0.30607541503049185,0.9352709855495418,0.6353421859039836,0.8860061299929455,1.0,50/194,18.75%,ABCA1;MLPH;LRRK2;MYCBP2;STOML2;RAPGEF4;AMBRA1;FGD4;MYO5A;ENO1;RABGAP1L;UNC13D;EXOC4;ABI2;AIMP1;MAPKAP1;GOLGA5;CHML;RRAGC;LCP1;RABGAP1;TRIP11;RAB3GAP2;ANKFY1;BRK1;PIH1D2;FGD6;PDE6D;AKAP13;SPHK2;RAB3GAP1;ANKRD27;YBX3;RAB34;ATG16L1;RANBP9;RTKN;RABGGTB;EXOC5;ALS2;RCC1;RASA1;CCDC186;GNB2;TBC1D20;PICALM;CDC42EP4;GNB1;EPS8;SPTBN1
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.24024383605684674,-0.935041652840182,0.5555555555555556,0.8947307694523002,1.0,8/49,8.42%,ANXA3;C2CD5;MCTP1;ESYT2;PCLO;ESYT1;DYSF;SYT7
prerank,G protein-coupled receptor binding (GO:0001664),0.31396361486839036,0.9298166466305055,0.6243496357960457,0.8944220837414082,1.0,13/132,10.99%,WNT2;CXCL12;XCL1;WNT9A;ADM;CCL5;FZD1;SFRP1;LRP6;S1PR2;WNT5A;ARHGEF12;GNAI1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.41933812973794804,0.927230722251228,0.5614567526555387,0.8967792803984277,1.0,2/14,2.54%,FETUB;TIMP1
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3348961839020254,-0.9258097561728225,0.5551948051948052,0.9111166149244218,1.0,3/16,8.47%,SLC25A42;SLC25A26;SLC22A4
prerank,epidermal growth factor receptor binding (GO:0005154),0.38349759638255887,0.924362274788671,0.5653333333333334,0.9000796906728074,1.0,7/25,16.56%,ATXN2;EGF;GRB2;ARF4;SNX2;BTC;SNX4
prerank,glucose transmembrane transporter activity (GO:0005355),-0.32470413229519623,-0.9239789144252047,0.5868852459016394,0.908453710604467,1.0,3/17,19.98%,SLC2A1;SLC5A3;SLC2A8
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3300168734174486,0.9235602189114215,0.5891829689298044,0.8989102473470227,1.0,20/60,22.74%,LRRK2;PTEN;CTDSPL2;LRRK1;LRRC39;PPP3CA;PPP1CB;ILKAP;PPP4C;CDC14A;TIMM50;PPP6C;PHLPP2;MTMR3;RPAP2;MTMR6;CDC14B;LRRC40;PPM1H;PPM1D
prerank,sequence-specific mRNA binding (GO:1990825),0.4471485813875612,0.9234641047309923,0.5477707006369427,0.8962845366877943,1.0,4/10,24.51%,SHFL;FMR1;ETF1;TYMS
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3226566529349667,-0.9185953969814226,0.5836065573770491,0.9152502797105122,1.0,1/16,0.62%,PIR
prerank,proton transmembrane transporter activity (GO:0015078),0.3492134074974746,0.9181475216249209,0.5869297163995068,0.9043894948229841,1.0,7/39,11.33%,SLC9A1;SLC11A2;CLCN5;COX7A2L;DMAC2L;UQCRC1;ATP6V1F
prerank,filamin binding (GO:0031005),-0.3661519198972858,-0.9179114909263658,0.5346260387811634,0.9096689840280618,1.0,1/11,0.02%,NEBL
prerank,fibroblast growth factor receptor binding (GO:0005104),0.38815179963091145,0.9168943288590706,0.5829662261380323,0.9040167842543153,1.0,4/21,15.69%,FGF7;FRS2;FGF2;FGF18
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.3695998738993025,-0.9153671374636242,0.568,0.9091473229535747,1.0,8/11,52.87%,HCN1;CNGB1;HCN4;CNGB3;AQP1;CNGA2;CNGA4;CNGA3
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.45134262026689614,0.9151473068471401,0.573228346456693,0.9047184826964149,1.0,2/10,14.24%,CDKN2B;CDKN1B
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.38958102136398476,0.9142482551891352,0.5704514363885089,0.9037893127648027,1.0,5/20,12.34%,CASK;DTYMK;GUK1;AK2;AK8
prerank,deoxyribonuclease activity (GO:0004536),-0.3433808295179728,-0.9118191318327291,0.5664739884393064,0.9108650008637509,1.0,3/14,7.93%,ERCC5;MRE11;APLF
prerank,ligand-gated calcium channel activity (GO:0099604),0.398792892680939,0.9111670863690854,0.5963687150837989,0.9070171599361774,1.0,2/19,4.84%,RASA3;ITPR1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.37725963496123016,0.9105347157385778,0.5950196592398427,0.9055236122503504,1.0,10/25,20.47%,GAB2;SESTD1;DAPP1;MAPKAP1;KIF16B;PLA2G4E;PLEK;AKT1;PLEKHA2;ZFYVE1
prerank,clathrin adaptor activity (GO:0035615),0.41298937987245665,0.9098098171922674,0.58,0.9042388635709334,1.0,1/15,0.76%,STON2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3074100354517972,0.9091319414273392,0.6552440290758048,0.9027427560466462,1.0,38/147,16.62%,FARP2;VAV2;FARP1;MYCBP2;VAV3;RAPGEF4;CYTH3;KALRN;ITSN1;DOCK1;ARFGEF2;RABIF;NUCB2;FGD4;EGF;DENND4C;RAB3GAP2;PREX1;FNIP1;DENND5A;FGD6;RASGEF1B;VAV1;RIN2;IQSEC2;AKAP13;SMCR8;SH3BP5L;RAB3GAP1;ANKRD27;ARHGEF18;DNMBP;ALS2;RCC1;RGL1;EIF2B3;DOCK2;LAMTOR5
prerank,antiporter activity (GO:0015297),0.387473052168344,0.9049292611229106,0.5798090040927695,0.90836721751113,1.0,7/20,23.97%,SLC25A16;SLC35C1;TMEM241;SLC35D2;SLC25A10;CLCN4;SLC35E3
prerank,GTP binding (GO:0005525),0.2978507124745976,0.903282873771487,0.6755102040816326,0.9088257458815983,1.0,29/172,15.00%,RND3;RHOJ;LRRK2;RAB2A;TUBG1;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB7A;RRAGC;RAB9A;RAB32;RAB27B;GBP7;RERG;ARF4;GNAI1;RIT1;RHOA;GNL3;RAB10;ARF1;RAC1;ANXA6
prerank,single-stranded RNA binding (GO:0003727),-0.25198550898440747,-0.9031096209229985,0.6373626373626373,0.9251437027619659,1.0,15/43,22.00%,STRBP;HNRNPU;AQR;U2AF2;ADARB2;SNRPC;HNRNPA1;SRA1;POLR2G;EIF4H;CNBP;FXR1;IFIH1;AGO3;EXOSC10
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3783690494114149,0.9028190536862649,0.5994513031550068,0.9070292279226473,1.0,5/22,16.50%,TNFAIP3;IKBKE;RNF169;SQSTM1;ATRIP
prerank,calcium:sodium antiporter activity (GO:0005432),-0.3747020487963759,-0.9008118377445038,0.5882352941176471,0.9241306408570832,1.0,4/10,19.38%,SLC24A2;SLC8A3;SLC8B1;SLC8A2
prerank,tRNA methyltransferase activity (GO:0008175),-0.32713930168230787,-0.9008089859921834,0.6020761245674741,0.917251594885603,1.0,8/16,27.66%,ALKBH8;TRMT9B;TRDMT1;LCMT2;TRMT5;TRMT44;TYW3;TRMT12
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.395340848336606,0.8995939211227214,0.607898448519041,0.9107774343751246,1.0,7/18,20.69%,ACVR1;TGFBR1;LTBP1;ACVR1B;ACVR2A;ACVRL1;BMPR1A
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.39125370142156535,0.8993109947543921,0.5940860215053764,0.9085625528421081,1.0,2/21,3.43%,PDE3A;PDE7B
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.3837546800886442,0.8992408114515774,0.5965834428383706,0.905975759652823,1.0,2/23,3.43%,PDE3A;PDE7B
prerank,endopeptidase activator activity (GO:0061133),-0.3679508359299911,-0.8982066996221826,0.5786666666666667,0.9167796974993276,1.0,5/10,25.21%,APH1A;VSIR;APH1B;PSME1;ADRM1
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.23541212152451552,-0.8978969828793832,0.6783216783216783,0.9107780428793739,1.0,7/55,5.30%,SLC24A2;CACNB2;ITPR2;TMEM165;ATP2B4;ATP2B2;TMCO1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.32569659719673627,-0.8942193844223618,0.6041055718475073,0.9065001732532538,1.0,9/16,37.28%,ATP6V1B2;ATP6V0B;ATP6V0E2;ATP6V0D1;ATP6V1A;ATP6V0C;ATP6V0A1;ATP6V0D2;ATP6V0A4
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.32569659719673627,-0.8942193844223618,0.6041055718475073,0.9065001732532538,1.0,9/16,37.28%,ATP6V1B2;ATP6V0B;ATP6V0E2;ATP6V0D1;ATP6V1A;ATP6V0C;ATP6V0A1;ATP6V0D2;ATP6V0A4
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.31372539575898245,0.8922669890873297,0.6568516421291053,0.9167223331617073,1.0,18/75,21.13%,EHHADH;DHRS4;AKR1A1;RDH12;RDH10;HSD17B8;KCNAB1;H6PD;GLYR1;UGDH;DHDH;ADH1A;SORD;IMPDH2;DHRS3;DCXR;ADH5;HIBADH
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.41561590185843106,0.891372466611799,0.6136363636363636,0.9158919742500872,1.0,2/13,5.33%,PIP5K1B;PIP4K2A
prerank,protein kinase regulator activity (GO:0019887),0.3092329182351644,0.8910127092972432,0.6550264550264551,0.9138033323936223,1.0,28/95,22.62%,CCNE2;PARVA;NCK1;CCNL1;CCND3;CXCL10;TAOK3;GSKIP;RPTOR;PRKAR1B;TPX2;CCNB2;GMFB;FGF13;CCNI;SMCR8;SH3BP5L;CDKN1B;TRIB1;CCNT1;DNAJC3;MAPK8IP1;CCNL2;DUS2;SPRY4;MARK2;RGCC;CCNH
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.3684551341175534,-0.890187936141466,0.5863013698630137,0.9095259834110168,1.0,3/11,11.11%,SRRM2;LEF1;GATA2
prerank,pyrophosphatase activity (GO:0016462),0.3313116329402396,0.8873592589472932,0.6430205949656751,0.9183127519230241,1.0,10/50,17.85%,ENPP1;PPA1;DCP2;ENTPD7;NUDT14;NUDT4;ENTPD6;DXO;DHX29;NUDT7
prerank,protein phosphatase 2A binding (GO:0051721),0.36923121852081103,0.8867655176919061,0.6208791208791209,0.9167455599572024,1.0,8/23,20.13%,SMG7;STRN;PPME1;CTTNBP2NL;PTPA;ANKLE2;MFHAS1;STRN4
prerank,kinase activity (GO:0016301),0.30206423268243876,0.8865974260142205,0.6687898089171974,0.914372392528208,1.0,24/109,17.14%,MAP4K4;PAPSS2;TAOK1;LRRK2;DCAKD;MVK;ITPKC;DGKH;FN3KRP;ADPGK;CSNK2A1;IP6K2;PANK2;GK;COQ8B;GSK3B;PI4KA;SPHK2;TRIB3;COASY;PANK1;NADK;PIK3C3;AKT1
prerank,gap junction channel activity (GO:0005243),0.3675808575038706,0.8813269647247807,0.6221009549795361,0.9215728796200698,1.0,3/22,7.90%,GJC2;GJD3;GJC1
prerank,N-methyltransferase activity (GO:0008170),-0.29938366339452216,-0.8805105353590182,0.6548042704626335,0.9253201011421691,1.0,7/20,18.35%,ZCCHC4;TRMT1L;HNMT;TFB1M;PRMT1;DIMT1;NNMT
prerank,ion gated channel activity (GO:0022839),0.36398913360281104,0.8791461226207199,0.6174033149171271,0.9230580545834429,1.0,6/24,20.68%,KCNT2;TRPM4;ANO10;TTYH1;ANO6;TMEM63B
prerank,microtubule binding (GO:0008017),0.2900928468932924,0.8783224990066825,0.7482376636455186,0.9218676363058969,1.0,47/222,17.93%,KIF26B;MID1;KIFC1;MAP4K4;CEP295NL;LRRK2;EML4;CCDC170;NAV3;KIF1C;MAP1S;KIF13B;KIF2A;HOOK2;RAE1;ALMS1;PLK1;VAPA;MAST2;EML3;FAM161A;TPGS1;TPX2;GAPDH;MAPRE2;CFAP157;MACO1;FMN1;CAMSAP2;FBXW11;FGF13;KIF5B;RMDN2;KIF16B;KIF27;FMR1;TUBGCP4;NDEL1;TOGARAM1;MAP4;FSD1;KIF5A;KIF9;TPPP;KIF20A;CKAP5;CLIP3
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3530988264980561,0.8774678586227276,0.6121919584954605,0.9208299028173123,1.0,11/27,23.21%,TERT;CRCP;POLR3A;POLR1B;POLRMT;POLR2L;POLR3K;POLR1D;MED21;POLR1A;POLR2D
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.35750522900307935,0.8769532893595652,0.6294820717131474,0.9191319246247742,1.0,12/27,24.09%,RNF144A;SIAH2;DCUN1D1;ARIH1;RNF19B;ZMYM2;ARIH2;DCUN1D5;RNF14;UBE3D;RNF144B;RNF217
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3121136032584887,0.8762904936481378,0.6736958934517203,0.9177636604643542,1.0,10/72,10.66%,SVIL;MYO1B;SLC9A1;MARK1;SESTD1;TIRAP;MAPKAP1;SNX18;EXOC1;VILL
prerank,C-C chemokine binding (GO:0019957),0.3658741140259719,0.8749127032026265,0.6557823129251701,0.9176082132064842,1.0,2/22,8.99%,CCR1;CXCR4
prerank,small GTPase binding (GO:0031267),0.287923882557868,0.8737068988098032,0.7191358024691358,0.9173123165447905,1.0,36/169,16.92%,ABCA1;MLPH;LRRK2;MYCBP2;RAPGEF4;FGD4;MYO5A;RABGAP1L;UNC13D;EXOC4;ABI2;MAPKAP1;GOLGA5;CHML;RABGAP1;TRIP11;RAB3GAP2;ANKFY1;BRK1;PIH1D2;FGD6;PDE6D;AKAP13;SPHK2;RAB3GAP1;ANKRD27;YBX3;RAB34;RANBP9;RTKN;RABGGTB;EXOC5;ALS2;RCC1;CCDC186;TBC1D20
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.35920421367440714,0.8729287880315871,0.6388888888888888,0.9160071527971198,1.0,4/24,12.34%,ITPKC;DTYMK;IP6K2;AK8
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.34088232376237343,-0.8723654752564343,0.6081871345029239,0.9376644122954753,1.0,3/13,14.31%,LPCAT2;AGPAT3;GPAT4
prerank,histone deacetylase binding (GO:0042826),0.3040472526526238,0.871779039930243,0.687292817679558,0.9155661936208858,1.0,22/88,19.93%,NCOR2;GLI3;SATB2;KCTD21;MIER2;USF1;ZMYND15;HDAC1;PRDM1;MTA2;TOP2B;LCOR;SPI1;DACT1;NIPBL;MTA3;YWHAE;RAD9A;HDAC5;BRMS1L;THAP7;KPNA2
prerank,aspartic-type peptidase activity (GO:0070001),0.4258559575158779,0.8715525277028306,0.6289808917197452,0.9133626070324803,1.0,2/10,13.92%,CTSD;PSEN1
prerank,wide pore channel activity (GO:0022829),0.3631980297736534,0.8681495938494435,0.6496551724137931,0.9169141302976391,1.0,3/23,7.90%,GJC2;GJD3;GJC1
prerank,chemokine binding (GO:0019956),0.3447374951366115,0.8657813712732377,0.6512226512226512,0.9185644167596609,1.0,4/30,12.48%,CCR1;CXCR4;PDPN;FGF2
prerank,vitamin D receptor binding (GO:0042809),0.4085948109698337,0.8628405279122544,0.6434108527131783,0.9209561791197812,1.0,6/14,22.53%,TAF7;MED13;THRAP3;MED12;MED1;MED14
prerank,FAD binding (GO:0071949),0.35315634495679604,0.8620285680481575,0.6450742240215924,0.9197667561860734,1.0,2/24,3.82%,STEAP4;MTHFR
prerank,ribonuclease activity (GO:0004540),0.31171951580223695,0.8596098336407634,0.6740654205607477,0.9215305641803538,1.0,18/56,24.18%,ERN2;RNASE7;SMG6;EXOSC4;RNASEH1;DICER1;SND1;RNASEH2A;RNASE1;RNASE12;AGO2;ZC3H12B;ZC3H12A;EXOSC5;RNASE3;RNASEL;CPSF3;AGO1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.39792422264394484,0.8586152559262792,0.6350148367952523,0.920722433538521,1.0,2/14,3.82%,CRYM;MTHFR
prerank,potassium ion antiporter activity (GO:0022821),0.382303128883217,0.8570372934759549,0.617339312406577,0.9209016692611449,1.0,3/15,7.91%,SLC9A1;SLC24A5;SLC9A8
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2794975037253822,0.8549866957177332,0.7967644084934277,0.9218044352715072,1.0,48/248,17.54%,RND3;RHOJ;LRRK2;DNA2;RAB2A;KIF1C;MYH9;KIF2A;NUGGC;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB8B;RAB7A;RRAGC;RAB9A;RAB32;RAB27B;GBP7;RERG;GNAI1;RIT1;RUVBL1;RNF213;ATP2B1;RHOA;RASD2;ENTPD7;ABCG4;RAB1A;DYNC2H1;GNAS;MYO1E;RAC1;GSPT1;RHOF;GPR88;GNB2;DHX29;GNA12;KIF5A;TPPP;RAB33B
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.32801800878448334,-0.8547553819121723,0.650887573964497,0.9700907136779215,1.0,2/12,7.53%,ENTPD1;SLC25A42
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4146054338946888,0.8532388436041105,0.639751552795031,0.9224000299730005,1.0,1/10,2.07%,B4GALT5
prerank,potassium:proton antiporter activity (GO:0015386),0.4089236820496398,0.8530812429382715,0.6206896551724138,0.9201024300287322,1.0,2/10,7.91%,SLC9A1;SLC9A8
prerank,solute:sodium symporter activity (GO:0015370),0.3463666845125291,0.8527847317028554,0.650200267022697,0.9180318059570876,1.0,4/27,10.22%,SLC28A2;SLC20A1;SLC13A5;SLC4A7
prerank,store-operated calcium channel activity (GO:0015279),0.41304492376947893,0.8500131627591365,0.6479099678456591,0.9202848039212388,1.0,3/10,19.46%,TRPC6;ORAI1;STIM2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3032508004285793,-0.8487796264425153,0.6848484848484848,0.97631568337202,1.0,7/16,30.63%,MACROD2;CD38;SMUG1;SARM1;ADPRS;NEIL3;NTHL1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4176869252749059,0.8465344414693461,0.6650943396226415,0.9236452862695634,1.0,2/10,15.11%,NAA50;NAA15
prerank,mannosyltransferase activity (GO:0000030),-0.2836324732640745,-0.8464638280934011,0.7056737588652482,0.9748541329478104,1.0,6/21,25.84%,TMTC1;PIGB;PIGZ;ALG1;PIGM;ALG12
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.38573528871270013,0.8463455155525832,0.6409495548961425,0.9214265207446274,1.0,7/14,19.90%,PTEN;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.35319030699147946,0.8450857896385953,0.6732542819499341,0.9209900437022899,1.0,4/21,15.52%,POLE3;POLI;REV1;POLG
prerank,peptide hormone receptor binding (GO:0051428),-0.35044922486571706,-0.8443154301008806,0.6762177650429799,0.9727998986274384,1.0,8/11,55.72%,PTHLH;ADCYAP1;CCK;GNRH1;PSMC5;UCN2;GPHB5;GHRH
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.34445990231227624,0.8442834482498013,0.6787204450625869,0.9198266403547598,1.0,7/24,16.09%,SESTD1;OSBPL5;PLEKHF1;PLA2G4A;PLEKHA5;PLA2G4E;RUBCNL
prerank,tau protein binding (GO:0048156),0.3207105985990457,0.8440676162941078,0.7002457002457002,0.9177392189146678,1.0,4/40,3.78%,TAOK1;SMAD2;MARK1;APOE
prerank,endoribonuclease activity (GO:0004521),0.3358073214290221,0.8385608405122749,0.6861979166666666,0.9242519774897229,1.0,11/32,24.18%,ERN2;SMG6;DICER1;SND1;AGO2;ZC3H12B;ZC3H12A;ENDOV;RNASEL;CPSF3;AGO1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.3032757573984561,-0.8360830162852451,0.6877076411960132,0.9841399834512135,1.0,4/15,11.57%,ALDH1A1;ALDH4A1;ALDH2;ALDH9A1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.3240591743176429,0.8350963077248088,0.7007389162561576,0.9274857198119029,1.0,14/37,24.03%,YARS1;CARS2;IARS2;TARS1;RARS2;RARS1;EARS2;GARS1;LARS2;NARS2;FARS2;NARS1;CARS1;DARS1
prerank,5'-3' exonuclease activity (GO:0008409),0.37861278585377506,0.8342596413080369,0.6551724137931034,0.9263963634864882,1.0,4/14,14.89%,DCLRE1C;DCP2;XRN1;DXO
prerank,lysophospholipase activity (GO:0004622),0.35468846756331407,0.8328788932540696,0.6901408450704225,0.9260476161770662,1.0,6/20,19.58%,ASPG;ABHD16A;LYPLAL1;PLA2G4A;LYPLA2;GDPD3
prerank,FMN binding (GO:0010181),-0.33818779100680557,-0.8323661550999761,0.6866485013623979,0.9852480432435161,1.0,2/11,3.09%,NOS3;PPCDC
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3557899588637299,0.8316098413489378,0.6760752688172043,0.9255790395414109,1.0,6/21,14.67%,ARFGEF2;GSKIP;ACBD3;PJA2;AKAP9;AKAP1
prerank,methyl-CpG binding (GO:0008327),0.35136538556639996,0.8311911913200892,0.693029490616622,0.9237575874156397,1.0,8/22,23.63%,MBD2;MBD1;ZBTB38;CXXC5;LRWD1;MBD3;ZBTB33;PRMT5
prerank,GTPase activity (GO:0003924),0.27496205173700855,0.8311616298669243,0.8116683725690891,0.9213153887663418,1.0,35/192,17.54%,RND3;RHOJ;LRRK2;RAB2A;NUGGC;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB8B;RAB7A;RRAGC;RAB9A;RAB32;RAB27B;GBP7;RERG;GNAI1;RIT1;RHOA;RASD2;ENTPD7;RAB1A;GNAS;RAC1;GSPT1;RHOF;GNB2;GNA12;TPPP;RAB33B
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.3458238246864421,-0.8309096136899178,0.6694214876033058,0.9818142730760734,1.0,6/10,20.16%,ATXN3;STAMBP;DESI2;CYLD;YOD1;OTUD4
prerank,TBP-class protein binding (GO:0017025),-0.2727609704217736,-0.8308219757122965,0.7322033898305085,0.9753583187988465,1.0,5/21,10.20%,ESR1;PSMC1;DR1;TAF13;GTF2A2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.37699062605629247,0.829518737679415,0.6772334293948127,0.9214945008501116,1.0,4/14,13.10%,ACO1;ACO2;SDHB;IREB2
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.25626440056937694,-0.8267639101424603,0.7462121212121212,0.9771887161587479,1.0,9/27,19.38%,SLC9A2;SLC8A3;SLC9B2;SLC4A8;SLC9A6;SLC9A7;SLC8B1;SLC9A5;SLC8A2
prerank,phosphatidylglycerol binding (GO:1901611),0.3857656763546726,0.826674653722451,0.6827067669172933,0.9237773194153343,1.0,2/13,4.28%,STOML2;PLTP
prerank,ATP hydrolysis activity (GO:0140603),-0.23185107980818137,-0.82321902193321,0.7790055248618785,0.9777017364895486,1.0,10/41,16.01%,HSP90AA1;SMCHD1;ABCA4;VWA8;MYO18A;ABCA3;CHD1L;KIF26A;ABCB10;TOR1A
prerank,titin binding (GO:0031432),-0.31481751940312575,-0.8228511121013288,0.713855421686747,0.9719541092113525,1.0,2/13,2.77%,ACTN2;CALM1
prerank,insulin-like growth factor receptor binding (GO:0005159),0.3855441168601378,0.8217147477375208,0.6898148148148148,0.9291703726391508,1.0,3/12,14.17%,IRS1;PIK3R1;GNAS
prerank,GABA receptor binding (GO:0050811),0.39071979202857726,0.8211659651775723,0.6753670473083198,0.9276230199917295,1.0,2/11,4.47%,TRAK1;ARFGEF2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3308779538539097,0.8190680152682424,0.6861219195849546,0.9284729622911393,1.0,5/28,12.47%,POP1;RNASEH1;DICER1;RNASEH2A;POP4
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.30555239721155836,-0.8190524990988549,0.6932153392330384,0.9735033928825605,1.0,4/13,11.57%,ALDH1A1;ALDH4A1;ALDH2;ALDH9A1
prerank,calcium channel activity (GO:0005262),0.28299048334967014,0.8188050837728746,0.7529665587918015,0.9264490919228422,1.0,15/84,17.18%,CACNA1A;CACNA2D1;CACNA1C;CACNB1;PKD2;TRPC6;SLC24A5;TPCN2;SEC61A1;PSEN1;CATSPER3;TRPM4;ANXA6;PKD1L3;ORAI1
prerank,P-type ion transporter activity (GO:0015662),-0.3219778826645986,-0.8152737311396459,0.7257617728531855,0.9747364496669001,1.0,4/12,14.73%,ATP2B4;ATP2B2;ATP2A3;ATP6V1E1
prerank,ankyrin binding (GO:0030506),0.3433919089837751,0.8133688512132367,0.7136812411847673,0.9326548795139368,1.0,5/19,22.84%,FLNC;PTPRC;SPTBN1;SPTBN4;PLEC
prerank,guanyl ribonucleotide binding (GO:0032561),0.2668375461289539,0.8123708764501146,0.8361981799797775,0.9317713968728626,1.0,31/196,15.00%,RND3;RHOJ;LRRK2;RAB2A;TUBG1;RHOD;GNL1;RAB42;RALA;RAP2A;ATL2;RAB21;CDC42;RAB8B;RAB7A;RRAGC;PDE5A;RAB9A;RAB32;RAB27B;GBP7;RERG;ARF4;GNAI1;RIT1;RHOA;GNL3;RAB10;ARF1;RAC1;ANXA6
prerank,ribonuclease P RNA binding (GO:0033204),0.3969239653082208,0.811406851727239,0.6786833855799373,0.9308728262368865,1.0,2/10,12.47%,POP1;POP4
prerank,phosphatidic acid binding (GO:0070300),0.3504494975546038,0.8099676268785166,0.6855172413793104,0.9306470416177828,1.0,4/19,7.85%,MARK1;PLTP;SESTD1;MAPKAP1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3929462890903943,0.8083098651878513,0.7109737248840804,0.9307017175926668,1.0,2/11,15.11%,NAA50;NAA15
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.39016754086608896,0.8071693990995962,0.6829652996845426,0.9300108290108371,1.0,2/10,11.05%,SLC10A6;SLC10A1
prerank,tubulin binding (GO:0015631),0.2629311555645844,0.8047455639583027,0.8807615230460922,0.9311831182034934,1.0,60/295,19.51%,KIF26B;MID1;KIFC1;DLEC1;MAP4K4;TAOK1;CEP295NL;LRRK2;EML4;CCDC170;NAV3;KIF1C;MAP1S;KIF13B;KIF2A;HOOK2;INO80;RAE1;ALMS1;NCALD;PLK1;VAPA;MAST2;RABGAP1;EML3;FAM161A;TPGS1;TPX2;SETD2;GAPDH;MAPRE2;IFT81;CFAP157;AGTPBP1;MACO1;FMN1;FGF13;KIF5B;RMDN2;KIF16B;KIF27;FMR1;WASHC1;TUBGCP4;NDEL1;TOGARAM1;MAP4;FSD1;KIF5A;KIF9;TPPP;KIF20A;CKAP5;CLIP3;BCAS3;HAUS6;PRNP;TBCEL;CAMSAP1;HOOK1
prerank,calcium channel regulator activity (GO:0005246),-0.22854577285355898,-0.8046065985714248,0.7948717948717948,0.9886266526226528,1.0,8/37,15.15%,NRXN1;CALM1;NRXN2;MCUB;CACNG7;PACSIN3;STIM1;FKBP1A
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.3270393437714745,-0.8033744369407415,0.7364130434782609,0.9846727537463469,1.0,3/10,13.05%,PIK3R3;PIK3CB;PIK3CD
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.29183533399026557,-0.8000682522622621,0.7753424657534247,0.9845748396545598,1.0,3/16,11.25%,SLC13A3;SLC1A1;SLC25A12
prerank,phospholipase binding (GO:0043274),-0.3030661826556601,-0.7974659794894433,0.7478005865102639,0.9832127213232269,1.0,4/13,18.52%,PRKN;BLNK;DGKQ;SYK
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.3843285674641299,0.7971928187832453,0.7074303405572755,0.9375540151056941,1.0,3/11,16.70%,BAG3;HSPH1;BAG4
prerank,adenyl nucleotide binding (GO:0030554),0.3843285674641299,0.7971928187832453,0.7074303405572755,0.9375540151056941,1.0,3/11,16.70%,BAG3;HSPH1;BAG4
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3227086979233509,-0.7961527616594839,0.7015706806282722,0.9794851336001172,1.0,8/11,54.73%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.31521611722530707,-0.7957926551217448,0.7471910112359551,0.973896817419953,1.0,4/12,23.13%,CNOT8;CNOT6L;TOE1;NOCT
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.31144043132661675,0.7928375398790943,0.7287917737789203,0.9416726794220835,1.0,15/33,26.67%,RNF144A;SIAH2;DCUN1D1;ARIH1;RNF19B;TCERG1;ZMYM2;ARIH2;DCUN1D5;RNF14;UBE3D;RNF144B;RNF217;PPARA;RPS3
prerank,transaminase activity (GO:0008483),-0.31475256807397367,-0.7899928119785833,0.7692307692307693,0.9775720720596636,1.0,2/11,16.37%,ABAT;PSAT1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3226003738077261,0.7896461026860592,0.7187910643889619,0.9441202647478972,1.0,7/29,14.24%,SPRED1;CDKN2B;SPRED2;RPTOR;PRKAR1B;SPRY2;CDKN1B
prerank,ATPase regulator activity (GO:0060590),0.30420209933647685,0.789225064451577,0.7459526774595268,0.9423590473989446,1.0,9/38,18.43%,DNAJC1;DNAJB1;BAG3;FNIP1;DNAJB6;HSPH1;TOR1AIP2;BAG4;TOR1AIP1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.25892729177667884,-0.7887034685440804,0.7854785478547854,0.9737678942374719,1.0,12/22,37.28%,ATP6V1B2;ATP2A3;ATP6V1E1;ATP6V0B;ATP6V0E2;ATP6V0D1;ATP6V1A;ATP6V0C;ATP6V0A1;ATP6V0D2;ATP2C2;ATP6V0A4
prerank,MHC protein binding (GO:0042287),-0.26514405684826253,-0.7879909803046115,0.7986577181208053,0.968920058894179,1.0,5/20,28.95%,CD81;DERL1;TUBB4B;ABCB9;LAG3
prerank,GTPase inhibitor activity (GO:0005095),-0.2985902461383301,-0.7868127881055639,0.7277777777777777,0.9651366050053826,1.0,5/13,23.38%,CDC42SE1;GPS2;SLIT2;RHOH;ARL2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.33926551934934435,0.7859607614961889,0.7344173441734417,0.9447852302721449,1.0,2/18,8.79%,HSD17B8;HSD11B1
prerank,intracellular chloride channel activity (GO:0061778),-0.27894588653316904,-0.7850880714490943,0.7438271604938271,0.9566921677968491,1.0,8/16,33.22%,ANO3;ANO4;TTYH2;ANO1;ANO8;ANO2;ANO5;NMUR2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.27894588653316904,-0.7850880714490943,0.7438271604938271,0.9566921677968491,1.0,8/16,33.22%,ANO3;ANO4;TTYH2;ANO1;ANO8;ANO2;ANO5;NMUR2
prerank,RNA stem-loop binding (GO:0035613),0.3621848155979411,0.7835516619915057,0.7360248447204969,0.9458154059618139,1.0,5/12,21.08%,METTL16;FMR1;RC3H2;CSDE1;ZC3H12A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.3308303109784443,0.7818554054855367,0.7384196185286104,0.9459067086334715,1.0,4/23,10.87%,EDNRA;CCR1;CCL5;PLCB3
prerank,voltage-gated cation channel activity (GO:0022843),0.2704279535270204,0.7796304084867147,0.8128342245989305,0.9467335385658948,1.0,8/97,5.01%,CACNA1A;HVCN1;CACNA2D1;CACNA1C;CACNB1;KCNF1;KCNA5;PKD2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3141569961295294,0.7766675951010478,0.7578534031413613,0.9485683108797724,1.0,4/28,9.84%,LRRK2;MAP2K4;MAP2K1;RPS6KB1
prerank,sodium:proton antiporter activity (GO:0015385),0.3619353179084051,0.7764703400600478,0.7184615384615385,0.9464954264366637,1.0,2/11,7.91%,SLC9A1;SLC9A8
prerank,protein phosphatase 1 binding (GO:0008157),0.3326071900532537,0.77643873660153,0.7471590909090909,0.9441587164111158,1.0,3/21,13.49%,PPP1R9B;PPP1R16A;AKAP11
prerank,calcium channel inhibitor activity (GO:0019855),0.36439150577068397,0.7756518177147189,0.728414442700157,0.9429608239930573,1.0,3/11,13.64%,ITPR1;FKBP1B;CALM2
prerank,death receptor binding (GO:0005123),0.3538154850811319,0.7746784516038235,0.7462462462462462,0.9420111765917195,1.0,3/15,15.12%,CASP8AP2;EDA;RIPK1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.3321148376292469,0.7720074386054716,0.7223796033994334,0.9434172359760469,1.0,5/18,15.64%,BAIAP2;ANXA1;CNN3;RAB10;CDC42EP1
prerank,protein kinase activator activity (GO:0030295),0.28321201596687545,0.7717488180224423,0.7979334098737084,0.9414202990063338,1.0,13/60,16.20%,TAOK1;RICTOR;FAM20A;RPTOR;MAP2K1;TPX2;DBF4;SPRY2;FGF13;ABI1;CALM2;ALS2;STK4
prerank,ribonuclease P activity (GO:0004526),0.3673059751518899,0.7693510535211577,0.7293577981651376,0.9424566510785056,1.0,2/11,12.47%,POP1;POP4
prerank,actin monomer binding (GO:0003785),0.3199950486165853,0.7671631787867026,0.7682758620689655,0.9429405915903023,1.0,2/22,4.59%,MRTFA;LIMA1
prerank,RNA methyltransferase activity (GO:0008173),-0.2637300179819115,-0.7646692611600273,0.85,0.9840872808372783,1.0,8/19,28.82%,TRMT9B;TRDMT1;METTL4;LCMT2;TRMT5;TYW3;TRMT12;FBL
prerank,5'-nucleotidase activity (GO:0008253),-0.29549607107328,-0.7623952721814093,0.7840909090909091,0.98174429923337,1.0,5/13,21.28%,NT5E;NT5DC3;NT5C3A;NT5C;NT5C3B
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3029695021480898,0.76224507375695,0.7752956636005256,0.9476387079503347,1.0,7/32,12.31%,TMLHE;FTO;ALKBH5;HSPBAP1;ALKBH1;TET2;KDM2A
prerank,myosin V binding (GO:0031489),-0.2851430888231629,-0.7617202053312222,0.7956656346749226,0.9769937043972156,1.0,6/15,25.01%,RAB3C;RAB11B;RAB14;RAB39B;RAB3D;RAB3B
prerank,histone deacetylase activity (GO:0004407),-0.2644305724618417,-0.7610487854308239,0.8188405797101449,0.9722164642998838,1.0,3/19,5.69%,HDAC4;HDAC9;SUDS3
prerank,protein kinase C binding (GO:0005080),0.2859458923823919,0.7583351551735747,0.8080568720379147,0.9505733212310352,1.0,13/43,21.80%,IRS1;NELL1;PRKCSH;PRKD2;TIRAP;TOP2B;DACT1;SQSTM1;PLEK;HDAC5;ADAM9;HINT1;PKN1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.32802331102274096,0.7579250525823142,0.7702888583218707,0.9488237427781816,1.0,3/20,7.16%,USP9X;OTULINL;EIF3H
prerank,endodeoxyribonuclease activity (GO:0004520),0.3221059893356187,0.7564513319347823,0.7776203966005666,0.9485747878025618,1.0,7/20,23.01%,DNA2;DCLRE1C;SETMAR;RBBP8;MBD4;ZRANB3;ENDOV
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3097395928688463,-0.7561585369474808,0.7875647668393783,0.974025066332908,1.0,4/10,13.46%,BRCA2;EP300;HAT1;NAA60
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.3359656429604052,0.7558703242264196,0.7666666666666667,0.9470180580004349,1.0,8/16,19.90%,PTEN;SACM1L;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.36251986097236977,0.7541019821218166,0.7550387596899225,0.9470523921077579,1.0,2/11,11.72%,PABIR1;PPP1R2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.2771815754180869,0.7530868191461692,0.7941888619854721,0.9462234780570153,1.0,9/49,15.26%,PDXP;PLCXD3;DUSP5;EPHX2;PTPRJ;PPP1CB;DUSP28;SACM1L;SMPDL3B
prerank,telomeric DNA binding (GO:0042162),0.2988139956347168,0.7524383489621085,0.7924050632911392,0.9448025069396209,1.0,13/32,25.79%,SMG7;ZBTB48;TERT;SMG6;CTC1;KDM1A;TELO2;TERF1;RPA1;SMG5;TERF2IP;TERF2;HNRNPA2B1
prerank,sodium channel activity (GO:0005272),-0.21686123395640003,-0.7496219592137745,0.885,0.9778588087036274,1.0,11/37,27.72%,GRIK4;SCN2A;SCN8A;SCN9A;GRIK2;HCN1;SCN4B;CACNA1I;SHROOM2;SCN3A;PKD2L1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.3551706878327695,0.7480590064972378,0.7620481927710844,0.9483277140554665,1.0,6/12,23.91%,ACVR1;TGFBR1;LTBP1;ACVRL1;BMPR1A;BMPR2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.29601756340868834,-0.7464673475623211,0.7707736389684814,0.9766671313352983,1.0,6/12,33.18%,SLC25A42;SLC25A25;SLC17A9;SLC25A17;SLC25A24;SLC35B2
prerank,symporter activity (GO:0015293),0.375241702928922,0.7460208326998115,0.774671052631579,0.9487631182967645,1.0,1/10,3.05%,SLC28A2
prerank,general transcription initiation factor binding (GO:0140296),-0.2359690584893005,-0.7458716565495814,0.8407407407407408,0.9718201558603132,1.0,5/25,10.20%,ESR1;PSMC1;DR1;TAF13;GTF2A2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.33655701188058185,0.7458102077067568,0.7496360989810772,0.9467431804351456,1.0,3/14,21.28%,DTYMK;AK8;NME2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2645540267583,0.7430861633812039,0.8382352941176471,0.9478588634534182,1.0,13/69,18.64%,CERS6;ASPG;CREBBP;SOAT1;HHAT;PLA2G4A;ZDHHC6;ZDHHC9;NAA15;PLA2G4E;ZDHHC3;LPCAT3;KAT6B
prerank,nucleotidase activity (GO:0008252),-0.27485771341363435,-0.7425471877949179,0.8299120234604106,0.9706766042495839,1.0,5/15,21.28%,NT5E;NT5DC3;NT5C3A;NT5C;NT5C3B
prerank,BMP binding (GO:0036122),0.36254079839317094,0.7419653262997632,0.781591263650546,0.9469541721135445,1.0,11/11,63.77%,GREM2;BMPR2;GREM1;NBL1;SOST;GDF5;HJV;UCMA;TCAP;SOSTDC1;ENG
prerank,protein phosphatase activator activity (GO:0072542),0.34483161796863016,0.7384796470311434,0.7818181818181819,0.949074767354156,1.0,9/13,27.73%,PPP2R5A;CALM2;PTPA;PPP2R5C;PHACTR4;CALM3;PPP2R5E;PPP2R5D;B3GAT3
prerank,ATPase activator activity (GO:0001671),0.3157026122501217,0.7370667359890892,0.7910662824207493,0.9485981785806095,1.0,5/20,18.43%,DNAJC1;DNAJB1;DNAJB6;TOR1AIP2;TOR1AIP1
prerank,snoRNA binding (GO:0030515),0.2924913097932236,0.7343334750166614,0.8132147395171537,0.9497033359138792,1.0,15/30,30.71%,NOP14;NUDT4;BYSL;PRKDC;NUDT7;DHX37;BMS1;DDX21;TSR1;NOP56;NUDT5;UTP6;TBL3;NUFIP1;HEATR1
prerank,deubiquitinase activity (GO:0101005),0.25324824576855476,0.7282828599832014,0.8716814159292036,0.9549806406765701,1.0,23/88,21.08%,TNFAIP3;USP9X;EIF3H;MINDY3;USP42;USP24;USP12;OTUD3;USP40;USP38;USP3;TANK;MYSM1;USP22;VCPIP1;STAMBPL1;USP28;PSMD14;USP36;MINDY4;USP21;USP25;ZC3H12A
prerank,omega peptidase activity (GO:0008242),0.2517697797325807,0.725726891281344,0.8700440528634361,0.9558759505106919,1.0,19/89,16.78%,TNFAIP3;USP9X;MINDY3;USP42;USP24;USP12;OTUD3;USP40;USP38;USP3;TANK;MYSM1;USP22;VCPIP1;STAMBPL1;GGT7;USP28;GGH;PSMD14
prerank,voltage-gated chloride channel activity (GO:0005247),-0.29579215559655936,-0.7247084286177973,0.7972222222222223,0.9887455053888208,1.0,3/10,16.94%,CLCN2;CLCN3;ANO1
prerank,exoribonuclease activity (GO:0004532),-0.29190308560572265,-0.7245937791788255,0.8284883720930233,0.9832980960201083,1.0,5/12,22.00%,EXOSC7;EXOSC8;EXOSC3;EXOSC1;EXOSC10
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.33006416335428956,0.7245498595926664,0.7689969604863222,0.9549918477603851,1.0,2/12,7.91%,SLC9A1;SLC9A8
prerank,glycine binding (GO:0016594),0.34730887965927165,0.7219235566311674,0.7911908646003263,0.9559961030120933,1.0,2/11,6.35%,GLRB;GLDC
prerank,phosphatidylinositol kinase activity (GO:0052742),0.3250127640393309,0.7215201134921178,0.7903930131004366,0.9542545823723417,1.0,4/15,16.47%,PI4K2B;ATM;PI4KA;PIK3C3
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.29767776315155847,-0.720031951132857,0.8253521126760563,0.9834625007272562,1.0,6/11,33.18%,SLC25A42;SLC25A25;SLC17A9;SLC25A17;SLC25A24;SLC35B2
prerank,actin binding (GO:0003779),0.23611861553815686,0.7191112016821397,0.934020618556701,0.954937776132133,1.0,27/170,13.76%,SLC6A2;MRTFA;MLPH;LRRK2;SYNPO;CALD1;FSCN1;MYH9;PARVA;MAP1S;LIMA1;NCALD;FHL3;ADD2;TMOD1;PDLIM4;LCP1;CXCR4;DBN1;SSH1;PTK2;DBNL;UTRN;GIPC1;SSH2;MAEA;PLEKHH2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.34864749102278025,0.7136776963220741,0.803486529318542,0.9592275329718774,1.0,4/10,14.92%,EHMT1;SETDB1;SETDB2;ASH1L
prerank,fibroblast growth factor binding (GO:0017134),-0.24412869432699452,-0.7102501125596945,0.8664495114006515,0.9893079684837648,1.0,7/21,22.81%,FGFR2;THBS1;FGFR4;KL;GPC1;RPS19;FGFBP3
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3110311245986813,0.7089017410466194,0.8314606741573034,0.9624925211405634,1.0,4/19,13.22%,CCL5;EGF;EFNA5;ABI1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.279304688757975,0.7086661943408031,0.835427135678392,0.9605261614253738,1.0,10/34,22.02%,UBE2F;UBE2L3;UBE2R2;UBE2J1;UBE2K;UBE2W;UBE2Q1;UBE2E1;UBE2Z;UBE2L6
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.28420595332217413,-0.7066501891091302,0.8491048593350383,0.9879496247487285,1.0,2/10,10.15%,PHF8;RIOX2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.2906474379561222,-0.7059608072019481,0.8114754098360656,0.9831114891013837,1.0,4/10,23.65%,DCLRE1A;MGME1;DCLRE1B;TATDN1
prerank,kinesin binding (GO:0019894),0.2870389021713276,0.703783248061037,0.8425692695214105,0.9639611897773603,1.0,2/27,6.19%,NEK6;IFT88
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.2968713366162421,0.7029451757471035,0.8283378746594006,0.958184566423624,1.0,4/22,13.82%,HTR1D;HRH4;HRH1;HRH3
prerank,G protein-coupled amine receptor activity (GO:0008227),0.2968713366162421,0.7029451757471035,0.8283378746594006,0.958184566423624,1.0,4/22,13.82%,HTR1D;HRH4;HRH1;HRH3
prerank,serotonin receptor activity (GO:0099589),0.2968713366162421,0.7029451757471035,0.8283378746594006,0.958184566423624,1.0,4/22,13.82%,HTR1D;HRH4;HRH1;HRH3
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2451421544544012,0.7013571925767685,0.9049217002237137,0.957759845354342,1.0,17/83,16.78%,TNFAIP3;USP9X;MINDY3;USP42;USP24;USP12;OTUD3;USP40;USP38;USP3;TANK;MYSM1;USP22;VCPIP1;STAMBPL1;USP28;PSMD14
prerank,metal ion:proton antiporter activity (GO:0051139),0.3172863859813766,0.7009949352003793,0.7857142857142857,0.9559655263636523,1.0,2/13,7.91%,SLC9A1;SLC9A8
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.260413994354717,-0.6997428166112104,0.8606811145510835,0.984648126889382,1.0,3/15,14.31%,LPCAT2;AGPAT3;GPAT4
prerank,histone demethylase activity (GO:0032452),0.2820701638881606,0.6992067163326616,0.8571428571428571,0.9556643790625017,1.0,9/27,26.60%,PHF2;KDM2A;FBXL19;KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.2843675271271113,0.6969169640774705,0.8369987063389392,0.9559955659178568,1.0,10/27,23.21%,CRCP;POLR3A;POLR1B;POLRMT;POLR2L;POLR3K;POLR1D;MED21;POLR1A;POLR2D
prerank,phosphatidate phosphatase activity (GO:0008195),-0.26394692465745967,-0.6966014601120072,0.8664596273291926,0.9828008142160539,1.0,7/13,43.75%,LPIN1;PLPPR4;PLPP5;PLPP2;LPIN3;PLPP4;LPIN2
prerank,adenylyltransferase activity (GO:0070566),-0.2250196576313093,-0.6964849631118223,0.8916967509025271,0.9775611785161291,1.0,4/21,16.25%,GPHN;NMNAT3;TUT1;OAS2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.32447851282897605,0.6919243566342363,0.8379629629629629,0.9591355323510752,1.0,2/12,10.07%,FXN;SDHB
prerank,carboxypeptidase activity (GO:0004180),-0.2057987277359269,-0.6907687399692845,0.940677966101695,0.9782559903135652,1.0,9/35,21.50%,CPD;CPE;FOLH1;MINDY1;CPM;NAALAD2;AGBL5;ACE2;VASH1
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.19669950480237836,-0.6869684135580972,0.9364406779661016,0.9770197420709942,1.0,10/34,23.13%,CNOT8;EXOSC7;CNOT6L;EXOSC3;ANGEL2;TOE1;ANGEL1;PDE12;EXOSC10;NOCT
prerank,CoA-ligase activity (GO:0016405),-0.25155431533222505,-0.6858271946300561,0.8872832369942196,0.9729392674187657,1.0,3/14,20.01%,ACSL1;ACSS1;ACSS2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.2707225773838779,-0.6856339454237385,0.8587257617728532,0.9679506394547354,1.0,2/12,11.02%,CYFIP2;DCPS
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3227826865017527,0.6846170885621911,0.8227060653188181,0.9649172153634031,1.0,4/11,20.43%,ALKBH1;HMCES;HMGA2;NEIL1
prerank,N-acyltransferase activity (GO:0016410),0.270811584028045,0.6844185665317852,0.8898963730569949,0.9629387963371547,1.0,2/32,4.17%,CERS6;NAA50
prerank,ribosomal small subunit binding (GO:0043024),0.3027392022264808,0.6831924419485581,0.8359712230215828,0.9620619147478929,1.0,4/17,16.97%,ABCE1;MTIF2;EIF1;DHX29
prerank,U6 snRNA binding (GO:0017070),-0.25801197481381116,-0.6827563376914015,0.8875379939209727,0.9656069266130493,1.0,5/14,23.76%,PRPF4;LARP7;TUT1;PRPF8;DDX39B
prerank,cation channel activity (GO:0005261),0.23499542774033735,0.6818833448990712,0.9282655246252677,0.9612273164874575,1.0,20/94,18.83%,HVCN1;KCNF1;PIEZO2;PKD2;TRPC6;SLC24A5;CALHM2;KCNK1;SEC61A1;PSEN1;UNC80;TRPM4;ANXA6;ANO10;KCNK9;PKD1L3;ORAI1;ANO6;PANX1;PIEZO1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.25404422396704107,0.6805557724267249,0.9020070838252656,0.9604495862606393,1.0,18/51,23.97%,SLC28A2;SLC20A1;SLC25A16;SLC7A8;SLC35C1;TMEM241;SLCO1B1;SLC35D2;SLCO4C1;SLC25A10;SLC28A3;SLC16A2;SLCO5A1;SLCO2B1;CLCN4;SLC25A3;SLCO4A1;SLC35E3
prerank,O-acyltransferase activity (GO:0008374),0.27147057853777945,0.6796678169187104,0.8711819389110226,0.9592005678882576,1.0,5/30,17.16%,PIGW;SOAT1;GPAT3;PLA2G4A;LPCAT3
prerank,dynactin binding (GO:0034452),-0.2655082898383287,-0.677118627218984,0.8662613981762918,0.9658417514898947,1.0,1/12,0.78%,BICD1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.28037993452289023,-0.6759158180936151,0.8587257617728532,0.9618991336379316,1.0,4/11,16.61%,SGMS1;SGMS2;AASDHPPT;PIGF
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3139882148312546,0.6749476230571965,0.8422619047619048,0.9618357250137678,1.0,3/12,20.33%,TENT5A;PAPOLG;TENT4A
prerank,calcium activated cation channel activity (GO:0005227),0.3005371725008283,0.6748082778329723,0.8461538461538461,0.9598612144588398,1.0,5/17,20.68%,KCNMB4;TRPM4;ANO10;ANO6;TMEM63B
prerank,DNA polymerase binding (GO:0070182),-0.23766180271674184,-0.674161403607664,0.8823529411764706,0.9582898948067683,1.0,4/18,14.10%,HSP90AA1;RTEL1;FANCI;PCNA
prerank,metallocarboxypeptidase activity (GO:0004181),-0.21130638127624762,-0.6717464588252661,0.920863309352518,0.9553723473451076,1.0,7/26,21.50%,CPD;CPE;FOLH1;CPM;AGBL5;ACE2;VASH1
prerank,ribosomal large subunit binding (GO:0043023),0.3230378103453116,0.6705152188441188,0.8412942989214176,0.9619462619706153,1.0,3/11,20.78%,NMD3;LTN1;NEMF
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.2957404785322665,0.6674182675088696,0.860655737704918,0.9628561407384802,1.0,1/18,2.96%,BIRC3
prerank,MAP kinase kinase kinase activity (GO:0004709),0.32132973912610086,0.6652510586663662,0.8679245283018868,0.9626909100436449,1.0,2/11,13.57%,EGFR;MAP3K6
prerank,SUMO transferase activity (GO:0019789),0.2979558853611114,0.6636325589207064,0.8588410104011887,0.9619680159658021,1.0,4/16,17.55%,PIAS2;NSMCE2;EGR2;MDM2
prerank,phospholipase A2 activity (GO:0004623),0.26943601380435106,0.6589003546193057,0.8686605981794538,0.9643742634712044,1.0,4/26,15.97%,PLA2G7;PLA2G12A;PLA2G4A;PLA2G4E
prerank,endonuclease activity (GO:0004519),0.24576778068574676,0.6588498295570071,0.9136253041362531,0.9622974554070406,1.0,14/49,24.18%,ERN2;SMG6;DICER1;SND1;SETMAR;PNKP;MBD4;AGO2;ZC3H12B;ZC3H12A;ZRANB3;RNASEL;CPSF3;AGO1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.29439124452940496,0.6565448400515957,0.86,0.9624195356398056,1.0,2/14,7.63%,USP9X;MINDY3
prerank,ion channel inhibitor activity (GO:0008200),0.2537707915580303,0.6564828188342797,0.9104665825977302,0.9603520065363613,1.0,7/35,16.40%,CAMK2D;ITPR1;FKBP1B;CALM2;KCNV1;NEDD4;RASA1
prerank,NF-kappaB binding (GO:0051059),0.27234775804674227,0.6563596356121961,0.868766404199475,0.9583597356073146,1.0,8/24,26.31%,PSMA6;HDAC1;GSK3B;COMMD7;NFKBIA;COMMD6;RELA;TAF4B
prerank,adrenergic receptor binding (GO:0031690),0.29257858553488514,0.6560271013981709,0.8653846153846154,0.9565867027533463,1.0,4/16,15.60%,DLG4;ARRDC3;GNAS;NEDD4
prerank,phosphatase activity (GO:0016791),0.22839673654340903,0.6390202119692451,0.9448198198198198,0.9693443507220124,1.0,9/73,13.66%,PDXP;DUSP5;EPHX2;NT5M;PTPRJ;PPP1CB;DUSP28;DUSP26;SACM1L
prerank,acid-thiol ligase activity (GO:0016878),-0.2463676797338967,-0.6389066899323796,0.927170868347339,0.9767194931799459,1.0,4/13,25.82%,ACSL1;ACSS1;ACSS2;AASDH
prerank,damaged DNA binding (GO:0003684),0.23976380390609908,0.6365443701136481,0.932934131736527,0.9693490572971026,1.0,9/44,20.29%,MPG;CREBBP;DCLRE1C;HMGB2;XRCC1;PNKP;DDB1;RBBP8;ERCC2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.23130692902731537,0.6331509156715925,0.9348079161816065,0.9700816542517615,1.0,6/54,9.69%,ASPG;MIER2;NADSYN1;NTAN1;HDAC1;PIGL
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.2464997014654989,-0.6328737137325892,0.9019607843137255,0.9759739054266664,1.0,6/12,37.12%,B3GALT2;B3GNT2;B3GNT3;B3GNT8;B4GAT1;B3GNT6
prerank,NADP binding (GO:0050661),0.24625867222076572,0.6307598078485228,0.9255455712451861,0.9699312906578818,1.0,11/32,23.49%,CRYM;GMDS;HSD11B1;KCNAB1;DPYD;DECR1;MTRR;DUS2;QDPR;NDOR1;SPR
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.25904601866319804,-0.6300595563851056,0.918918918918919,0.9725932039242372,1.0,5/11,27.59%,STN1;HNRNPA1;RAD50;RPA2;NABP2
prerank,acetyltransferase activity (GO:0016407),0.24787468244969857,0.6264969652153651,0.929778933680104,0.9712698873726584,1.0,5/31,18.64%,NAA50;CREBBP;NAT10;NAA15;KAT6B
prerank,NADPH binding (GO:0070402),0.2840228397882966,0.6200775518274474,0.891044776119403,0.9741061312099573,1.0,6/13,22.54%,KCNAB1;DECR1;MTRR;DUS2;QDPR;NDOR1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2449509528937885,0.6181581855493519,0.9225888324873096,0.9734195443954113,1.0,9/31,22.02%,UBE2L3;UBE2R2;UBE2J1;UBE2K;UBE2W;UBE2Q1;UBE2E1;UBE2Z;UBE2L6
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.29703087952246665,0.6145113728318499,0.9010819165378671,0.9739975786744284,1.0,4/11,23.63%,CARM1;PRMT3;NDUFAF7;PRMT5
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.24812775155413183,0.610270619729664,0.9375,0.9751014097947993,1.0,7/29,19.30%,HPSE;GAA;NEU3;GALC;NEU1;GANAB;MGAM
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.22157584708990674,-0.6097956284280893,0.944954128440367,0.9801023602071295,1.0,4/14,23.68%,MICAL1;NCF2;NOX1;CYB5R4
prerank,voltage-gated sodium channel activity (GO:0005248),0.255582278823545,0.6081993697662037,0.9282758620689655,0.9744999108323371,1.0,2/22,5.83%,PKD2;SCN7A
prerank,nuclear export signal receptor activity (GO:0005049),0.29066390833131917,0.6078931953855238,0.9040247678018576,0.9726554635722506,1.0,5/11,26.00%,XPO7;NUP214;XPO1;RANBP17;NUP42
prerank,Hsp90 protein binding (GO:0051879),0.23827135760458984,0.6074597928647238,0.9420103092783505,0.9708611149715679,1.0,8/33,19.70%,PPID;AHR;CYP1A1;CSNK2A1;HIF1A;NPAS2;NR3C1;TELO2
prerank,microtubule plus-end binding (GO:0051010),0.26204007149363806,0.6062945516892299,0.9236016371077762,0.9696242723352275,1.0,10/20,28.83%,MAPRE2;FBXW11;CLIP3;DST;CLIP4;CLASP2;CLASP1;PAFAH1B1;CLIP2;MAPRE1
prerank,transferrin receptor binding (GO:1990459),-0.24385558207866803,-0.6025943565719144,0.9206798866855525,0.9788667532033677,1.0,1/10,2.25%,CD81
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.20557991996017827,-0.5984576451338004,0.935064935064935,0.9759807753351156,1.0,10/18,34.39%,PIK3R3;PIK3R6;PIK3R2;SOCS7;SOCS2;SOCS3;CCKBR;AGAP2;SOCS1;CISH
prerank,nuclear import signal receptor activity (GO:0061608),0.2679680639703944,0.5983463249278912,0.9244186046511628,0.9729144748985845,1.0,4/15,23.08%,KPNA3;TNPO1;KPNA2;KPNB1
prerank,rRNA binding (GO:0019843),0.2252634713774564,0.5961408336711507,0.9600484261501211,0.9722340565526041,1.0,10/42,19.35%,ERI1;MTERF4;DDX28;GTF3A;RPL12;MRPS18A;RPL11;MDM2;RPS9;MRPS27
prerank,lipid phosphatase activity (GO:0042577),0.27679563703048715,0.595748668830246,0.9201741654571843,0.9704198793048405,1.0,1/14,4.96%,EPHX2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.26180550240658473,0.5946478151255913,0.9289772727272727,0.9690551126538965,1.0,2/17,12.34%,DTYMK;AK8
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.2769532619364623,0.5910987621753625,0.9244992295839753,0.9691734546239135,1.0,2/13,9.90%,METTL1;THUMPD3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.22795788395728736,0.585130526515553,0.9511568123393316,0.9707417795282162,1.0,4/33,11.16%,ERI1;EXOSC4;DCP2;XRN1
prerank,water transmembrane transporter activity (GO:0005372),0.27573007811675443,0.5761562436044667,0.9357945425361156,0.9739506829668751,1.0,1/11,11.38%,PDPN
prerank,acetylcholine receptor activity (GO:0015464),-0.18591609138309279,-0.5738052506270934,0.967741935483871,0.9822554242960079,1.0,1/22,1.10%,CHRM2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.254208535128468,0.573211125289614,0.948051948051948,0.9735430249518463,1.0,4/17,22.83%,ACOT13;ACOT9;THEM4;ACAA2
prerank,calcium-activated potassium channel activity (GO:0015269),-0.22461082043398128,-0.5552106198787389,0.946524064171123,0.984570171140989,1.0,8/11,42.96%,KCNN2;KCNN3;KCNMB2;PKD2L1;KCNN4;KCNN1;KCNU1;KCNMB1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.21184796213843748,0.5548571813810508,0.9781818181818182,0.9807575629425231,1.0,8/40,20.89%,ASMT;THUMPD3;DNMT3B;PCMT1;COMT;SETD3;THUMPD2;N6AMT1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.22450270367051114,-0.5522732785116709,0.9555555555555556,0.9807148054409282,1.0,7/10,47.46%,NCF2;NOX1;CYBA;NCF1;NOX3;NCF4;DUOX1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.25826403225567596,0.5519060465897134,0.9365325077399381,0.9800524949602133,1.0,3/12,21.39%,SPPL3;PSEN1;HM13
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.25721752764187705,0.5382387575463699,0.9494799405646359,0.983703628266747,1.0,3/11,17.85%,DCP2;NUDT4;NUDT7
prerank,MHC class I protein binding (GO:0042288),-0.2007532956685499,-0.5299075708727159,0.9641791044776119,0.9824556351048572,1.0,13/13,79.95%,DERL1;TUBB4B;ABCB9;LILRB1;ATP5F1B;TAP2;TUBB;PILRA;CD8A;TAPBP;CD8B;TAP1;ATP5F1A
prerank,tRNA binding (GO:0000049),0.1975185562537375,0.5159198816446938,0.9854368932038835,0.9898698367092484,1.0,9/43,20.78%,XPOT;AIMP1;TERT;ALKBH1;NAT10;ELP1;MRPS27;FARS2;NEMF
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.21143602452690902,0.5129111301690101,0.9692923898531375,0.9887851061106867,1.0,3/24,14.09%,CAMK2D;PHKA2;MKNK1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.22330351956844258,0.49034412346887885,0.9748148148148148,0.9929821479341766,1.0,3/15,13.29%,PIK3R5;SOCS5;PIK3R1
prerank,snRNA binding (GO:0017069),0.18771939908437216,0.48748120526811944,0.9963724304715841,0.9915531956216368,1.0,9/42,19.40%,NCBP2;SNRNP35;SNRPB2;RNPC3;PRPF31;CCNT1;LSM7;CDK9;EFTUD2
prerank,RNA cap binding (GO:0000339),0.21837533437287915,0.48407753560252065,0.9798270893371758,0.9903319626093234,1.0,2/16,10.14%,EIF4A1;NCBP2
prerank,microtubule minus-end binding (GO:0051011),0.21627472716665158,0.4664239701234708,0.9907834101382489,0.9917904283419794,1.0,3/13,19.33%,CAMSAP2;TUBGCP4;CAMSAP1
prerank,RNA polymerase binding (GO:0070063),0.16296570428979823,0.3756720913025537,0.9970887918486172,0.998786199005379,1.0,4/18,21.58%,CCNT1;NEDD4;TCERG1;PHRF1
